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ABSTRACT 
 
Superficial cancerous lesions are commonly treated through low energy X-ray or electron 
radiation in radiotherapy. The treatment units that produce the radiation are equipped with 
square, rectangular and round applicators of different sizes. These applicators attach to the 
treatment units and define the radiation field size applied during treatment. An applicator is 
chosen to fit the shape of the cancerous lesion on the patient as closely as possible. Since 
cancerous lesions are irregular in shape, there will always be an area of healthy tissue between 
the edge of the lesion and the edge of the standard field shape. This healthy tissue will be 
irradiated along with the lesion during treatment which is undesirable since the cancer wound 
heals through reparative growth of the surrounding healthy tissue after treatment. Traditional 
techniques that were developed to shield this healthy tissue and thus shape the radiation field 
to the shape of the lesion present various shortcomings. 
 
This study introduces a new thermal-spray process for producing radiation field shaping 
shields which overcomes most of the shortcomings encountered with the traditional field 
shaping techniques. Since none of the commercially available thermal-spray equipment could 
be used to produce field shaping shields, new thermal-spray equipment was designed and 
fabricated tailor made to the application. Different techniques to determine the contours of the 
treatment area on the patient were investigated. These included a patient contact technique 
using a plaster bandage impression and a non-contact technique using 3D laser scanning. 
From the plaster bandage impression a plaster model can be produced onto which a high 
density low melt material such as Wood’s alloy can be thermally sprayed to produce a field 
shaping mask. A model can also be produced from the 3D laser scanning data through laser 
sintering (LS) in nylon polyamide powder or through computer numerical controlled (CNC) 
milling in a block of low density polyurethane. The thermal-spray technique was evaluated by 
 v 
comparing the field shaping ability of radiation shields produced through the technique to the 
field shaping ability of shields produced through the traditional techniques. Radiographic film 
was used for this purpose and the results are presented in the form of isodensity charts. The 
required thicknesses of thermal-sprayed field shaping masks to shield radiation of various 
energies were also determined. The thicknesses were determined through radiation 
transmission measurements of known thicknesses of sprayed sheets of Wood’s alloy. X-ray 
imaging showed that there were no defects present within thermal-sprayed layers of Wood’s 
alloy that may negatively affect the shielding ability of masks produced through the 
technique. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UITTREKSEL 
 
 vi 
Oppervlakkige kankeragtige letsels word algemeen behandel deur middel van lae energie X-
straal of elektron bestraling in radioterapie. Die behandelingseenhede wat die bestraling 
produseer is toegerus met vierkantige, reghoekige en ronde toedieners van verskillende 
groottes. Hierdie toedieners koppel aan die behandelingseenhede en definieer die 
bestralingsveldgrootte wat toegedien word tydens behandeling. ‘n Toediener word gekies om 
die vorm van die kankerletsel op die pasiënt so goed as moontlik te pas. Aangesien 
kankeragtige letsels onreëlmatig in vorm is, sal daar altyd ‘n area van gesonde weefsel tussen 
die rand van die letsel en die rand van die standaard veldvorm wees. Hierdie gesonde weefsel 
sal saam met die letsel bestraal word wat ongewens is aangesien die kankerwond genees deur 
regenererende groei van die omliggende gesonde weefsel na behandeling. Tradisionele 
tegnieke wat ontwikkel is om hierdie gesonde weefsel af te skerm en dus die bestralingsveld 
te vorm volgens die vorm van die letsel het verskeie tekortkominge. 
 
Hierdie studie stel ‘n nuwe termiese-sproei proses bekend vir die vervaardiging van straling 
veldvormingskerms wat die meeste van die tekortkominge ondervind met die tradisionele 
veldvormingstegnieke oorkom. Aangesien geen van die kommersieel beskikbare termiese-
sproei toerusting gebruik kan word om straling veldvormingskerms te vervaardig nie, is nuwe 
termiese-sproei toerusting ontwerp en vervaardig wat pasgemaak is vir die toepassing. 
Verskillende tegnieke om die kontoere van die behandelingsarea op die pasiënt te bepaal is 
ondersoek. Dit sluit in ‘n pasiënt kontak metode deur gebruik te maak van ‘n gipsverband 
afdruk en ‘n nie-kontak metode deur gebruik te maak van 3D laserskandering. Van die 
gipsverband afdruk kan ‘n gips model vervaardig word waarop ‘n hoë digtheid lae smeltpunt 
materiaal soos Wood se allooi termies gesproei kan word om daardeur ‘n 
veldvormingsmasker te vervaardig. ‘n Model kan ook vervaardig word vanaf die 3D laser 
skanderingsdata deur laser-sintering (LS) in nylon poliamiede poeier of deur rekenaar 
numeries-beheerde (RNB) freesmasjinering in ‘n blok lae digtheid poliuretaan. Die termiese-
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sproei tegniek is geëvalueer deur die veldvormingsvermoë van stralingsafskerms vervaardig 
deur die tegniek te vergelyk met die veldvormingsvermoë van afskerms wat deur die 
tradisionele metodes vervaardig is. Radiografiese film is vir die doel gebruik en resultate 
word getoon in die vorm van iso-digtheidskaarte. Die nodige diktes van termies-gesproeide 
veldvormingsmaskers om straling van verskillende energië af te skerm is ook bepaal. Die 
diktes is bepaal deur stralingstransmissiemetings van bekende diktes van gesproeide plate van 
die allooi te neem. X-straalafbeelding het getoon dat daar geen defekte teenwoordig is in 
termies-gesproeide lae van Wood se allooi wat die afskermingseffek van maskers wat deur die 
tegniek vervaardig is negatief sal beïnvloed nie. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1  Foreword 
 
Skin and breast cancer have profound effects on the lives of many people everyday, not only 
physically but also emotionally. This project combines the study fields of engineering, 
radiotherapy and nuclear physics in an attempt to lend support in the ongoing fight against 
this crippling disease. 
 
1.2  Problem statement 
 
Superficial cancerous lesions are commonly treated by means of low energy X-ray or electron 
radiation in radiotherapy. The treatment units that produce the radiation are equipped with 
standard applicators of different sizes. These applicators attach to the treatment units and are 
used to define the treatment field sizes. An applicator is selected to fit the size of the lesion as 
closely as possible. The problem with the applicators is that those available are only able to 
produce square, rectangular or round field shapes while the lesions are irregular in shape. 
There will thus always be an area of healthy tissue between the edge of the lesion and the 
field’s edge that will be unnecessarily irradiated during treatment. This problem becomes 
even worse when the lesion is large and situated across a curved area of the patient’s body. 
Considering the fact that the treatment-end of the applicator that comes into contact with the 
patient’s body during treatment is flat, there could be a considerable stand-off between the 
applicator and the patient’s skin at the field’s edges. This is especially problematic with 
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electron treatments since the electrons scatter past the edges of the treatment field with a 
stand-off resulting in a larger area being irradiated than intended. Existing methods of shaping 
the radiation fields are either too time consuming or do not accurately shape the radiation 
fields according to the cancer affected areas. 
 
1.3  Hypothetical resolution 
 
Some of the problems with existing field shaping techniques for low energy radiation in 
radiotherapy can be resolved by producing field shaping masks by means of low temperature 
thermal-spray. The equipment necessary for thermal-spray can be fabricated from affordable 
components with available tools. 
 
1.4  Purpose of the study 
 
The purpose of the study is to develop the necessary equipment as well as work procedures in 
order to implement an improved field shaping technique for low energy radiation in 
radiotherapy. 
 
1.5  Importance of the study 
 
Radiation field shaping masks produced through the thermal-spray technique is likely to show 
improvement over the existing methods of shaping radiation fields in terms of accuracy and 
production time. Should the thermal-sprayed masks prove to be more successful, patients with 
superficial cancerous lesions will benefit through an improvement in the quality of treatment 
they receive. The technologists that will produce the masks will also benefit by saving time.  
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1.6  Methodology 
 
The methodology was as follows: 
 
a) Gather information on existing field shaping techniques for low energy radiation in 
radiotherapy. 
b) Gather information on existing thermal-spray equipment. 
c) Design and construct the necessary equipment for low temperature thermal-spray. 
d) Investigate what techniques could be used to determine the contours of the treatment 
area on the patient. 
e) Determine what techniques could be used to produce thermal-sprayed field shaping 
masks according to the gathered contour information. 
f) Evaluate the thermal-spray radiation field shaping technique through comparison with 
traditional field shaping techniques. 
g) Determine the mask thicknesses required for effective shielding of different radiation 
energies through measurements. 
h) Test thermal-sprayed masks for internal defects that may negatively influence the 
shielding ability of masks produced through the technique. 
 
The composition of the thesis is represented in Figure 1.1 through a flowchart. 
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Figure 1.1  Flowchart of the composition of the thesis 
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CHAPTER 2 
 
RADIOTHERAPY AND RADIATION PHYSICS 
 
2.1  Introduction 
 
The first patient with cancer was treated a mere four weeks after the publication of the 
momentous discovery of X-radiation by Wilhem Roentgen in 1895. Much progress has been 
made in the intervening time, but it is nonetheless humbling to recognize how far-seeing 
physicians and scientists at the turn of the century were to enlist the miracles of X-radiation in 
the battle against this most feared of human diseases [49, p. 1]. 
 
2.2  Radiotherapy 
 
This section presents the reader with a brief explanation of what cancer is and how ionizing 
radiation is used in the treatment of the disease. 
 
2.2.1  Normal and malignant growth 
 
Cancer can be described as a pathological variation of normal growth. The mechanism 
through which growth takes place is by division and multiplication of cells within the body. 
The rate of growth varies widely from the foetus where growth is very rapid then gradually 
diminishes until adulthood. Cells divide and multiply at different rates within different tissues 
in the body. The lining of the epithelium of the intestine and the epidermis of the skin are for 
instance replaced continuously. Other organs such as the liver and kidney have a much lower 
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replacement rate. Nerve and muscle cells are all present at birth and can never be replaced if 
damaged later in life. Cell division and multiplication are under strict control and only take 
place where cells need to be replaced during the normal functioning of the body or to repair 
damaged tissue. Malignant cells are under no such controlling constraints and as a result 
multiply without taking the needs of the body into consideration [51, p. 11]. Examples of this 
lost of control is shown through the negative effect skin and breast cancer have on patients as 
explained in Chapters 3 and 4. 
 
2.2.2  The biological effect of radiation on tissue 
 
Ionization¹ is produced in living cells whenever X-rays or other types of ionizing radiation are 
absorbed in the body during radiation treatment. This ionization causes physical and chemical 
changes within cells which will interfere with the functioning of the cells. Both normal and 
cancerous cells are affected alike by these changes. If the radiation damage to the cells is 
small they will recover and function normally. Extensive damage however will cause some of 
the cells to be killed outright. Others will only die later while attempting to divide. The time it 
takes before this happens depends on the cell’s growth rate. It may take only hours but then 
again it may not happen for days or weeks or even years. Because of the nature of cancer 
cells, ionization has a greater effect on them than it has on normal cells. After destruction of 
the cancer cells by irradiation, the wound heals by reparative growth of surrounding normal 
tissue. It is imperative that the radiation dosage (i.e. the amount of ionization) that is delivered 
to the growth does not exceed the tolerance of the surrounding normal tissue. 
 
 
___________________________________________________________________________ 
¹ The process of removing electrons from or adding electrons to neutral atoms thereby creating atoms with 
unbalanced electrical charges.  
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If this is the case, healing will not take place and the result will be a permanent necrosis. The 
aim of the radiation oncologist is to inflict the maximum damage on cancerous cells while 
retaining the reparative powers of the surrounding normal tissue [51,, p. 87]. 
 
2.2.3  Radiosensitivity of tissue 
 
Different types of cells and tissue reacts differently to a specified dose of radiation. Rapidly 
dividing cells will be seriously damaged by a dose which will have no obvious effect on cells 
with a slow rate of division. This resistance or vulnerability is referred to as sensitivity of 
tissue or growth and is of great importance in radiotherapy. Radiotherapy is possible only 
because most cancers are more radiosensitive than their surrounding tissue. The cancer cells 
can thus be lethally damaged by a dose of radiation which will weaken but not kill the 
surrounding normal tissue. If a cancerous growth has the same radiosensitivity as its 
surrounding tissue, radiotherapy will fail because a cancercidal dose would at the same time 
prohibit healing [51, p. 87]. 
 
2.2.4  Time and dose factors 
 
In planning radiation treatment, not only what amount of dose needs to be delivered to the 
tumour needs to be decided, but also how this dose should be distributed over time. It was 
initially thought that a single large dose would be optimal for cancers in general. Negative 
side effects such as poor cosmetic results and necrosis however soon led to the use of smaller 
repeated doses over a longer period of time. This technique, which came to be known as 
protracted fractionation, is better tolerated by tissue and takes advantage of the difference in 
radiosensitivity between cancerous and normal tissues. The effectiveness of this technique is 
graphically represented in Figure 2.1. 
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Figure 2.1  Schematic representation of a successful course of radiation treatment [51, p.80] 
 
The cell viability gap between the cancer cells and the normal cells widens because the cancer 
cells suffer progressive damage as the treatment course proceeds. Eventually all tumour cells 
are irreversibly damaged while the normal cells still have the ability to recover [51, p. 79]. 
 
2.3  Radiotherapy treatment options 
 
Today, there are various radiotherapy treatment options available for patients with malignant 
disease. These include the following: 
 
 External beam therapy: Radiotherapy that is applied from outside the body by X-ray, 
gamma ray, electron or neutron beams. 
 Intracavitary radiotherapy: Radioactive sources that are introduced into body cavities. 
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 Interstitial radiotherapy: Radioactive sources that are implanted into tissue. 
 Nuclear medicine: Radioactive fluids that are introduced into the body via a vein or 
into a cavity. 
 
The treatment that will be applied depends on the body site and type of cancer that affects the 
patient [51, p. 73]. For the purpose of this study only external beam radiotherapy, in particular 
X-ray and electron radiation will be described in detail. 
 
2.3.1  Production of low energy X-rays 
 
Low energy X-rays are produced by means of a special X-ray tube as shown in Figure 2.2.  
The tube consists of a cathode (negative electrode) and an anode (positive electrode), both 
sealed in an evacuated glass envelope. The cathode is a coiled tungsten filament while the 
anode consists of a small piece of tungsten (i.e. the target) mounted on a thick copper rod. If 
the tungsten filament is heated to a high temperature by passing an electrical current through 
it, electrons will be emitted from its surface. When a high voltage is applied between the 
anode and cathode, the electrons emitted from the filament will be accelerated towards the 
anode. Because the tube is evacuated to a high vacuum, the electrons do not collide with gas 
molecules between the cathode and anode and in this way acquire very high velocities. When 
the electrons are suddenly stopped in the tungsten target, X-rays are emitted [22, p. 37]. The 
X-rays pass through a beryllium window and emerges through a thin glass window in the tube 
envelope. 
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Figure 2.2  Schematic diagram of a therapy X-ray tube [23, p. 29] 
 
A large part of the energy carried by the electrons appears as heat in the anode which needs to 
be removed. This is achieved by conduction of heat from the target to the copper rod onto 
which it is mounted. The copper rod extends to the outside of the tube where it is cooled by 
oil. Secondary electrons are produced from the target when it is being bombarded by electrons 
from the cathode. 
 
 
 
Figure 2.3  A Philips Medical Systems™ RT 250 kilovolt unit 
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To prevent these stray electrons from hitting other non-target components in the tube, the 
anode needs to be hooded by a tungsten covered copper shield. The copper in the shield 
absorbs the stray electrons while the tungsten absorbs the unwanted X-rays produced in the 
copper. The cathode filament is mounted in a focussing cup, the purpose of which is to focus 
the emitted electrons onto the target in the smallest possible area. This area known as the focal 
spot needs to be kept small in order to produce a sharply defined radiation field [23, p. 28]. X-
ray tubes used for diagnostic work operate in the 80 kV range while those used for 
radiotherapy purposes can produce X-rays in the so called orthovoltage range of 100–250 kV. 
These low energy X-ray machines used in radiotherapy are also referred to as kilovolt units, 
an example of which is shown in Figure 2.3. A selection of applicators is available for these 
machines to collimate the radiation beam to different treatment field sizes. Additional field 
shaping is possible by shielding the area surrounding the tumour with lead sheet placed 
directly on the patient’s skin. Kilovolt units can be used to treat most superficial cancerous 
lesions, especially skin cancers. These machines are however now replaced with linear 
electron accelerators in most cancer departments that are able to provide a variety of treatment 
options [23, p. 38]. 
 
2.3.2  Production of high energy X-rays and electrons 
 
High energy X-ray and electron beams as produced by a linear electron accelerator can be 
used to treat both superficial and deep-seated tumours. The principles of operation of a linear 
electron accelerator (shortened to linac) are explained with reference to Figures 2.4 and 2.5. 
Negative polarity pulses are applied simultaneously to the cathode of a magnetron and an 
electron gun as shown in the diagram. The magnetron generates pulses of radio frequency 
(RF) waves at a nominal frequency of 2856 MHz. This RF power is fed through a rectangular  
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waveguide and is launched into the linear accelerator waveguide by a mode transformer. At 
the same instant, a pulse of electrons from the electron gun is injected into the accelerator 
waveguide, entering it with a velocity of about 0.4 times the velocity of light. The phase 
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velocity of the RF wave at the accelerator input is reduced to this electron velocity, so that 
some electrons are captured by each wave and accelerated by it [40, p. 8-5]. The accelerator 
waveguide consists of a cylindrical copper structure with copper irises inserted along its 
length at defined intervals to form a series of cavities. Each iris has a circular aperture through 
which the electrons injected by the electron gun can pass [18, p. 24]. The RF travelling waves 
have an axial component of electric field from which the electrons gain energy. The wave 
velocity and the amount of energy transferred to the electrons are governed principally by the 
accelerating guide radius and the iris apertures. Electrons injected into the accelerator 
waveguide increase in energy from 38 kV to 52 kV (depending on the machine’s mode of 
operation) to their final energy of 4 MeV to 25 MeV. In the first part of the accelerator 
waveguide the electrons captured by the RF travelling waves are formed into electron bunches 
near the peaks of the waves. 
 
 
 
Figure 2.5  An Elekta™ SL 25 linear electron accelerator 
These electron bunches are rapidly accelerated to near the velocity of light. In the rest of the 
accelerator waveguide the electron velocity remains approximately constant at this level. In 
order to overcome defocusing effects on the electron beam during acceleration, a static axial 
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magnetic field is applied to the accelerator by means of a series of focus coils placed at 
intervals along its length. Compensation for deviation of the electron beam from the axis is 
provided by two sets of centring coils sited near each end of the accelerator [40, p. 12-4]. The 
travelling waves propagated down the accelerator waveguide transfer some power to the 
electron beam and some to the waveguide walls. Surplus RF power at the accelerator output is 
extracted by a mode transformer and absorbed by a RF load. High power machines employ 
feedback to recirculate unused output RF power to the waveguide input. Recirculated RF 
power is combined with the magnetron input power through a directional coupler to give an 
increased power flux into the accelerator. The correct phasing of the feedback RF for power 
recombination is set by a high-power phase-shifter in the feedback waveguide loop. The 
rectangular waveguide between the magnetron and the accelerator waveguide is pressurized 
with dielectric gas to prevent RF breakdown at the power levels used. Two ion pumps 
connected to the input and output ends of the accelerator waveguide maintain a high vacuum 
within the waveguide to facilitate electron acceleration [18, p. 48]. The rectangular and 
accelerator waveguides are separated by two RF windows situated in the input and output 
rectangular waveguide feeds. 
 
On emerging from the accelerator waveguide the high-energy electrons pass into a flight tube 
which is connected to the waveguide via a bellows section. The flight tube passes through an 
achromatic triple-magnet beam bending assembly. Under the influence of the magnetic fields, 
the electron beam is deflected through various angles until it finally emerges at the target 
assembly area at the flight tube exit. The bellows section allows the entire flight tube and 
target assembly to be moved by a motorized drive so that either a target (X-ray mode) or an 
electron window (electron mode) is presented to the electron beam. In the X-ray mode the 
electrons are stopped by a high density metal target (e.g. tungsten). Some of the electron 
energy is converted into a symmetrical X-ray beam with the maximum intensity of radiation 
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directed forward in the same direction as the incident electrons. In the electron mode the beam 
passes centrally through a thin metal foil window. Beyond the target assembly the X-ray or 
electron beam passes into the radiation head. By the action of flattening filters in the radiation 
head, the X-ray beam becomes even or commonly referred to as “flat” in the treatment plane. 
The electron beam is scattered by a dual-foil filter arrangement to provide a uniform treatment 
beam [40, p. 12-1]. A beam-limiting device (i.e. the collimator) and adjustable diaphragms are 
used to define the X-ray field sizes. The four diaphragms can be moved independent of each 
other making possible asymmetric arrangements about the beam axis to provide offset as well 
as symmetrical treatment fields. Electron applicators can be attached to the radiation head to 
assist in the definition of the electron irradiation fields. Two ionization-chambers are mounted 
below the flattening and scattering filters in the radiation head. The ionization-chambers form 
part of a two-channel dosimetry system that monitors the radiation beam. The ionization-
chamber assembly also monitors the radiation field flatness by providing data signals to the 
beam control system [40, p. 12-2]. Mounted in the radiation head is a light source that projects 
a light field that corresponds exactly with the radiation field. This field light also projects a 
cross wire that represents the centre of rotation of the radiation head. The field light is used 
during patient set-ups to show the treatment field’s centre and borders. Linacs are able to 
produce X-rays in the so called megavoltage range of 4-20 MV while electrons are available 
from 4-25 MeV. 
 
 
2.3.2.1  Linear electron accelerator design features 
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The layout of a modern linac is explained with reference to Figure 2.6. The waveguide 
assemblies, magnetron, etc. as described in the previous section are mounted on a large 
rotatable drum that is referred to as the gantry. 
 
 
 
Figure 2.6  Linear accelerator gantry and table movements [19, p. 91] 
 
Protruding from the front of the gantry is an arm containing the accelerator waveguide. The 
radiation head is attached to the outer end of this arm. It is possible to rotate the gantry 
through 360° so that treatment fields may be directed at the patient from any angle. It is also 
possible to rotate the radiation head through 360°. The axis of rotation of the radiation head is 
also the central axis of the radiation beam. If the axis of rotation of both the gantry and 
radiation head is extended they will intersect at a point in space known as the isocentre. The 
distance from the isocentre to the X-ray target in the radiation head is exactly 1 m. This 
distance is referred to as the source-to-axis distance (SAD). The treatment table rotates on a 
turntable mounted in the floor of the treatment room. The axis of rotation of the turntable also 
crosses the machine’s isocentre [19, p. 16]. If the isocentre is placed at the centre of a tumour, 
irrespective of the machine’ s angle, the radiation will always be directed at the tumour. 
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2.4  Radiation measurements and dosage for X-irradiation 
 
In radiotherapy the amount and distribution of radiation dosage is crucial to the success or 
failure of treatment. As described in section 2.2.2, the very purpose of radiotherapy is to do 
maximum damage to the volume containing the cancerous tissues without inflicting excessive 
damage on the healthy tissue surrounding it. Radiation dose and distribution is an exact 
science that requires the expertise of a physicist, who is considered an essential member of a 
radiotherapy department. Dose distribution and the amount of radiation required for treatment 
pertaining to X-irradiation will be discussed next: 
 
2.4.1  Radiation dose distribution 
 
The dose distribution from an external radiation beam within a medium can be described by 
two methods namely: Central axis depth-dose distribution and isodose distribution.  
 
2.4.1.1  Central axis depth-dose distribution 
 
When a beam of ionizing radiation penetrates a patient, the absorbed dose varies with depth 
within the tissue. Of particular importance in dose calculation is to establish the depth-dose 
variation along the central axis of the beam. For this purpose dose measurements are made at 
different depths in a water phantom (i.e. a water bath) with a device that measures ionization 
known as an ionization chamber. Water is used for these measurements since it closely 
approximates the radiation absorption and scattering properties of muscle and other soft 
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tissues. The variation in depth-dose along the central axis of the beam may be characterized 
by the percentage depth-dose. This concept is explained with reference to Figure 2.7. 
 
WATER PHANTOM
RADIATION BEAM
do
d
Ddo
Dd
WATER SURFACE
 
 
Figure  2.7  Water phantom setup to determine percentage depth-dose [23, p. 162] 
 
Percentage depth-dose may be defined as “the quotient, expressed as a percentage, of the 
absorbed dose D(d) at any depth (d) to the absorbed dose D(do) at a fixed reference depth 
(do), along the central axis of the beam” [23, p. 161].  Percentage depth-dose P(d) is thus: 
 
  100%x 
)(
)(
doD
dD
dP        (2.1) 
 
For orthovoltage (up to 400 kV) and lower-energy X-rays, the reference depth is usually 
taken as the water surface (do = 0). For higher radiation energies, the reference depth is taken 
as the position of the peak absorbed dose (do = dm). This peak absorbed dose is called 
maximum dose or simply D
max
. 
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 
100% x 
)(
max
dP
dD
D        (2.2) 
 
Central axis depth-dose distribution depends on various factors including beam energy, field 
size and source-to-surface distance. These factors will be discussed next: 
 
a)  Beam energy 
 
The percentage depth-dose (at depths greater than maximum dose) increases with beam 
energy. Radiation beams with higher-energy have greater penetrating power and thus deliver 
a higher percentage depth-dose. This effect is graphically illustrated in Figure 2.8. 
 
 
Figure 2.8  Central axis depth-dose distribution for different energy photon beams 
[23, p. 163] 
The percentage depth-dose decreases with depth beyond the depth of maximum dose as can 
be seen in Figure 2.8 [23, p. 163]. There is however a build up of dose before the depth of 
maximum dose which becomes more pronounced as the energy is increased. For orthovoltage 
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the dose builds up to a maximum on or very close to the surface while for higher-energy 
beams the point of maximum dose lies deeper. The region between the surface and point of 
maximum dose on the graphs is referred to as the dose build-up region. For higher-energy 
beams such as produced by linacs, the surface dose is much lower than the maximum dose. 
This offers a great advantage over the lower energy beams where maximum dose occurs at 
the skin surface. A much higher dose can thus be delivered to a deep-seated tumour with a 
high-energy X-ray (photon) beam without exceeding the tolerance of the skin. This advantage 
of high-energy beams is clinically known as the skin-sparing effect [23, p. 162]. 
 
b)  Field size 
 
Radiation field size may either be specified geometrically or dosimetrically. The geometric 
field size is defined as “the projection, on a plane perpendicular to the beam axis, of the distal 
end of the collimator as seen from the front centre of the source” [23, p. 164]. The dosimetric 
or physical field size is defined as “the distance intercepted by a given isodose curve² 
(usually 50% isodose) on a plane perpendicular to the beam axis at a stated distance from the 
source” [23, p. 164]. In this research, unless stated otherwise, field size refers to geometric 
field size. It will also be defined at a predetermined distance such as source-to-skin distance 
(SSD) or source-to-axis distance (SAD). The SAD is the distance from the source to the 
isocenter on a linac. 
 
___________________________________________________________________________ 
² see section 2.4.2 
For a very small radiation field, the depth-dose at a point along the central axis of the beam is 
effectively the result of primary radiation. The contribution of scattered radiation to the 
depth-dose can be considered as insignificant. If however, the field size is increased the 
contribution of scattered radiation to the absorbed dose will also increase. The increase in 
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percentage depth-dose as a result of increase in field size depends on beam energy. With 
higher-energy beams that scatter more predominantly in the forward direction, the effect of 
field size on percentage depth-dose will be less pronounced than for lower energy beams 
[23, p. 164]. 
 
c)  Source-to-surface distance 
 
The dose rate emitted by a point source of radiation varies inversely as a square of the 
distance from the source. This statement is motivated with reference to Figure 2.9. 
 
 
SOURCE r1 r2
 
 
Figure 2.9  Radiation from a radioactive point source 
 
 
For explanation purposes a few assumptions need to be made: 
 
 Assume that the radiation originates from a point source. 
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 Assume that the radiation is isotropic; there will thus be the same amount of radiation 
in all directions from the source. The amount of radiation that penetrates any point on 
the surface of an imaginary sphere surrounding the source will be the same 
independent of the radius of the sphere. This is when the radiation is measured in a 
vacuum where there is no attenuation. 
 Assume that the total amount of energy emitted by the source per second (W) stays 
constant. 
 
Radiation intensity (I) can be defined as the energy that passes per unit time through a unit 
surface. From this follows: 
 
Radiation intensity at a distance r
1
:  
2
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1
4 r
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I

    (2.3) 
 
Radiation intensity at a distance r
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Equation (2.4) / Equation (2.3):  
2
2
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    (2.5) 
 
Substitute r
1
 = 1 in Equation (2.5):  
2
2
12
1
x
r
II                (2.6) 
 
 
Percentage depth-dose increases with SSD because of the effect of the inverse square law. 
Although the actual dose rate at a specific point decreases with an increase in distance from 
the source, the percentage depth-dose, which is a relative dose with respect to a reference 
point, increases with SSD. This statement is illustrated with reference to Figure 2.10. 
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Figure 2.10  Relative dose rate as inverse square law function of distance from a source 
 
In the diagram the relative dose rate from a point source of radiation is plotted as a function 
of distance from the source following the inverse square law. The plot shows that the drop in 
dose rate per unit interval between two points (P and Q) is much greater at smaller distances 
from the source than it is at large distances. 
 
From Figure 2.10 follows that: 
1
1
2
2
Q
P
Q
P
     (2.7) 
 
This means that the percentage depth-dose, which represents depth-dose relative to a 
reference point, decreases more rapidly closer to the source than further away from it. SSD is 
a very important parameter in clinical radiation therapy. Because percentage depth-dose 
determines how much dose can be delivered at a certain depth relative to the surface dose or 
D
max
, the SSD needs to be as large as possible. In practice however, since dose rate decreases 
with distance, the SSD is set at a distance which provides a compromise between dose rate 
and percentage depth-dose [23, p. 166]. 
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2.4.1.2  Isodose distribution 
 
Depth-dose distribution along the central axis of a radiation beam as described in 
section 2.4.1.1 is important for dose calculations. It is however insufficient to characterize a 
radiation beam that produces a dose distribution in a three-dimensional volume such as a 
human body. Variation in absorbed dose in a volume can be depicted by isodose curves 
which are lines passing through points of equal dose. These isodose curves are plotted at 
equal increments of absorbed dose and expressed as a percentage of the dose at a reference 
point. A series of isodose curves for a beam of radiation is referred to as an isodose chart. 
Standard isodose charts are drawn for each field size and radiation energy, examples of which 
are shown in Figure 2.11 [23, p. 204]. 
 
 
Figure 2.11  Comparison between isodose charts for (A) 200kV, (B) 4MV and (C) 10MV X-
rays at 10 x 10 cm² field size [23, p. 204] 
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These standard isodose charts are used by radiotherapy personnel in planning a patient’s 
treatment. Another way of depicting the dose variation across the treatment field is to plot 
isodose curves in a plane perpendicular to the central axis of the beam as shown in 
Figure 2.12. 
 
 
 
Figure 2.12  Cross-sectional isodose distribution in a plane perpendicular to the central axis 
of the treatment beam [23, p. 201] 
 
In this depiction the isodose values are normalized to 100% at the centre of the field 
[23, p. 201]. Some of the parameters that effect isodose curves are beam energy, source size, 
skin-to-source-distance (SSD), source-to-diaphragm distance (SDD), beam collimation and 
field size. These parameters will be discussed next: 
 
a)  Beam energy 
 
The central axis depth-dose distribution depends on beam energy as was explained in 
section 2.4.1.1a. The depth of a given isodose curve increases with an increase in beam 
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energy. This is because higher-energy beams, that have greater penetrative ability, produce a 
higher percentage depth-dose at a given depth. Beam energy also has an effect on the shape 
of isodose curves near the borders of the treatment field. Greater lateral scatter associated 
with lower-energy beams causes the isodose curves outside the field to bulge out as shown in 
Figure 2.11 A. The absorbed dose in the medium outside the primary beam is thus greater for 
low-energy beams than those for higher energies. Physical penumbra³ also depends on beam 
energy. The isodose curves outside the primary beam (e.g. 10% and 5%) are greatly distended 
in the case of the orthovoltage beam as is shown in Figure 2.11 A. This scattered dose to 
tissue outside the treatment region is one of the disadvantages of orthovoltage radiation. The 
scatter outside the field for megavolt beams is minimized as a result of predominantly 
forward scattering [23, p. 203]. 
 
b)  Source size, SSD and SDD 
 
Source size, SSD and SDD affect the shape of isodose curves at the treatment field’s edges 
through influencing the width of the geometric penumbra. SSD also affects the percentage 
depth-dose and therefore the depth of the isodose curves as was explained in 
section 2.4.1.1c). It is possible to distinguish between physical and geometrical penumbra. 
The physical penumbra can be defined as the lateral distance between two specified isodose 
curves (usually 20% and 80%) at a specified depth. The geometrical penumbra is explained 
with reference to Figure 2.13. 
 
 
 
___________________________________________________________________________ 
³ The penumbra is the region at the edge of the radiation beam over which dose rate changes rapidly as a 
function of distance from the beam axis [23, p. 53]. 
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Figure 2.13  Diagram for calculating geometric penumbra [23, p. 54] 
 
The geometric width of the penumbra (P
d
) at any depth (d) from the surface of a patient can 
be determined by considering similar triangles ABC and DEC. From geometry, we have: 
 
OM
OMFNOF
OM
MN
CB
CD
CA
CE
AB
DE 
    (2.8) 
 
If AB = s, the source diameter, OM = SDD, the source-to-diaphragm distance, OF = SSD, the 
source-to-surface distance, then from the previous equation, the penumbra (DE) at depth d is 
given by: 
 
 
SDD
SDDdSSDs
Pd

       (2.9) 
 
The penumbra at the surface can be calculated by substituting d = 0 in Equation 2.9. 
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As Equation 2.9 indicates, the penumbra width increases with increase in source diameter, 
SSD and depth but decreases with an increase in SDD. The dose variation across the field 
border is a complex function of geometric penumbra, lateral scatter and collimation. 
Therefore, the field sharpness at depth is not simply determined by the source or focal spot 
size [23, p. 203]. 
 
c)  Collimation 
 
The term collimation not only refers to the collimator blocks that give shape and size to the 
beam but also the flattening filter and other absorbers or scatterers in the beam between the 
source and the patient. Amongst these, the flattening filter has the greatest influence in 
determining the shape of isodose curves. This is especially the case with megavoltage X-ray 
beams where the isodose curves will have a conical shape without this filter. The beam will 
thus show increased X-ray intensity along its central axis and a rapid reduction transversely. 
Since the function of the flattening filter is to make the beam intensity distribution uniform 
across the field, the filter is made thickest in its middle and tapers off towards the edges. 
 
d)  Field size 
 
Field size is one of the most important parameters in treatment planning. For the tumour to be 
adequately covered dosimetrically, an appropriate field size needs to be determined. This 
decision on field size should always be made dosimetrically rather than geometrically. An 
isodose curve (e.g. 90%) that encloses the treatment volume should thus be used as a guide in 
choosing a field size rather than the geometric dimensions of the field. Care should be taken 
in using field sizes smaller than 6 cm since a large part of the field falls in the penumbra 
region. Depending on the source size, collimation and design of the flattening filter, the 
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isodose curves for small fields tend to be bell-shaped. Treatment planning with isodose 
curves should thus be considered mandatory for small field sizes [23, p. 205]. 
 
2.4.2  Radiation dose 
 
Just as the distribution of dose within the patient is important, so the amount of dose applied 
to the patient during treatment is of equal importance. The following section explains how 
radiation data are gathered, displayed and daily dose calculated. 
 
2.4.2.1  Commissioning tests for linacs 
 
Upon acquisition of a new linear electron accelerator, certain commissioning tests need to be 
undertaken on the machine before it may be used clinically. This includes the collection of 
beam data to provide sufficient information to accurately predict the outcome of all possible 
treatment procedures. Measurements also need to be done to compare the performance of the 
radiation beam with that specified by the manufacturer and national and international 
guidelines. The measurements that need to be done include radiation energy, beam symmetry 
and flatness and machine output. 
 
a)  Beam energy 
 
The nominal energy of the radiation beam is equal to the energy of the electron beam incident 
on the target. The beam specification is further defined in terms of the penetrating power of 
the X-rays produced [19, p. 66]. 
b)  Beam symmetry and flatness 
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To ensure that the dose delivered to the patient is constant across the radiation field, the 
profile of the beam should be flat in the plane which is parallel to the incident plane of the 
radiation field. The flatness of the beam is measured at right angles to the central axis, across 
the width and length of the field and across the diagonals for different field sizes. 
 
Figure 2.14  Diagram for showing beam flatness and symmetry [19, p. 66] 
 
Symmetry is the overall balance between the two halves of a radiation beam during treatment 
delivery as shown in Figure 2.14. The beam symmetry is constantly monitored by the built-in 
ionization chambers in the linacs radiation head [19, p. 66]. The tolerance for beam flatness 
and symmetry is 5% for large fields and 3% for fields < 10 x 10 cm². 
 
c)  Machine output 
 
The amount of radiation delivered by the treatment machine in a given time under treatment 
conditions is known as the output of the machine. The dose received by tissue is known as 
absorbed dose and gives an indication of the energy deposited in the body tissue from the 
radiation. The unit of absorbed dose is the gray (Gy) which is equivalent to an energy transfer 
of one joule per kilogram. The output is measured in monitor units (MU) per gray. This 
 31 
output measurement is standardised for a 10 x 10 cm² field size, where 100 monitor units 
delivers a dose of 1 Gy at the dose maximum point. With a decrease in field size, there will 
be less scatter in the irradiated medium and therefore it is necessary to give more monitor 
units to deliver 1 Gy. The reverse applies with an increase in field size. The output will also 
decrease with increasing treatment distance. 
 
2.4.2.2  Presentation of dosimetry data 
 
Variation in the measured machine data with changing field sizes is presented using a system 
of equivalent squares. This system is used to ease the presentation of the data and for dose 
calculation. The equivalent square of a given treatment field is the equivalent irradiated area 
to that if the treatment field were square. The equivalent square of any given field will 
produce equivalent scatter conditions to the given field. Thus, before dose calculation can be 
performed, it is necessary to find the equivalent square of the prescribed treatment field. 
Equivalent square data are available in look-up table format from where any rectangular field 
can be easily converted to an equivalent square field. 
 
2.4.2.3  Dose calculation 
 
A planning computer is required for complex treatment plans where multiple radiation beams 
are required to obtain the desired clinical results. It is however possible to calculate simple 
single beam treatments using central axis depth-dose data and machine output data. 
 
a)  Central axis depth-dose data 
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Central axis depth-dose data are necessary to find the percentage depth-dose delivered to the 
target volume under treatment conditions. These data are available in look-up table format 
and shows changes in central axis depth-dose with changing equivalent square and depth for 
each field-to-source distance (FSD) in common clinical use. 
 
b)  Machine output data 
 
Machine output data are necessary to calculate the monitor units needed to deliver the 
required dose under treatment conditions. Machine output varies with the equivalent square 
of the treatment field to be irradiated and the FSD at which the treatment is to be delivered. 
Output can be described by monitor units per gray. 
 
GyMUdoseGivenunitsMonitor /x                 (2.10) 
 
Machine output data are presented in look-up table format where output over a range of 
equivalent squares is given at a fixed FSD. 
 
2.4.2.4  Method for calculation dose for a single beam treatment 
 
For dose calculation, the percentage depth-dose delivered to the target volume as well as the 
monitor units required to deliver the specified dose must be determined. The dose and beam 
energy of the radiation to be received by the tumour, the number of treatments as well as the 
radiation field size to be used are specified by a radiation oncologist. Since percentage depth-
dose is affected by depth in tissue, beam energy and field size as described in section 2.4 it is 
necessary to determine the percentage depth-dose delivered under treatment conditions 
[19, p. 74]. This can be done using the following steps: 
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1. By making use of the equivalent square look-up tables, the equivalent square of the 
prescribed field size is found. 
2. The depth of the tumour in relation to the skin can be determined from a lateral X-ray 
film of the body. 
3. Using the depth-dose data provided for the prescribed beam energy, the percentage 
depth-dose delivered at the tumour depth can be found from the percentage depth-
dose look-up tables. 
 
The monitor units required to deliver the prescribed dose to the tumour can be determined by 
following the subsequent steps: 
 
1. Determine the total dose for the treatment by making use of the following equation: 
 
    100x 
dosedepthPercentage
Gydosetreatment Prescribed
GydosegivenTotal

   (2.11) 
 
 
2. The total dose for the treatment must be divided by the number of treatments to give 
the daily dose. 
3. Using the equivalent square, find the output for the treatment field from the output 
look-up table. 
4. Combine the output and the daily given dose by multiplying the daily dose with the 
output to give linac monitor units 
5. The calculated monitor units are applied daily to deliver the required tumour dose. 
2.5  Radiation measurements and dosage for electron radiation 
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Radiation dose distribution as described in sections 2.4.1 and 2.4.2 is explained with 
reference to X-ray irradiation. The dose distribution in a medium by an electron beam does 
however differ significantly from that of X-rays. Electron beams have certain unique features 
that make it the modality of choice for some treatments as will be explained next. 
 
2.5.1  Central axis depth-dose distribution 
 
The major advantage of electron beam irradiation lies in the shape of the percentage depth-
dose curve as shown in Figure 2.15 [23, p. 310]. 
 
 
 
 
Figure 2.15  Comparison between central axis percentage depth-dose curves for different 
energy electron beams [23, p. 310] 
 
The curves demonstrate a plateau of relatively even dose followed by a sharp dose fall-off 
beyond the 80% depth-dose. In terms of patient treatment, this means a homogeneous dose 
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can be delivered by a single beam to a defined depth of tissue with little dose received beyond 
that depth [19, p. 40]. The principal clinical applications for electron irradiation are: 
 
 treatment of skin cancer 
 chest wall irradiation for breast cancer 
 administering boost dose to nodes 
 treatment of head and neck cancers. 
 
The most useful treatment depth, or therapeutic range, of electrons is represented by the depth 
of the 90% depth-dose. Because the dose decreases abruptly beyond this dose level, the 
electron energy must be chosen carefully. 
 
2.5.2  Isodose curves 
 
When an electron beam penetrates a medium, the electrons do not scatter primarily in a 
forward direction as is shown in Figure 2.16 [23, p. 311]. The electron beam expands rapidly 
below the surface, thus at depth a significant dose is deposited outside the defined field on the 
surface. Individual spread of the isodose curves varies depending on the isodose level, 
energy, field size and the accelerators collimation system. 
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A      B 
 
Figure 2.16  Comparison between isodose curves for (A) 7 MeV and (B) 18 MeV electron 
beams [23, p. 311] 
 
All the isodose curves show some expansion in the lower energy beam as shown in 
Figure 2.16 while only the isodose levels lower than 50% bulge out in the higher energy 
beam. The higher isodose levels (70% to 95%) also show some lateral constriction for both 
energies. This effect becomes more pronounced with a decrease in field size [23, p. 309]. 
 
2.5.3  Defining the electron beam 
 
The electron field size is defined by a combination of the accelerator’s adjustable diaphragms 
and the electron applicators that attach to the radiation head. The electron applicators are 
required to collimate the beam between the machine and the patient. This is to achieve good 
field definition since electrons are readily scattered by air. It is usual for the face of the 
applicator to be brought into contact with the patient’s skin during treatment. The treatment 
distance is thus defined by the length of the applicator. Electron applicators are available that 
can produce rectangular, square or circular field shapes over sizes that range from 6 x 6 cm² 
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to 25 x 25 cm² [35, p. 137]. The required field size is further defined by an end-frame that fits 
into the treatment end of the applicator [23, p. 42]. These end-frames are usually produced by 
machining from 10 mm lead sheet or through a casting process making use of a low melt 
shielding alloy. This end-frame casting process is described in Chapter 5. 
 
2.5.4  Beam data and dose calculation 
 
The performance of the electron beams and other relevant data that is required for treatment is 
collected as part of the commissioning process of the linac. Depth-dose data for each 
applicator and electron energy is measured and represented in look-up table format. Machine 
output is represented likewise and includes the output for each end-frame of each electron 
applicator at each electron energy. End-frames that are custom-made should also be measured 
for output, especially if the treatment field is irregular in shape making the scatter conditions 
for the field unpredictable. A radiation oncologist decides on an electron energy that will best 
deliver a homogeneous dose to the tumour. A treatment depth is also chosen; this may be the 
skin surface and/or a defined depth beneath it. Bolus (i.e. a tissue equivalent medium such as 
dental wax) of varying thickness may be applied to the treatment field to modify the skin dose 
and the dose at depth. The required radiation dose is prescribed to the selected percentage 
depth-dose, and the skin dose calculated if considered relevant. The applied dose is calculated 
using Equation 2.11. The number of monitor units can finally be calculated using the output 
and the applied dose as described in section 2.4.2.4 [19, p. 45]. 
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CHAPTER 3 
 
SKIN CANCER AND TREATMENT THEREOF 
 
3.1  Introduction 
 
Skin cancer is the most common form of cancer found in humans with more than 800 000 
cases diagnosed in the United States each year. One in every three new cancers is a skin 
cancer. It is estimated that 40 to 50% of fair-skinned people who live to be 65 years old will 
have at least one skin cancer [10, p. 658]. 
 
3.2  Anatomy of the skin 
 
The skin consists of two major layers namely the epidermis and dermis as shown in 
Figures 3.1 and 3.2. 
 
3.2.1  Epidermis 
 
The most important function of the epidermis is to produce a highly complex mixture of 
proteins collectively termed keratin. The outermost layer of the epidermis is composed of 
completely keratinized cells that provide the skin with much of its protective properties 
[38, p. 479]. The basal layer rests on the basement membrane separating the epidermis from 
the dermis. 
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1.  Langerhans’  cells 
 
5. Granular layer 
2. Spinous or prickle cell layer 
 
6. Basal layer 
3. Melanocytes 7. Basement membrane 
  
4. ‘Basket weave’  keratin  
 
Figure 3.1  Schematic representation of normal epidermis [50, p. 674] 
 
The cells in the basal layer divide and daughter cells progress through the epidermis to 
eventually die and contribute to the outer keratin layer. Melanocytes, located between the 
basal cells produce and donate pigment to surrounding epidermal cells [50, p. 674]. 
 
3.2.2  Dermis 
 
The principal cells of the dermis are spindle-shaped fibroblasts. These fibroblasts secrete the 
characteristic dermal proteins collagen and elastin giving the skin much of its strength. Also 
located in the dermis are blood vessels, nerves, sweat glands, sebaceous glands, muscles and 
hair follicles [50, p. 675]. 
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1. Lymphatics 6. Arrector pilorium 
2. Nerve 7. Sebaceous gland 
3. Eccrine sweat gland  8. Deep dermal vascular plexus 
4. Apocrine sweat gland 9. Hair follicle 
5. Superficial dermal vascular plexus  
 
Figure 3.2  Schematic representation of normal skin [50, p. 674] 
 
3.3  Carcinomas of the skin 
 
Chronic sun exposure is the single most common cause of skin cancer as well as the most 
preventable. Fair skinned people living in countries with a high intensity of sunlight are most 
at risk. Because sun exposure is additive, skin cancer most often affect the elderly. Genetic 
relationship is also associated with increased incidence of skin cancer. Diagnostic radiologists 
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working without adequate protection or people repeatedly exposed to ionizing radiation 
during treatment of benign skin disorders are also at risk of contracting skin cancer. Long-
term chronic ulceration seen in syphilis or burns or exposure to various chemicals such as 
arsenic trioxide, soot and tar can give rise to skin cancer [38, p. 480]. Examples of malignant 
lesions are the following: 
 
 Basal cell carcinoma 
 Intraepithelial carcinoma (Bowen’s) 
 Squamous cell carcinoma 
 Keratoacanthoma (acute epithelial cancer) 
 Melanoma 
 Merkel cell carcinoma 
 Adnexal tumours 
 Connective tissue tumours 
 Malignant lymphomas 
 Mycosis fungoides 
 Kaposi’s sarcoma. 
 
Basal cell carcinoma and squamous cell carcinoma are the most common making up 
approximately 95% of all malignant skin lesions while melanomas are considered to be most 
serious [38, p. 480]. 
 
 
 
3.3.1  Basal cell carcinoma 
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Basal cell carcinomas are the most common malignant tumours of the skin and are closely 
associated with chronic sunlight exposure. The tumours are believed to arise from the basal 
layer of the epidermis and from hair follicles. Most basal cell carcinomas occur on hair-
bearing skin on the head and neck [38, p. 482]. Clinically it presents as ulcerated irregular 
lesions (hence their common name as rodent ulcers) with a raised pearly border, often with 
tiny blood vessels visible on the border [50, p. 686]. Sometimes proliferating basal cells 
remain contiguous with overlying epidermis and only invade superficially. They may 
however also invade deeply, as far as bone or even through bone, causing gross deformity or 
even death.  Basal cell carcinomas rarely metastasize¹ and if diagnosed and treated at an early 
stage the prognoses is usually good [44, p. 253]. 
 
3.3.2  Squamous cell carcinoma 
 
Squamous cell carcinoma is very common and is induced by chronic sunlight exposure or 
chemical carcinogens such as arsenic, soot or tar. They also occur in areas of chronic 
ulceration or scarring as well as areas of previous X-irradiation [50, p. 687]. Squamous cell 
carcinoma is a tumour of the keratinizing cells of the epidermis which have invaded beyond 
the dermal epidermal junction [38, p. 482]. They vary in their clinical presentation but the 
typical lesion is round to irregular in shape, plaque-like or even nodular and is overlaid with a 
warty keratotic scale. 
 
 
 
 
___________________________________________________________________________ 
¹ Spread of tumours to distant sites. 
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Metastasis to lymph nodes by the sun-induced carcinoma of skin occurs at a late stage in less 
than 0.5% of cases [44, p. 251]. Lesions arising from chronic ulceration or scarring are more 
aggressive with metastases occurring in about 10% of all cases [38, p. 482]. 
 
3.4  Treatment of basal cell and squamous cell carcinoma 
 
There are many widely used methods to treat basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC). Factors to be considered in treatment selection include: 
 
 
 Size and anatomic location of the lesion 
 Involvement of adjacent cartilage or bone 
 Depth of invasion 
 Tumour grade 
 Previous treatment 
 Type of lesion 
 Definition of its borders 
 General medical condition of patient. 
 
The most appropriate method of curing a specific skin cancer is the most effective, least toxic, 
most efficient and cosmetically elegant therapy [10, p. 662]. The treatment options are: 
 
 Curettage and electrodessication 
 Cryosurgery 
 Chemotherapy 
 Mohs micrographic surgery 
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 Laser therapy 
 Radiation. 
 
3.4.1  Curettage and electrodessication 
 
With the patient under local anesthesia, the tumour is scooped out with a curette (sharp-tipped 
instrument) and electrodessicated. The procedure is repeated two or three times to ensure that 
all residual tumour is destroyed. Well defined superficial BCC and noninvasive SCC can 
usually be treated effectively with curettage and electrodessication [10, p. 662]. 
 
3.4.2  Cryosurgery 
 
With this technique liquid nitrogen at -50°C is applied to the tumour surface freezing it in the 
process. The frozen tissue is then allowed to thaw for about two minutes. The frozen tumour 
cells lyse following their expansion by ice. This cycle is repeated two or three times. 
Cryosurgery is effective for treating superficial BCC and noninvasive SCC [21, p. 386]. 
 
3.4.3  Surgery 
 
The standard treatment for both BCC and SCC is excision biopsy. In general the entire lesion, 
with an appropriate margin of apparently normal tissue, is excised. This is a more invasive 
and time consuming procedure than curettage and electrodessication [21, p. 385]. 
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3.4.4  Mohs micrographic surgery 
 
This technique was first described by Dr. Frederick Mohs in 1936. It involves the successive 
excision of thin horizontal layers of tissue with a 1–2 mm margin of normal appearing skin. 
Each layer is microscopically examined and the area that involves tumour is marked. The 
entire tumour is removed layer by layer with the marked area on the previous layer used as a 
guide for further excision. Mohs micrographic surgery has the highest cure rate of all 
treatment methods whilst sacrificing a minimum of unaffected skin. This treatment is 
recommended for all types of BCC and SCC. The disadvantages are that a great deal of 
expertise is required from the physician, the procedure is time-consuming and it requires more 
equipment than the other methods [10, p. 664]. 
 
3.4.5  Chemotherapy 
 
The most widely used chemotherapeutic agent for the treatment of non-invasive epidermal 
tumours is 5% Fluorouracil (5 – FU). It is applied directly to the skin and works by blocking 
DNA synthesis, thereby preventing normal cell growth and ultimately causing cell death. 
While it is possible to control a tumour on the surface with 5 – FU it may continue to invade 
at the base. Recurrence rates are estimated to be 20 to 50%, so follow-up is important 
[10, p. 663]. 
 
3.4.6  Laser therapy 
 
A carbon dioxide laser may be used for surgery where the laser is used as a cutting 
instrument, much like a scalpel. It is useful for removing superficial BCC and SCC in 
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locations that might be bloody or for patients who have a bleeding disorder or are taking 
anticoagulants [10, p. 665]. 
 
3.4.7  Radiation 
 
Superficial radiation treatment of BCC and SCC has a reported cure rate of 89 to 95% over 
5 years. The treatment is painless with very little risk to the patient. Radiotherapy is the 
preferred method for treating certain body sites such as the nose where cosmetic results of 
surgery are often disappointing [21, p. 387]. Radiation treatment of lesions on the trunk and 
extremities are less advantageous since the radiation may cause possible side effects at the site 
of radiation. This includes changes in the skin pigment and the formation of telangiectasias². 
These side effects are mild initially, but become more marked in time, even to the extent that 
radionecrotic ulcers occasionally develop. There is also a small possibility of radiation 
treatment eventually causing new cancers at the radiation site. For these reasons, radiotherapy 
is usually recommended for patients older than 50 years of age [10, p. 663]. Different 
radiation sources are available for the treatment of skin cancer. Low energy X-rays as 
produced by kilovolt units are still in use in some cancer departments although electron 
treatments from linear accelerators are much more popular nowadays. Electrons do not 
penetrate as deeply as X-rays thereby offering the advantage of sparing underlying healthy 
structures. Bolus material (a tissue equivalent medium) of an appropriate thickness needs to 
be placed on the patient’s skin during electron treatments above 18 MeV to ensure maximum 
dose to the skin surface. The radiation field size must include at least a 1 cm border of normal 
tissue for small lesions while 2 cm is recommended for larger lesions. 
 
________________________________________________________________________ 
² Small obvious blood vessels. 
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Lead masks (as described in Chapter 5) are used to give shape to the treatment area and to 
protect the surrounding normal tissue. A standard square or rectangular electron applicator is 
chosen to fit over the opening in the mask as closely as possible. The applicator is fitted to the 
accelerator head and the gantry and head are rotated to bring the applicator perpendicularly 
into contact with the mask on the patient. The recommended radiation dose for skin cancers is 
dependant on the following factors: 
 
 Histological type 
 Size and depth of lesion 
 Size of treatment field 
 Dose fractionation 
 Overall time of delivery. 
 
Daily treatment fractions for most BCC may range from 200-500 cGy with total tumour doses 
of 3000-5000 cGy in 6-20 fractions. For most SCC 5000-6000 cGy in 6-30 fractions over a 
period of 10-35 elapsed days is recommended. BCC larger than 5 cm or thicker than 0.5 cm 
should be treated with doses similar to SCC [38, p. 484]. 
 
3.5  Melanoma 
 
Melanoma is a malignant tumour of the skin arising in the epidermis. The cell of origin is the 
melanocyte which is present in the basal layer at the junction of the epidermis and dermis. It 
starts multiplying and invades upwards through the epidermis to the surface and downwards 
into the underlying dermis. Melanoma accounts for about 3% of all cancers and about 0.5% of 
all cancer deaths [44, p. 256]. It occurs most frequently in white adults where the lower leg in 
females and the trunk and back of males are commonly affected. It is rare in dark skinned 
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races and if it does occur it only does so on the palms of hands or the soles of feet. Sunlight 
exposure seems to be the main factor associated with the development of malignant 
melanoma. Instead of BCC or SCC which are associated with chronic sun exposure, 
melanoma appears to be initiated by episodic acute exposure to burning [50, p. 695]. 
 
 
3.5.1  Variants of malignant melanoma 
 
The main variants of invasive malignant melanoma are: 
 
 Lentigo maligna melanoma 
 Superficial spreading melanoma 
 Nodular melanoma 
 Acral lentiginous melanoma. 
 
3.5.1.1  Lentigo maligna melanoma (Hutchinson’s melanotic freckle) 
 
This is a flat pigmented lesion usually occurring on the sun-damaged skin of the elderly. It 
consists of a linear proliferation of atypical melanocytes within the epidermis. This may 
persist for years before becoming invasive [44, p. 256]. 
 
 
 
 
3.5.1.2  Superficial spreading melanoma 
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This type of melanoma accounts for 60 to 70% of cases and is characterized by nests of 
atypical melanocytes which grow horizontally within the epidermis with invasion into the 
dermis. Individual melanocytes migrate upwards through the epidermis [44, p. 257]. 
 
3.5.1.3  Nodular melanoma 
 
Nodular melanoma does not have a significant radial growth phase and invasion takes place at 
an early stage. This melanoma makes up about 30% of all cases [44, p. 258]. 
 
3.5.1.4  Acral lentiginous melanoma 
 
This is the most common form of malignant melanoma in dark skinned races. It shows a 
radial growth phase similar to that of Lentigo maligna but invasion takes place in an earlier 
stage. 
 
3.5.2  Clinical course of melanoma 
 
The prognosis of invasive melanoma depends predominantly on the depth of the lesion and 
the presence or absence of surface ulceration. The cure rate for completely excised non-
ulcerated melanoma with thickness below 1 mm can be as high as 100% [50, p. 694]. The 
prognosis worsens with increased thickness. The chances of patients surviving 5 years after 
contracting malignant melanoma with lesions deeper than 4 mm or more is down to 40% 
[44, p. 256]. All malignant melanoma finally lead to metastatic spread as soon as they come 
into contact with superficial dermal vessels. The tumour spreads to all parts of the body with a 
predilection for the brain, skin and gastrointestinal tract [50, p. 694]. 
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3.5.3  Treatment of Melanoma 
 
3.5.3.1  Surgery 
 
Surgery is considered to be the only curative treatment for all but the most advanced stages of 
the disease. Lesions with little or no invasion are surgically excised with a safe border of skin 
around it. Removal of a larger radius of surrounding skin is needed with excision of thicker 
lesions. Regional lymph nodes should also be removed with thicker lesions as a precautionary 
measure since they may be tumour-bearing [38, p. 490]. 
 
3.5.3.2  Chemotherapy 
 
One method of treating regional or distant spread of melanoma is through the administration 
of chemotherapy. Single-drug chemotherapy is however effective in no more than 20% of 
patients with the disease in advanced form. Drug combinations can cause 50% shrinkage of 
all tumour masses for at least four weeks in 40 to 60% of cases according to recent reports. 
The duration of response is still fairly short and the percentage of complete remissions is low 
but the increased percentage of response is encouraging [10, p. 574]. 
 
 
 
 
3.5.3.3  Immunotherapy 
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This technique involves stimulating the patient’s immune system with biological response 
modifiers to reject the tumour. Moderate doses of interferon-alpha has resulted in about a 20% 
response rate while a new biological substance called Interleukin – 2 (IL – 2) has had 
responses in 25% of patients. Remarkable degrees of shrinkage of lesions have for example 
been observed in the liver. Active specific immunotherapy (melanoma vaccines) has also 
shown considerable promise in treating advanced melanoma. The most successful of the 
melanoma vaccines resulted in about 20% of patients having had partial or complete 
remissions [10, p. 574]. 
 
3.5.3.4  Radiation 
 
Malignant melanoma cells show apparent resistance to radiation with the result that high 
individual doses are required to enhance cell kill. Radiotherapy can be used to treat isolated 
large lesions if surgical excision is deemed too radical or it can be used to help relieve pain. 
Brain metastases are treated by somewhat lower radiation doses.  Stereotactic radiotherapy 
(focused radiation) is now replacing neurosurgery in some centers for treatment of small brain 
metastases [10, p. 574]. 
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CHAPTER 4 
 
BREAST CANCER AND TREATMENT THEREOF 
 
4.1  Introduction 
 
Breast cancer accounts for 20% of all cancers in the United Kingdom and is the most common 
cause of death among women in the 35 to 55 year age group. Recent reports show there to be 
39500 new cases each year in the UK. Internationally, the highest incidence rates are found in 
North America, North–West Europe and Australia with much lower rates in Asia and parts of 
Africa. It is estimated, in the higher risk areas, that any individual woman has a one in nine 
chance of developing the disease in her lifetime [50, p. 479]. 
 
4.2  Types of breast cancer 
 
Virtually all breast cancers arise from the epithelial cells lining the lactiferous ducts and acini 
that are contained in the lobules as shown in Figure 4.1. These types of cancers are generally 
divided into: noninvasive or in situ cancers and invasive cancers [32, p. 17]. The many 
lobules in the breast produce milk while the ducts carry it to the nipple. Cancers originating in 
the ducts and lobules are referred to as ductal and lobular cancers respectively. 
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1. Lactiferous duct 6. Intralobular duct 
2. Lactiferous sinus  7. Acini 
3. Nipple 8. Myoepithelial cells 
4. Duct (drainage system) 9. Epithelial cells 
5. Lobules containing acini 10. Basement membrane 
 
Figure 4.1  Structure of the adult female breast, showing the major components [50, p. 478] 
 
4.2.1  Non–invasive carcinomas 
 
The term „non–invasive‟  means that the malignant cells are confined within the lining of the 
ducts or lobules. There is thus no evidence of penetration of the tumour cells through the 
basement membranes of these structures into the surrounding fibrous tissue [50, p. 479]. 
There are two types of non–invasive breast carcinoma: ductal carcinoma in situ and lobular 
carcinoma in situ. 
4.2.1.1  Ductal carcinoma in situ (DCIS) 
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DCIS accounts for about 5% of breast carcinomas and can occur in both pre- and post 
menopausal women, usually in the 40 to 60 year age group. The disease is usually confined to 
one quadrant of the breast although a larger area could be involved with large lesions. 
Occurrence of the disease in both breasts is uncommon [50, p. 482]. DCIS has the ability over 
a long period to become invasive if left untreated making it necessary for the tumour to be 
completely removed [10, p. 357]. 
 
4.2.1.2  Lobular carcinoma in situ (LCIS) 
 
LCIS is usually diagnosed in pre-menopausal women. It affects more than one quadrant of the 
breast in up to 90% of cases and is found in both breasts in 25% of cases. About 25 to 30% of 
patients with LCIS will go on to develop invasive carcinoma within 20 years if the condition 
is left untreated. This may occur in either or both breasts and may be of the ductal or lobular 
type [21, p. 515]. 
 
4.2.2  Invasive breast carcinoma 
 
An „ invasive‟  breast tumour is one whose cells have broken through the basement membrane 
around the breast structure in which they have arisen and spread into surrounding tissue 
[50, p. 483]. The types of invasive carcinoma and their relative incidence are: 
 
 Infiltrating ductal (75%) 
 Infiltrating lobular (10%) 
 Mucinous (3%) 
 Medullary (3%) 
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 Tubular (2%) 
 Others (7%). 
 
4.2.2.1  Invasive ductal carcinoma 
 
Invasive ductal carcinoma makes up the majority of infiltrating breast carcinomas. It can 
occur in both pre- and post-menopausal women and usually forms at one focus in a single 
breast [50, p. 484]. 
 
4.2.2.2  Invasive lobular carcinoma 
 
While lobular carcinoma in situ is usually diagnosed in pre-menopausal women, the 
infiltrating lesion can also occur in post-menopausal women. Invasive lobular carcinoma can 
be multifocal not only in the same breast, but also in the opposite one [50, p. 485]. 
 
4.3  Spread of breast carcinoma 
 
Behavior of breast carcinoma is particularly unpredictable. It is not unusual to encounter 
patients with widespread bone disease but without any evidence of soft tissue disease while 
others develop relentless local recurrence without distant metastasis [47, p. 253]. It also 
exhibits marked variation in the time span between presentation of the primary carcinoma and 
the appearance of recurrent / metastatic disease. In some patients breast carcinoma never recur 
while in others reappearance of the disease may be within two to five years. 
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It is however also possible for the disease to recur as much as 20 years after the original 
excision [50, p. 488]. Breast carcinoma can infiltrate locally through direct spread or 
metastasize to more distant sites via lymphatics and the bloodstream as shown in Figure 4.2. 
 
 
1. Brain 7. Internal mammary nodes 
2. Lung 8. Axillary lymph nodes 
3. Pleural effusion 9. Chest wall 
4. Bone marrow 10. Bone (especially axial skeleton) 
5. Skin 11. Ovary 
6. Supra clavicular lymph nodes 12. Pathological fracture 
 
Figure 4.2  Local, nodal and distant spread in breast cancer [47, p. 252] 
4.3.1  Direct spread 
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Local infiltration may occur either to the underlying muscles and chest wall or to overlying 
skin [47, p. 252]. 
 
4.3.2  Lymphatics 
 
Sites of metastasis via lymphatics are axillary, supraclavicular, internal mammary or 
tracheobronchial regional lymph nodes. The axillary nodes provide the major drainage of the 
breast tissue. Histological analysis of these nodes presents the single most important 
prognostic factor for breast cancer [29, p. 233]. Finding tumour deposits in the supraclavicular 
lymph node group is a particular adverse clinical sign since this indicates advanced local 
infiltration [21, p. 515]. 
 
4.3.3  Blood stream 
 
Blood-borne metastasis of breast carcinoma involves the lungs, bone (especially the axial 
skeleton), liver, skin and central nervous system (both brain and spinal cord). Intra-abdominal 
and pelvic metastases are also common [47, p. 253]. 
 
4.4  Risk factors associated with breast cancer 
 
Despite great effort and enormous expenditure, the main factor that causes breast cancer still 
eludes researchers. Several risk factors are however well established [12, p. 1]. 
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 Family history of breast cancer in first degree relatives (e.g. mother, sister, daughter).  
The risk is about six times greater if a mother or sister had breast cancer before 
menopause and up to 10 times greater if the cancer involved both breasts. 
 Women who carry a first full-term pregnancy over the age of 30 years are three times 
more likely to develop breast cancer than those who do so under 20 years. 
 Early onset of menstruation and late onset of menopause increases risk. 
 Obesity, with postmenopausal women at higher risk. 
 
4.5  Staging of breast cancer 
 
When a woman is diagnosed with breast cancer, it is of the greatest importance to determine 
the advancement of the disease both locally and distantly through metastatic spread. To this 
end a process termed staging is undertaken. With the TNM classification system, as shown in 
Table 4.1, staging is done according to the primary tumour size (T), involvement of the 
axillary nodes next to the affected breast (N) and if metastasis is present or not (M). The 
clinical stages range from I to IV [10, p. 363]. 
 
 
 
 
 
 
 
 
 
Table 4.1  TNM (Tumour Node Metastasis) classification for breast cancer 
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Stage I T1 N0 / N1a M0 
Stage II T0 N1b M0 
 T1 N0,1a, 1b M0 
 T2 N0, 1a, 1b M0 
Stage III T1 N2 M0 
 T2 N2 M0 
 T3 N0 / 1 / 2 M0 
Stage IV T4 Any N / M  
 Any T N3 Any M  
 Any T / M M1  
 
T1 Tumour < 2 cm 
a. Without fixation to underlying structures 
b. Fixed to underlying structures 
T2 Tumour between 2 and 5 cm – a and b 
T3 Tumour > 5 cm but < 10 cm or < 5 cm with infiltration, ulceration or fixation 
T4 Tumour of any size fixed to chest wall or skin 
a. Chest wall 
b. Oedema, ulceration of the skin of the breast or satellite skin nodules 
c. a and b 
d. Inflammatory 
 
N0 Node-negative 
N1 Mobile nodes 
a. Clinically uninvolved 
b. Clinically involved 
N2 Nodes involved and fixed 
N3 Supraclavicular or infraclavicular nodes or arm oedema 
 
M0 No distant metastases 
M1 Metastases present 
 
Staging determines the treatment to be offered to the breast cancer patient especially if several 
treatment techniques are available as will be discussed next. 
 
4.6  Treatment of breast cancer 
 
Significant advances have been made in the treatment of breast cancer in recent years. A 
multidisciplinary treatment approach is now standard with a combination of surgery, 
radiotherapy and chemotherapy. 
4.6.1  Surgery 
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The primary method for the treatment of invasive breast cancer, which is apparently confined 
to the breast, is surgical removal of the tumour. Very small tumours can be excised by a 
procedure termed a lumpectomy while most early breast cancers can be treated with a 
segmental resection [10, p. 364]. Larger tumours require a quadrantectomy. With this 
procedure the quadrant of the breast centered on the cancer is removed [21, p. 521]. If the 
tumour has spread throughout the breast a mastectomy needs to be performed. In advanced 
situations where the cancer is attached to underlying muscle, a Halsted radical mastectomy 
which removes the entire breast with the affected muscle is performed [47, p. 257]. Lymph 
nodes in the axilla (armpit) are generally removed as part of the surgical procedures. This is 
done to determine the extent of the cancer. Cancer present in these nodes indicates a 
significant risk of metastases outside the breast requiring additional therapy [10, p. 365]. 
 
4.6.2  Chemotherapy 
 
Although chemotherapy was introduced much more recently, it has rapidly become one of the 
most important treatment methods for breast cancer. Different drug combinations are often 
prescribed as an adjuvant therapy for patients after surgery. This is in an attempt to prevent or 
minimize the growth of microscopic deposits of tumour cells that might grow into recurrent 
tumours [10, p. 372]. A variety of drug combinations are also widely used in the treatment of 
metastatic and locally advanced breast cancer. Since cure is usually not possible in these 
situations the main aim of therapy is relief of disease related symptoms which may last for 
months and often years [21, p. 529]. Another type of treatment that can be prescribed on an 
adjuvant basis or as treatment of metastatic disease is hormonal therapy. The hormonal 
balance was once manipulated through removal of the ovaries or adrenal glands and 
sometimes the pituitary gland. The same effects can now be achieved through the use of 
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various drugs. With hormonal therapy there is a 30% likelihood of women responding to 
treatment while chemotherapy has a response rate of double this figure. Hormonal induced 
responses are however much less toxic to the patient and tend to be more durable [47, p. 265]. 
 
4.6.3  Radiotherapy 
 
There are various recommended radiotherapy techniques for the treatment of both breast-
conserving and post mastectomy breast cancer patients. Some of the most successful 
techniques will be discussed next. 
 
4.6.3.1  Radiation therapy techniques for the breast-conserving 
patient 
 
Following removal of the primary breast tumour by surgery, local recurrence of the disease in 
the chest wall, regional lymph nodes or residual breast occurs with a frequency of 7 to 30% 
[47, p. 257]. This is due to microscopic cancer cells remaining in the surrounding tissue or 
lymph nodes after surgery. To overcome this problem in the past, the Halsted radical 
mastectomy procedure was performed as standard. This procedure has a low recurrence rate 
of around 4% but often has negative psychological implications for the patient [47, p. 259]. 
The preferred treatment for early breast cancer nowadays is a lumpectomy or segmental 
resection followed by radiation treatment to the breast and internal mammary, axillary and 
supraclavicular lymph nodes if involved. Results from these procedures have shown to be 
equivalent to the radical mastectomy in terms of patient survival [10, p. 371]. 
a)  Opposing tangential fields to the chest wall and breast 
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A widely used method for the treatment of the intact breast is by irradiation with two 
opposing photon fields applied tangentially to the chest wall with no more than 2 to 3 cm of 
the lung included. Figure 4.3A shows an anterior view of treatment fields commonly applied 
to breast cancer patients while Figure 4.3B shows a transverse slice of the body with 
tangential photon fields applied. 
 
1. Supraclavicular field 3. Tangential fields 
2. Internal mammary field 4. Internal mammary node 
  
Figure 4.3A  Anterior view of treatment fields 
commonly applied to breast 
cancer patients [19, p. 176] 
Figure 4.3B  Transverse slice of the body 
with tangential photon fields 
applied [38, p. 913] 
 
The gantry angle is adjusted to achieve alignment of the anterior edges of the tangential fields 
to prevent divergence into the lung. The patient is positioned supine on the linear accelerator 
table with the thorax supported by a rigid wedge. The angle of the support wedge is chosen so 
that the patient‟s sternum lies parallel to the treatment table. This is done to simplify the 
tangential field setup [19, p. 177]. The patients arm on the treatment side is supported at 90° 
to the body and the head is turned sharply to the contra lateral side. The entire breast needs to 
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receive a total dose of 4500-5000 cGy of radiation in five to six weeks at 180-200 cGy per 
day with five fractions in a week [38, p. 904]. 
 
b)  Internal mammary lymph node treatment 
 
If the internal mammary nodes require irradiation they may be included in the tangential 
treatment beams by moving the field border 3 to 5 cm across the patient‟s anterior midline. It 
should however be ascertained that an excessive amount of lung or heart tissue will not be 
included in the tangential beams as shown in Figure 4.4A. If this is the case, a separate photon 
or electron field may be applied adjacent to the tangential field‟s edge as shown in 
Figure 4.4B. The recommended total dose to the internal mammary field is 4500-5000 cGy at 
180-200 cGy per day. Electron radiation in the order of 13 MeV is preferred for a portion of 
the treatment to spare underlying lung, mediastinum and spinal cord. The usual proportion is 
1440 cGy with 4-6 MV photons and 3060 cGy with electrons at 180 cGy per day [38, p. 912]. 
Also shown in Figure 4.4B is a potential dosimetric “cold” area (indicated in blue) between 
the internal mammary and tangential fields with large chested women. 
 
 
 
 
A B C 
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Figure 4.4A, B and C  Transverse slices showing different radiation techniques to include 
internal mammary nodes in the treatment of breast cancer 
[38, p. 913] 
 
To overcome this problem, Woudstra and van der Werf describe a technique using an oblique 
incidence of the internal mammary field as shown in Figure 4.4C. By matching the orientation 
of the adjacent tangential fields a more homogeneous distribution at the field junction will 
result [38, p. 911]. 
 
c)  Supraclavicular lymph node treatment and field matching 
problems 
 
The recommended total dose to the supraclavicular lymph nodes is 4600 cGy at 200 cGy per 
day in five fractions per week [38, p. 913]. Field matching problems often occur between the 
supraclavicular treatment field and the opposing tangential fields. Because of the divergence 
of the tangential beams into the supraclavicular field and the supraclavicular beam into the 
tangential field a dosimetric “hot spot” (indicated in red) will exist just beneath the skin 
surface where the fields meet as shown in Figure 4.5A and B. This increase in dose may result 
in severe match line fibrosis or even rib fracture [38, p. 910]. 
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Figure 4.5A  Anterior view showing field 
matching problems with 
tangential and supraclavicular 
radiation treatment fields 
[19, p. 180] 
Figure 4.5B  Lateral view showing field 
matching problems with 
tangential and supraclavicular 
radiation treatment fields 
[19, p. 180] 
 
Careless field matching may also result in a dosimetric “cold spot” (indicated in blue in 
Figure 4.5A) with possible recurrence of the disease in that area. Various methods of 
matching the treatment fields are in use, each with their own limitations and difficulties which 
will be discussed next. 
 
i)  Table and gantry rotation 
 
Treatment table rotation can be applied as a means of matching the supraclavicular field to the 
tangential field as shown in Figure 4.6A. By rotating the table alternately to the divergent 
superior borders of the tangential fields, they can be arranged to line up perfectly with the 
inferior border of the supraclavicular field. 
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Figure 4.6A  Anterior view showing field 
matching through table and 
gantry rotation [19, p. 182] 
Figure 4.6B  Lateral view showing field 
matching through table and 
gantry rotation [19, p. 180] 
 
To match the supraclavicular field to the tangential fields, the treatment table can be rotated 
through 90° and the gantry angled to take up the divergence of the anterior beam as shown in 
Figure 4.6B. In addition to this, the anterior beam should be angled 15° laterally to spare the 
spinal cord [19, p. 182]. 
 
ii)  Asymmetry 
 
If the linear accelerator that is used for treatment is equipped with asymmetric diaphragms 
(meaning that the diaphragms are able to move independently of each other), matching of 
treatment fields can be simplified. 
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Figure 4.7A  Anterior view showing field 
matching through asymmetric 
diaphragms [19, p. 181] 
Figure 4.7B  Lateral view showing field 
matching through asymmetric 
diaphragms [19, p. 181] 
 
Half blocking the superior borders of the tangential and inferior border of the supraclavicular 
beams with the asymmetric diaphragms ensures no divergence of the beams into each other as 
shown in Figure 4.7A & B. Again the anterior beam should be angled 15° laterally to spare 
the spinal cord [19, p. 181]. 
 
d)  Axillary lymph node treatment 
 
If the axillary lymph nodes are at risk the supraclavicular field may be extended both 
inferiorly and laterally to include the axillary nodes. Once treatment to the supraclavicular 
field is competed, the dose to the axilla can be supplemented by a posterior axillary field. The 
patient is positioned prone on the treatment table without a wedge support and the field is 
administered anteriorly to correspond with the supraclavicular field [29, p. 238]. The total 
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dose recommended for the axillary lymph nodes is 4600-5000 cGy at 200 cGy per day 
[38, p. 914]. 
 
4.6.3.2  Post mastectomy radiotherapy techniques 
 
Radiation treatment is prescribed after a mastectomy procedure if the tumour was very large, 
if it invaded the chest wall muscles or if many lymph nodes were involved. In these cases it is 
assumed that there are undetectable tumour cells present in the chest wall or lymph nodes that 
can be eradicated through radiation. Radiation fields are in most cases applied to the skin 
flaps on the chest wall and the regional lymph nodes of the same side [51, p. 118]. 
 
a)  Electron treatment to the chest wall 
 
The post mastectomy patient can be treated with the same irradiation techniques as that which 
will be used for a patient who had breast-conserving surgery. However since a mastectomy 
procedure simplifies the body contours in the chest area the opportunity arises to use electron 
treatment fields instead of tangential photon fields. Electron beams have the advantage of 
rapid dose fall-off after achieving maximum dose, making it ideally suitable for irradiation of 
the chest wall where underlying lung tissue needs to be spared. If the patient has a fairly flat 
chest wall contour, a single electron field can be used for treatment as shown in Figure 4.8A. 
For patients with a fairly curved chest wall, a second treatment field with 35° lateral tilt can 
be added that abuts the first field as shown in Figure 4.8B. The match line needs to be moved 
laterally on a weekly basis to avoid dose buildup [29, p. 236]. 
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Figure 4.8A  Anterior view showing two 
electron fields setup [29, p. 237] 
Figure 4.8B  Anterior view showing three 
electron fields setup [29, p. 237] 
 
If the mastectomy scar extends beyond the mentioned electron fields, an additional field may 
be added to cover this area. Bolus may be added to the chest wall during electron treatments 
to minimize lung dose and to increase skin surface dose. The recommended total dose for 
electron treatment of the chest wall is 5000 cGy over a period of five weeks [29, p. 236]. 
Internal mammary, supraclavicular and axillary lymph nodes are treated in the same way as 
was described for the breast-conserving treatment techniques. 
 
b)  Opposing tangential fields to the chest wall 
 
If the skin flaps left after the mastectomy procedure are very thick or electron treatment is not 
available opposing tangential photon beams can also be used for the treatment of post 
mastectomy patients. To ensure adequate skin dose, bolus can be added to the entire photon 
treatment field for one third of the treatments and to only the scar for an additional third of 
treatments [38, p. 959]. A disadvantage of using bolus is the formation of telangiectasias and 
resultant poor cosmetics [19, p. 176]. The radiation dose to the chest wall is the same as that 
will be applied to the treatment of the intact breast. 
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c)  Isocentric rotational electron beam irradiation 
 
An electron irradiation technique developed at the Division of Radiation Oncology, 
University of Utah involves rotating the gantry in a semi arc around the patient‟s thorax while 
irradiating the chest wall in a continuous field [31, p. 1287]. This technique can be used for 
post mastectomy patients that will be difficult to treat with conventional photon or fixed 
electron beam irradiation. Long mastectomy scars, tumours extending across the midline or 
onto the posterior thorax and variation in target volume depth are common problems that 
make treatment with conventional techniques technically difficult [6, p. 1969]. The patient is 
positioned supine on the treatment table with the isocenter at a depth within the patient so as 
to maintain a uniform SSD throughout the arc. Figure 4.9 shows the setup for rotational 
electron beam irradiation schematically. Two shielding blocks that are screw mounted onto an 
acrylic tray with the central part of the tray removed are placed in the linear accelerator‟s 
shadow tray. These blocks are adjustable to be opened or closed symmetrically about a central 
point producing a rectangular or trapezoid shape. The purpose of the shielding blocks is to 
serve as a secondary collimator to account for changes in the radius of the thorax from the 
superior to the inferior field borders [28, p. 988]. It is also necessary to sharply define the 
edges of the treatment field on the patient. For this purpose a radiation shield needs to be 
produced that conforms to the individual patient‟s thorax. This can be done by pouring molten 
Lipowitz metal into a mould that was produced from an impression taken of the treatment 
area on the patient. The Lipowitz metal cast is lined with foam and is placed on the patient‟s 
thorax during treatment [28, p. 989]. All patients who are to be treated by rotational electron 
beam irradiation needs to be scanned on a computerized tomography (CT) scanner. This is 
done to determine the chest wall thickness as well as depth of internal mammary nodes that 
can be included in the treatment field if required. Bolus may be added to the chest wall in 
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places where it is thin to produce a more uniform chest wall thickness. The radiation dose to 
variable depths within the treatment volume is controlled by varying the electron energy and 
dose rate through the arc. Different radiation energies, are for example, required over the 
internal mammary nodes and the chest wall [37, p. 2150]. 
 
1. Electron beam 3. Shielding blocks 
2. Diaphragms 4. Cerobend cast 
 
Figure 4.9  Isocentric rotational electron beam irradiation [28, p. 988] 
 
Disadvantages of this technique are that the fabrication of the Lipowitz metal shielding cast 
and CT treatment planning are time and labour intensive. Advantages of the technique are 
better dose uniformity and reduction in dose to underlying lung when compared to standard 
treatment techniques [28, p. 995]. 
4.6.3.3  Boost to the tumour site 
 
Breast cancer that recurs after a combination of surgery and irradiation occurs in 65–80% of 
cases around the primary tumour site [38, p. 908]. This statistic provides strong motivation for 
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a radiation boost to the scar for both conservation surgery and post mastectomy patients to 
have a greater probability of tumour control. The preferred boost technique is by applying an 
electron field with a 2-3 cm margin around the tumour bed. An electron energy is selected that 
will cover the target volume depth without delivering substantial dose to the underlying lung 
[49, p. 259]. Several methods are in use to delineate the treatment borders as will be explained 
in Chapter 5. 
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CHAPTER 5 
 
TRADITIONAL RADIATION FIELD SHAPING TECHNIQUES 
 
5.1  Introduction 
 
Both linacs and kilovolt units make use of applicators to collimate the radiation beams 
produced by the units to required treatment field sizes as described in sections 2.3.1 and 2.5.3. 
Square, rectangular and round applicators of different field sizes are available to both types of 
treatment units. One of these standard field shapes is chosen to fit the shape of the cancer 
affected area on the patient as closely as possible as shown in Figure 5.1A. 
 
A B 
 
 
Figure 5.1A  Rectangular treatment field 
applied to cancer affected area 
Figure 5.1B  Electron applicator setup 
showing stand-off 
 
Since the cancer affected areas are irregular in shape, there will always be an area of healthy 
tissue between the edge of the cancer affected area and the edge of the standard field shape. 
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This healthy tissue will be inadvertently irradiated along with the cancer during treatment. 
This is undesirable since the cancer wound heals through reparative growth of the surrounding 
healthy tissue after treatment as described in section 2.2.2. The problem will be made worse if 
the cancer affected area is large and located across a curved area of the patient’s body. During 
treatment, the radiation unit’s applicator is brought into contact with the patient’s skin as 
shown in Figure 5.1B. Considering that the treatment end of the applicator is flat, there can be 
a considerable stand-off between the patient’s skin and the applicator at the field’s edges. A 
stand-off will result in radiation scatter beyond the field’s edges resulting in a larger area 
being irradiated than intended. 
 
5.2  Existing radiation field shaping techniques 
 
Different field shaping techniques where developed to overcome the problems mentioned in 
section 5.1. These techniques will be discussed next together with their respective 
disadvantages. 
 
5.2.1  Lead masks 
 
Lead masks are commonly used to shield healthy tissue surrounding malignant skin tumours 
during treatment with low energy X-rays or electrons [24. p. 883]. These masks are used with 
small treatment fields that are applied across a relatively even treatment area. For large 
treatment fields applied across a curved area, the wax casting field shaping technique as 
described in section 5.2.2 is preferred. The fabrication of a lead mask is explained with 
reference to Figure 5.2A-R. To begin with a radiation oncologist identifies and marks the 
cancer affected area on the patient’s skin by means of a water based marker. If the cancer 
affected area is located in the facial area, as is often the case, thin plastic film is cut to size 
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and is placed over the patient’s eyes (Figure 5.2A). Strips of wet plaster bandage are laid 
down on the patient’s skin up to two or three layers (Figure 5.2B). The plastic film prevents 
the plaster from sticking to the eyelids and eyebrows. When the plaster bandage impression 
has set, it is removed from the patient’s skin (Figure 5.2C). The water based markings are 
dissolved by the wet plaster bandages and are thus transferred to the impression. These 
transferred markings are redrawn on the impression. The open ends of the impression are 
blocked with additional plaster bandages (Figure 5.2D). Liquid soap is painted onto the 
plaster bandage impression to serve as separation medium (Figure 5.2E). Yellow-stone™ 
plaster is mixed to a liquid consistency and is poured into the impression (Figure 5.2F). Again 
the markings are transferred this time to the stone plaster model. 
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Figures 5.2A-R  Fabrication of a lead mask 
 77 
When the stone plaster has set, the plaster bandages are removed (figures 5.2G and 5.2H). 
Lead sheet with thickness according to the intensity of the radiation to be applied during 
treatment (2–6 mm) is roughly cut according to the size of the required mask [16, p. 336]. The 
lead sheet is placed onto the model and is formed according to the shape of the model by 
means of a special hammer (Figure 5.2I). Excessive lead sheet is trimmed away with tin snips 
(Figure 5.2J). Often the shape of the model requires the mask to be partially split to be able to 
take on the shape of the model (Figure 5.2K). This split line needs to be soldered once 
shaping is completed (Figure 5.2L). To prevent the joint line from hurting the patient it needs 
to be trimmed on the inside of the mask (Figure 5.2M). For higher radiation energies, extra 
pieces of lead sheet need to be cut to shape and soldered on to the mask in the position of the 
patient’s eyes. This is to assure that no radiation will pass through to these radiation sensitive 
areas. To transfer the position of the tumour from the model to the mask, a thin sheet of dental 
wax is lightly heated and is pressed onto the marked area on the model (Figure 5.2N). The 
wax is cut according to the shape of the marked area on the model by means of a heated 
instrument (Figure 5.2O). The mask is heated slightly and is pressed firmly onto the model, in 
so doing transferring the wax to the mask (Figure 5.2P). A hole is cut in the mask according 
to this marker with a jig saw (Figure 5.2Q). Finally the mask is dipped in molten dental wax 
in order to prevent the patient’s skin from coming into contact with the lead mask. The mask 
is placed onto the patient’s skin during treatment thereby limiting the radiation to only the 
cancer affected area (Figure 5.2R). 
 
 
 
 
 
Disadvantages of the Lead mask technique are: 
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 The Yellow-stone™ plaster has to be left at least overnight to harden sufficiently to 
prevent it from breaking up while forming the lead sheet on it. A technologist can thus 
only start fabricating the mask a day after the plaster bandage impression was taken. 
 The technique of forming the lead sheet on the model requires a great deal of skill, 
effort and time especially if the lead sheet needs to be thicker than 2 mm. 
 Most radiotherapy departments are unable to recycle the lead from used masks since 
special equipment is required to melt the lead and role it into sheets of the required 
thickness. Lead is thus only used to shield around small treatment fields since it is 
uneconomical to use the material for large fields where wax castings are preferred. 
 The procedure of taking a plaster bandage impression of a patient, especially in the 
facial area, is often traumatic and uncomfortable for the patient. 
 
5.2.2  Wax castings 
 
Wax castings are used for field shaping purposes with large electron treatment field sizes that 
are applied across a curved area of a patient’s body. A typical example of this is the treatment 
of the scar left after a radical mastectomy procedure was performed on a breast cancer patient 
as described in section 4.6.3.3. An electron boost of 4–10 MeV is applied to ensure that no 
cancerous cells remain in that area that may result in further cancerous growth [29, p. 236]. 
The traditional method of shielding the healthy tissue surrounding the scar is by means of a 
wax casting, the fabrication process of which is explained with reference to Figure 5.3A-U. A 
radiation oncologist identifies and marks the borders of the scar tissue on the patient’s skin 
with a water based marker. Two or three layers of wet plaster bandages are laid down across 
the marked area on the patient while allowing for a sufficient border around the area. When 
the plaster bandage impression has set it is removed from the patient (Figure 5.3A). The 
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markings that were transferred from the patient’s skin to the inside of the impression are 
redrawn with the marker. The open ends of the impression are blocked with additional plaster 
bandages (Figure 5.3B). Plaster of Paris is mixed to a medium thick paste and the impression 
is filled with it (Figure 5.3C). After the plaster has set the plaster bandages are removed and 
the markings redrawn on the model (Figure 5.3D). 
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Figures 5.3A-U  Fabrication of a wax casting  
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A rectangular Perspex™ frame with a size according to the radiation field size to be applied 
during treatment is placed on the model (Figure 5.3E). The gap between the flat underside of 
the frame and the curvature of model is filled in with plaster bandages (Figure 5.3F). Papier 
mâché is used to fill the space between the frame and the edge of the scar tissue on the model 
(figures 5.3G and 5.3H). Liquid soap is painted over the area of scar tissue on the model to 
serve as separating medium (Figure 5.3I). Plaster of Paris is again mixed to a medium thick 
paste and the cavity formed by the papier mâché is filled with it (figures 5.3J and 5.3K). 
When the plaster has set it is taken out of the frame along with the papier mâché (figure 5.3L 
and 5.3M). The plaster as formed by the papier mâché is sawn on a band saw according to the 
shape of the markings that were transferred from the model (Figure 5.3N). The sawn piece of 
plaster is replaced inside the Perspex™ frame according to the position of the scar tissue and 
molten dental wax is poured into the cavity between the frame and the plaster (figures 5.3O 
and 5.3P). The wax has to be poured in consecutive layers with a cooling period in between to 
prevent cavities forming inside the casting while the wax cools (Figure 5.3Q). With the 
casting process complete, the plaster and frame are removed from the wax casting 
(Figure 5.3R). The wax needs to be at least 5 cm thick to shield a 4-6 MeV electron beam. For 
higher radiation energies additional shielding is required. For this purpose Wood’s alloy is 
melted and cast in a frame according to the size of the wax casting. The thickness of the alloy 
casting is dependent on the intensity of the radiation to be applied during treatment. The shape 
of the cavity in the wax casting is drawn on the alloy casting and is sawn on a band saw 
(Figure 5.3S). A heated instrument is used to solder the joint line once sawing is completed 
(Figure 5.3T). Masking tape is used to tape the alloy casting to the wax casting (Figure 5.3U). 
The finished wax and alloy casting is placed on the patient during treatment thereby limiting 
the radiation to the scar tissue. 
 
Disadvantages of the wax field shaping technique are: 
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    A wax casting is typically produced over a period of three days making this field 
shaping technique time consuming. The technologist has to wait for the plaster to set 
during each step of the process as well as for each layer of the wax to cool during 
casting. 
 A plaster bandage impression has to be taken of the area with the scar tissue that may 
be traumatic and uncomfortable to the patient. 
 Great care should be taken in trimming the plaster casting as formed by the papier 
mâché on the band saw (Figure 5.3N). This casting may be as thick as 11 cm and may 
easily slip while sawn with the possibility of serious personal injury to the 
technologist producing the wax casting.  
 
5.2.3  Shaped end-frames 
 
An electron field shaping technique often used in oncology departments is to fabricate 
Wood’s alloy shaped end-frames (also referred to as endplates) [17, p. 792], [39, p. 882], 
[46, p. 561]. Wood’s alloy, named after American metallurgist B. Wood is a eutectic alloy 
that becomes a liquid at a temperature of approximately 70 °C. The alloy is made up of 
bismuth, lead, tin and cadmium with the following percentages by weight: 50% Bi, 26.7% Pb, 
13.3% Sn and 10% Cd [43]. The alloy is also known as Cerrobend™, Bend alloy™, 
pewtalloy or Lipowitz metal [48]. Instead of conforming to the contours of the treatment area 
on the patient such as with lead masks or wax castings, shaped end-frames fit into the electron 
applicators in place of the standard square or rectangular end-frames. The fabrication process 
of a shaped end-frames is explained with reference to Figure 5.4A-F. The shape of the area to 
be treated on the patient is usually determined on the oncology department’s treatment 
planning system. A printout of the treatment plan is sent to the department’s workshop where 
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the treatment area is cut from the plan with scissors (Figure 5.4A). This piece of paper is 
glued to a block of polystyrene that is slightly thicker than what the end-frame needs to be. 
The shape of the treatment area is cut from the polystyrene on a hot wire cutter using the 
paper as guide (Figure 5.4B). 
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Figures 5.4A-F  Fabrication of a shaped end-frame 
 
The cut piece of polystyrene is centred on a special jig and is weighed down by means of lead 
blocks to prevent it from floating while casting the end-frame (Figure 5.4C). The jig is 
adjustable to accommodate all the different sizes of electron applicators that are available in 
the oncology department. There are four holes partially drilled through the base plate of the 
jig into which either removable inserts to blank off the holes or pegs can be inserted 
(Figure 5.4D). While casting the end-frame corresponding holes will be formed in the insert 
by the pegs. When the end-frame is fitted into the electron applicator the holes in the insert 
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line up with four micro switches in the applicator. This is registered by the accelerator as a 
binary code. Each end-frame can thus be individually coded to verify that the correct end-
frame will be used for a specific patient. The base plate is also equipped with two additional 
repositionable pegs that form locating holes in the end-frames. These locating holes are used 
to centre the end-frame in the applicator. The jig is placed on an aluminum block that has 
internal waterways. The block is connected to a hot water supply and is heated to a 
temperature above the melting point of the Wood’s alloy. Molten Wood’s alloy is poured into 
the cavity between the frame of the jig and the polystyrene up to the top level of the frame 
(Figure 5.4E). Cold water is passed through the aluminum block allowing the end-frame to 
cool rapidly.  It is preferable to cool the end-frame rapidly since slow cooling often causes air 
cavities forming inside the Wood’s alloy. When the end-frame has completely cooled it is 
removed from the jig and is spray painted to finish it off (Figure 5.4F). 
 
Disadvantage of shaped end-frames are: 
 
While this is a quick and easy way to create a radiation field shaping shield, it makes no 
provision for any curvature of the treatment area. Electrons will scatter past the edges of the 
shielded area with a stand-off allowing a larger area to be irradiated than intended. 
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CHAPTER 6 
 
THERMAL-SPRAY PROCESSES 
 
6.1  Introduction 
 
To overcome some of the disadvantages of the traditional low energy radiation field shaping 
techniques described in Chapter 5, the author investigated the possibility of using a thermal-
spray process as an alternative means of producing radiation field shaping shields.  A 
literature study was undertaken to determine if any one of the existing thermal-spray 
processes could be used as is or modified to fulfil this new role intended for it. 
 
6.2  What is thermal-spraying? 
 
Thermal-spraying is a generic term to describe a collection of processes involving 
acceleration of at least partially melted metallic or non–metallic particles to impact a surface 
thereby forming a coating. The first thermal-spray process was developed by Schoop in the 
late 19
th
 century. He discovered that the passage of zinc particles through a flame resulted in 
adhesion of the particles onto a surface [20]. This experiment initiated a series of process 
improvements leading to a wide range of coating methods. Today any material that can be 
plastically formed can be deposited onto a surface (i.e. the substrate) by thermal-spraying [3]. 
Functions, applications and recommended coating materials for different thermal-spray 
processes are shown in Table 6.1. 
 
Table 6.1  Functions, applications and coating materials for thermal-spraying [14] 
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Function 
 
Application Coating material 
Adhesive Wear Bearings, piston rings, 
hydraulic press sleeves 
  
Chrome Oxide, Babbit, 
Carbon Steel 
Abrasive Wear Guide bars, pump seals, 
concrete mixer screws 
 
Tungsten Carbide,    
Alumina  / Titania, Steel 
Surface Fatigue Wear Dead centers, cam followers, 
fan blades (jet engines), wear 
rings (land based turbines) 
 
Tungsten Carbide, Copper    
/ Nickel / Indium Alloy, 
Chrome Carbide 
Erosion Slurry pumps, exhaust fans, 
dust collectors 
 
Tungsten Carbide, Stellite 
Heat Resistance Burner cans / baskets (gas 
turbines), exhaust ducts 
 
Partially Stabilized Zirconia 
Oxidation Resistance Exhaust mufflers, heat treating 
fixtures, exhaust valve stems 
 
Aluminum, Nickel / 
Chrome Alloy, Hastelloy 
Corrosion Resistance Pump parts, storage tanks, 
food handling equipment 
Stainless Steel, Aluminum, 
Inconel, Hastelloy 
 
Electrical Conductivity Electrical contacts, ground 
connectors 
 
Copper 
Electrical Resistance Insulation for heater tubes, 
soldering tips 
 
Alumina 
Restoration of dimensions Printing rolls, undersize 
bearings 
 
Carbon Steel, Stainless Steel 
 
The raw coating material that is fed into the spray source may either be in wire, rod, powder 
or liquid form depending on the process. Solid materials are melted and atomized, powder 
particles are heated to semi-molten or molten state and liquids atomized before being 
propelled towards the substrate. The heat source may be either electrical or chemical 
(combustion) while the particles or droplets are accelerated by either compressed air or as a 
result of the combustion process [14]. The high thermo-kinetic energy imparted to the 
particles or droplets during the thermal-spraying process causes them to deform upon impact 
with the substrate. A coating forms by layering individual flattened particles, also known as 
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lamellae or “splats”, on top of one another. The lamellae form around prior surface features, 
cool and solidify [20].  Bonding of the coating to the substrate depends on both the material 
being deposited and the process used for deposition. If the materials are compatible, a 
chemical bond may form between the coating and base material. More commonly this is not 
the case making it necessary for the base surface to be roughened by a process such as grit 
blasting to provide a basis for a mechanical bond. The bonding strength between the structural 
elements within the coating determines the coating strength. This is referred to as cohesive 
strength while the bonding strength of the coating to the substrate is termed adhesive strength 
[20]. Defects found in thermal-spray coatings are pores or micro cracks in brittle materials 
while oxides and porosity characterize metal sprayed layers. Imperfections in coatings arise 
from unmelted particles, isolated large particles, low velocity impact, metal oxidation and 
cold induced fragmentation of splats [2]. 
 
6.3  Thermal-spray processes 
 
The most widely utilized thermal-spray processes are: Flame spray, Arc spray, Plasma spray, 
High velocity oxy-fuel spray and Molten material spray. A comparison between the different 
processes in terms of form of coating material, spray temperature and the velocity at which 
the particles or droplets are accelerated is shown in Table 6.2. Each of these processes is now 
discussed, in turn. 
 
 
 
Table 6.2  Comparison between different thermal-spray processes [2] 
Process 
 
Coating Material Temperature °C Velocity m/s 
Flame Spray Metal 3000 40-100 
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Arc Spray 
 
Metal 3000-6000 50-150 
Plasma Spray Metal, Ceramics, 
Thermo-plastics 
 
5000-25000 80-300 
HVOF Spray Metal, Ceramics 
 
3000 400-800 
Molten material Spray Metal, 
Thermo-plastics 
 
400-3000 50-150 
 
6.3.1  Flame spray process 
 
With this process oxygen and acetylene are burnt in a special nozzle as shown in Figure 6.1. 
 
 
 
 
1. Wire feed rollers 3. Compressed air 
2. Wire 4. Oxygen and acetylene 
 
Figure 6.1  Flame spray gun [34] 
 
The coating material, in wire form, is fed through the centre of the nozzle into the flame 
where it is melted. The molten material is atomized by a cone of compressed air around the 
flame and is propelled towards the substrate [34]. 
1  
2 
3 
4 
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6.3.2  Arc spray process 
 
In the arc spray process, two wires made of the coating material are fed simultaneously 
through a gun at an angle so as to meet as they exit from the gun. The wires are electrically 
charged, one positive and one negative as shown in Figure 6.2. 
 
 
 
1. Positive wire 4. Negative wire 
2. Compressed air 5. Shroud 
3. Contact tube 6. Nozzle 
 
Figure 6.2  Arc spray gun [34] 
 
When the wires come into contact with each other an electric arc (ionized path) is formed 
melting the material. Compressed air is injected just behind the arc, atomizing the metal and 
propelling it towards the substrate. Advantages of the arc spray process are high adhesive 
strength of the deposits while the use of compressed air and electricity alone produce more 
economic coatings [14], [34]. 
1  
2 
3 
4 
5 
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6.3.3  Plasma spray process 
 
A plasma is created by an electric arc forming in an inert gas atmosphere between the cathode 
and anode within a plasma spray gun as shown in Figure 6.3. The expanding inert gas passing 
through the gun is formed into a high velocity plasma jet by the gun’s nozzle. 
 
 
 
1. Nozzle (Anode) 4. Coating material 
2. Cathode 5. Plasma 
3. Inert gas  
 
Figure 6.3  Plasma spray gun [34] 
Coating material in powder form is injected into this jet where it is melted and accelerated 
towards the coating surface [34]. This process is termed atmospheric plasma spraying (APS). 
To avoid oxidization of the heated particles traveling to the coating surface, spraying can be 
carried out in an inert gas atmosphere at reduced pressure. This is known as vacuum plasma 
spraying (VPS) or low pressure plasma spraying (LPPS) [5, p. 205]. Deformation of the 
1  
2 
3 
4 
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coating surface is limited with plasma spraying since the heat source in the form of a plasma 
is localized at the gun [34]. 
 
6.3.4  High Velocity Oxy-Fuel (HVOF) spray process 
 
Hydrogen and oxygen are fed under regulated pressure into a combustion chamber where they 
burn to produce a hot, high pressure gas stream as shown in Figure 6.4.  
 
 
 
1. Fuel 4. Cooling water in 
2. Oxygen 5. Coating material 
3. Hydrogen 6. Cooling water out 
 
Figure 6.4  HVOF spray gun [34] 
This gas stream is expanded through a Laval type nozzle increasing the gas velocity and 
decreasing the pressure to slightly above atmospheric. At this reduced pressure the coating 
material in powder form can easily be injected into the gas stream.  The gas stream heats and 
accelerates the powder particles to a high velocity within the nozzle so that they impact the 
substrate with tremendous energy. Oxidation and decomposition of sprayed coatings are 
1 
2 
3 
4 
5 
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minimal with this process since the particles are not subjected to very high temperatures and 
traveling time from the gun to the substrate is short [34]. 
 
6.3.5  Molten material spray 
 
Molten material spray refers to pre-melted feedstock material that is fed to the thermal-spray 
gun in molten rather than solid or powder form as is the case with the spray processes already 
mentioned. A number of different types of apparatus are available, as discussed below. 
 
6.3.5.1  Force fed spraying apparatus 
 
In his 1943 patent, Brennan describes an invention for spraying pure pre-melted aluminum. 
The spraying apparatus comprises a cylindrical pressure chamber with a removable lid that is 
secured by a number of bolts as shown in Figure 6.5. An electrically heated crucible is 
supported on rails within the pressure chamber. Aluminum billets are placed inside the 
crucible and melted with the pressure chamber’ s lid bolted shut. Gas is forced into the 
pressure chamber thereby applying pressure onto the surface of the molten aluminum inside 
the crucible. An inert gas such as nitrogen is utilized for pressurization to prevent oxidization 
of the molten aluminum. 
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1. Pick-up tube 4. Nozzle 
2. Heating elements 5. Compressed air 
3. Crucible 6. Compressed inert gas 
 
Figure 6.5  Force fed spraying apparatus [8] 
 
The molten aluminum is forced out of the pressure chamber to a spray nozzle through an 
insulated conduit. Compressed air is supplied to the spray nozzle to atomize the liquid 
aluminum and to accelerate the metal droplets onto the coating surface [8]. 
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6.3.5.2  Portable spraying apparatus 
 
In 1973 Payne patented a portable thermal-spraying apparatus. The apparatus is equipped with 
an insulated container with a heating element installed at the bottom as shown in Figure 6.6. 
 
1. Heating element 4. Heating element 
2. Nozzle 5. Trigger 
3. Pick-up tube 6. Compressed air supply 
 
Figure 6.6  Portable spraying apparatus [36] 
 
A spray head with a pick-up tube that is connected to venturi inside the head is mounted on 
top of the container. Fusible metal or metal alloy billets are placed inside the container and are 
melted by the heater. Heated air is supplied under pressure to the spray gun. A second electric 
heater is installed in the spray head. This heater super heats a portion of the air from the air 
supply to a temperature at or above the melting point of the metal. The pre-heated air from the 
air supply flows at high velocity through the venturi inside the spray head. This causes the 
molten metal to be siphoned from the container through the pick-up tube and transported to 
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the spray nozzle. The air from the nozzle atomizes the liquid metal and together with the air 
flowing through the venturi accelerates the droplets. The super heated air from the nozzle 
ensures that the droplets remain in a liquid state while traveling to the coating surface [36]. 
 
6.3.5.3  Gravity fed spraying apparatus 
 
Baiker (1954) describes a thermal-spray apparatus in his patent for spraying thermo-plastic 
materials such as synthetic resin, bitumen or shellac. The spraying apparatus consists of an 
insulated container, a double walled flexible hose and a spray gun as shown in Figure 6.7. 
 
1. Heating elements 3. Spray gun 
2. Heated compressed air 4. Flexible hose 
 
Figure 6.7  Gravity fed spraying apparatus [4] 
 
Heating elements are installed in the walls of the container to melt the thermo-plastic material. 
The molten material flows under gravity through the flexible hose to the spray gun. To 
prevent the material from cooling and solidifying in the gun and hose, pre-heated compressed 
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air is forced between the inner and outer walls of the hose and out of the gun’s nozzle. 
Besides heating the hose and gun the air also atomizes the thermo-plastic material in the spray 
gun’s nozzle and accelerates the droplets onto the coating surface [4]. 
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CHAPTER 7 
 
DEVELOPMENT OF NEW THERMAL-SPRAY EQUIPMENT 
 
7.1  Introduction 
 
This chapter describes the patented thermal-spray equipment (see Addendum D), that was 
designed and fabricated for the research project. The author decided on the following criteria 
regarding the thermal-spray equipment and the feedstock material used for producing 
radiation field shaping shields. The criteria were set to be in the best interest of the operator 
that will be producing the shields as well as the patient during treatment. 
 
 The spray of shielding material should be contained to prevent the material from 
spreading in the radiotherapy departments mould room where the radiation field 
shaping shields will be produced. 
 The equipment used for producing the radiation field shaping shields should be both 
user and environmentally friendly not to expose the operator or environment to 
hazardous metal dust or gasses. 
 It should be possible to fabricate the thermal-spray equipment with locally available 
tools and machinery from affordable components to make the project financially 
viable. 
 The material used for producing radiation field shaping shields should be recyclable in 
order to make the technique cost effective. 
 It should be possible to produce a radiation field shaping shield within a reasonable 
time frame using the thermal-spray equipment. 
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 The shielding material used in the process should be of high enough density to 
effectively block low energy radiation without the shield becoming too heavy for the 
patient to bear. 
 
7.2  Shielding material 
 
The material chosen for producing radiation field shaping shields by thermal-spraying was 
Wood’s alloy. This is the same material as described in section 5.2.3 for casting shaped end-
frames. Wood’s alloy is used in modern radiotherapy departments where the alloy is 
commonly used to shield radiosensitive areas during high energy X-irradiation. It is cast in 
9 cm blocks according to the shape of the area to be shielded and is positioned in the radiation 
field during treatment for that application. Because of the alloy’s low melting point of 70ºC it 
was decided to pre-melt the alloy and feed it to the thermal-spray gun in liquid rather than 
solid or powder form. A high flow rate of the alloy through the gun is possible with this 
technique resulting in a rapid build-up of the alloy on the substrate during spraying. 
 
7.3  Thermal-spray cabinet: Mechanical design and fabrication 
 
Since none of the existing thermal-spray techniques and equipment described in Chapter 6 
meets all of the criteria set in section 7.1, it was decided to design new thermal-spray 
equipment tailor-made to produce radiation field shaping shielding masks. In this design the 
alloy is sprayed in an enclosed cabinet as shown in Figure 7.1. The spray cabinet is of steel 
construction with a framed Perspex™ lid hinged at the back of the cabinet. 
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Figure 7.1  Thermal-spray cabinet Figure 7.2  Inside spray chamber 
 
Over-center catches are used to lock the lid shut before spraying. Access to the inner 
workings of the apparatus is possible through two hinged doors at the front of the cabinet.The 
top half of the cabinet is a double walled construction with the inner wall made of stainless 
steel. This inner container (referred to as the spray chamber) has a sloped bottom with a drain 
hole at the lowest point and has two rubber gloves attached to its front wall as shown in 
Figure 7.2. The operator has access to the spray gun and model to be sprayed through these 
gloves. The spray gun is similar to that used for paint spray purposes but was modified by 
attaching a 12 V heating element to the frame of the gun as shown in Figure 7.3. The gun is 
connected to a melting pot as shown in Figure 7.4 attached to the outside of the cabinet by 
means of a tube to feed the molten Wood’s alloy to the gun. The feed tube consists of an inner 
and outer silicone tube with a nickel-chrome resistance wire coiled around the inner tube. 
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Figure 7.3  Spray gun Figure 7.4  Melting pot 
 
An electrical current of 24 V is applied to the resistance wire to provide heat to the Wood’s 
alloy flowing through the inner tube. This is to prevent the alloy from cooling and setting 
while passing through the tube. The melting pot is a double walled construction with two 
12 V heating elements installed in the inner container. The outer wall is insulated from the 
inner container to prevent heat transfer to the outer surface of the pot that might lead to injury 
to the operator. Compressed air from an outside source is supplied to the spray gun via a 
pressure regulator / water trap to ensure a constant flow of clean air. 
 
7.3.1  Model support stands 
 
To support the models in the spray chamber while spraying two stands and a support frame 
were constructed. The first stand as shown in Figure 7.5 is equipped with a turntable that is 
supported by a lockable universal joint and is intended for small models. The second stand is 
intended for larger models and is a square tubing construction mounted on a ball bearing as 
shown in Figure 7.6. 
 101 
    
 
Figure 7.5  Stand for small models Figure 7.6  Stand for large models 
 
Both stands were made to slide on the square tubing support frame. The stands and frame are 
positionable inside the spray chamber to suit the operator. 
 
7.3.2  Cleaning system of spray chamber 
 
A result of spraying Wood’s alloy inside the spray cabinet is that over sprayed alloy and dust 
accumulate on the inner walls and bottom of the spray chamber. In order to clean the spray 
chamber a small boiler was constructed as shown in Figure 7.7 with the inside of it’s lid 
shown in Figure 7.8. The boiler is equipped with a 3 kW heating element that is able to heat 
the 20 liters of water it holds to boiling point in 45 minutes. The working principal of the 
cleaning cycle is explained with reference to Figure 7.9. Hot water is pumped from the boiler 
to the spray chamber by means of a small circulating pump. The hot water is sprayed onto the 
accumulated alloy on the walls and floor of the chamber by the operator. A removable 
flexible hose that connects to a socket in the inner left side wall of the spray chamber is used 
for this purpose. The alloy melts and flows with the water back to the boiler where the alloy is 
caught in a trap. 
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Figure 7.7  Boiler Figure 7.8  Boiler lid 
 
The boiler can be removed from the spray cabinet by disconnecting the couplings to the spray 
chamber outlet and the circulating pump as well as the heating element’s plug. After opening 
the four over-centre catches that keep the boiler’ s lid shut, the alloy trap can be removed in 
order to recover the Wood’s alloy. 
 
7.3.3  Air filtration system 
 
Compressed air is forced into the spray chamber via the spray gun during the spraying process 
resulting in a higher air pressure inside the chamber than outside. This excess air needs to be 
filtered to remove the Wood’s alloy dust that forms as a result of spraying before it exits the 
spray cabinet. Inhalation of this dust will be very detrimental to the operator’s health 
considering the lead and cadmium content of the alloy. 
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To overcome this problem an air filtration system was devised as explained with reference to 
Figure 7.9. A vacuum cleaner with a high efficiency particulate (HEPA) filter is connected to 
the boiler inside the spray cabinet as shown in Figure 7.10. 
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Figure 7.10  Inside of spray cabinet 
 
HEPA filters are able to remove at least 99,97% of airborne particles with a diameter of 
0,3 micrometers (µm). Particles of this size are considered to be the most penetrating and are 
consequently the most difficult to filter. Larger or smaller particles are removed with even 
higher efficiency by a HEPA filter [13]. The boiler is connected to the outlet of the spray 
chamber, the same way as it would be for the cleaning cycle. Vacuum is drawn on the boiler 
by means of the vacuum cleaner resulting in air flowing from the spray chamber through the 
boiler to the vacuum cleaner.  Since the inlet into the boiler is below the water surface inside 
the boiler the airflow will cause the water to bubble trapping airborne alloy dust in the 
process. Any dust passing through the boiler will subsequently be caught by the vacuum 
cleaner’s air filter. Air from the vacuum cleaner’s outlet pipe is split allowing part of the air to 
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be recirculated back to the inlet of the spray chamber via a control valve. The surplus air is 
vented outside the building. By adjusting the control valve the vacuum inside the spray 
chamber can be increased or decreased as required. The spray chamber is constantly 
ventilated by air passing through the chamber from the inlet to the outlet while the air 
filtration system is in operation. This flow of air effectively removes any airborne alloy dust 
particles resulting from spraying from the air inside the chamber. The possibility of the 
operator inhaling any of the dust upon opening the spray cabinet’s lid to take out the model 
after spraying is thus minimized. 
 
7.3.4  Interlock system 
 
In order to prevent the operator from operating the spray gun with the spray cabinet’s lid open 
or without the air filtration system switched on some interlocks were installed as safety 
precautions. The air line to the spray gun is equipped with a solenoid valve and the cabinet’s 
lid with a switch. The lid’s switch is positioned such that it rests on the Perspex™ window of 
the lid. When vacuum is drawn on the spray chamber with the lid closed, the window flexes 
slightly inwards thereby operating the switch and switching on the solenoid valve. Should the 
lid be opened while spraying or the airflow of the filtration system interrupted in any way, the 
vacuum in the spray chamber will fall away switching off the solenoid valve, thereby 
terminate spraying. A water level switch is also mounted inside the boiler. When the water 
level falls below a specified depth, it will not be possible to switch on the heating element. It 
will also not be possible to switch on the vacuum cleaner without sufficient water in the 
boiler. Too low a water level inside the boiler will not allow the air to bubble sufficiently 
through the water rendering the air filtration system ineffective. Without vacuum the lid 
switch will not be activated and as a result neither will the solenoid valve open, making 
spraying impossible. 
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7.4  Thermal-spray cabinet: Electronic design and fabrication 
 
All electrical features of the thermal-spray cabinet are controlled by a PIC18F452 
microcontroller running at a clock speed of 40 MHz. The microcontroller, a liquid crystal 
display (LCD), push buttons and circuitry are all mounted in a control box that is attached to 
the left-hand side of the cabinet. The control box is shown in Figure 7.11 with its inner 
workings in Figure 7.12 while Figure 7.13 shows the complete layout of the thermal-spray 
cabinet’s circuitry schematically. 
 
    
 
Figure 7.11  Cabinet control box Figure 7.12  Inner workings of control box 
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The microcontroller switches the vacuum cleaner, water heating element, circulating pump 
and solenoid valve on or off as required through solid state relays. The status of the vacuum 
and water level switches provide the microcontroller with input in determining switching for 
these components. 
 
7.4.1  Spray gun, feed tube and melting pot heating 
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Also controlled by the microcontroller through solid state relays are the temperatures of the 
heating elements in the spray gun, alloy feed tube and melting pot. The 12 V to the heating 
elements in the gun and pot and 24 V to the alloy feed tube are supplied by a transformer 
mounted in a separate compartment in the back of the spray cabinet as shown in Figure 7.14. 
 
 
 
Figure 7.14  Solid state relays, transformers and circuitry 
Also mounted in the compartment are the solid state relays, a 9 V transformer that supplies 
power to the microcontroller and a distribution board that connects the relays to the 
microcontroller. LM35 heat sensors mounted on the gun, pot and pipe sends analogue signals 
to the microcontroller. The microcontroller converts the analogue signals to digital signals 
through a built-in 10 Bit analogue to digital converter. This information allows the 
microcontroller to accurately regulate the temperatures of the gun, pot and pipe at the 
temperatures set by the operator. 
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7.4.2   Duty cycle of heating element 
 
The duty cycle and thus the rate of heating of the elements in the gun and pot are adjustable 
through the microcontroller. Since it was not possible to mount the heat sensors directly onto 
the heating elements, they had to be mounted in the closest convenient position on the gun 
and pot. This distance between the elements and sensors causes the sensor readings to lag 
behind the temperature of the elements. This is because it takes time for the heat to conduct 
from the elements to the sensors. By the time the heat sensor reaches the temperature set by 
the operator and the microcontroller switches off the element, the element has over-run this 
set temperature by a number of degrees Celsius. This effect is dependant on the rate at which 
the elements are heated. The higher the rate of heating, the greater the temperature over-run. 
Heating the elements at a reduced duty cycle will allow more time for heat conduction to the 
sensors making more accurate temperature control possible through the microcontroller. An 
over-run in temperature may cause the Wood’s alloy close to the elements to be heated to 
above its boiling point of 120 ºC which is undesirable. 
 
 
7.4.3  Airflow switch 
 
Provision was made to boost the spray gun’ s temperature while spraying. Air flowing through 
the gun when the trigger is pulled causes the gun’s nozzle to cool down rapidly to below the 
melting point of the Wood’s alloy. This causes a blockage in the flow of the alloy making 
further spraying impossible. Spraying can only continue by stopping the air flow through 
releasing the trigger and waiting for the nozzle to heat up again. The reduced duty cycle at 
which the gun is normally operated is insufficient to keep the nozzle properly heated during 
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spraying. It is possible to heat the element at a higher duty cycle but this will cause an 
unacceptable temperature over-run as described in the previous section. 
 
The problem was solved by having the microcontroller switch the gun’s element to a higher 
duty cycle only while air is flowing through the gun. Mounting a switch behind the trigger on 
the gun’s frame was considered a means of signaling airflow to the microcontroller. The gun’s 
design did however not allow for a switch to be mounted in that position. As an alternative the 
author fabricated an airflow switch that is mounted in the air line between the gun and the 
solenoid valve. The airflow switch consists of a tube into which a cylindrical magnet fits 
loosely. A magnetic reed switch is mounted next to and close to the top of the tube. When the 
spray gun’s trigger is pulled, air passes through the tube and forces the magnet upwards. This 
brings the magnet into close proximity with the reed switch activating it through its magnetic 
field. This is noted by the microcontroller with which the switch is connected. The 
microcontroller overrides the signal from the heat sensor mounted on the gun and switches on 
the element at an increased duty cycle (as specified by the operator) for as long as the trigger 
is held in. When the spray gun’s trigger is released the airflow stops, the magnet falls back, 
the reed switch is deactivated and the microcontroller returns the gun’s element to normal 
temperature control. The additional heat generated by switching on the element at a higher 
duty cycle during spraying is sufficient to compensate for heat loss due to the airflow through 
the gun. Spraying can thus be performed continually without blockages in the flow of Wood’s 
alloy. 
 
7.5  Thermal-spray cabinet: Software 
 
The microcontroller performs its functions under the directions of a software program written 
in the programming language C. The functions of the program are presented in the form of a 
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flow chart shown in Figure 7.15. It consists of a sequence of representations of the control 
box with the LCD display, indicator lights and four push buttons shown. The program 
displays information pertaining to the thermal-spray apparatus and possible control options on 
the LCD screen. Two-colour light emitting diodes (LED’s) mounted in the push buttons 
indicate to the operator which buttons are available to choose from under a given control 
option. The LED’s in the buttons turn from green in standby mode to red if pressed to show 
that a specific function has been activated. Two indicator lights mounted above the LCD 
screen indicate to the operator whether the thermal-spray cabinet is in spraying or cleaning 
mode. Figure 7.16A shows the setup sequence for adjusting the gun, pot and pipe 
temperatures as well as for the water pump speed. The duty cycle setup sequence for the gun, 
pot, pipe and the temperature boost to the gun during spraying is shown in Figure 7.16B. The 
temperature and duty cycle menus are accessible by pressing the buttons on the control box 
indicated in the flow charts in combination. 
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Figure 7.15  Flowchart indicating spray cabinet control options 
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Figure 7.16A  Flowchart indicating 
 
temperature setup 
Figure 7.16B  Flowchart indicating duty 
 
cycle setup 
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CHAPTER 8 
 
THERMAL-SPRAY RADIATION FIELD SHAPING TECHNIQUE 
 
8.1  Introduction 
 
To overcome some of the disadvantages of the traditional radiation field shaping techniques 
described in Chapter 5, the author developed a new thermal-spray field shaping technique¹. 
Different procedures to obtain the contours of the treatment area and methods to fabricate the 
model onto which the shielding alloy is sprayed to produce a field shaping mask were 
investigated. Figure 8.1 shows the thermal-spray field shaping technique with the different 
contour acquisition and model fabrication techniques graphically. 
 
8.2  Treatment area contour acquisition techniques  
 
In order to produce a thermal-sprayed field shaping mask that fits the patient properly, the 
topography of the treatment area on the patient needs to be determined accurately. The 
contours of the treatment area can be acquired either through direct contact with the patient’s 
skin or through various non-contact techniques. 
 
 
 
____________________________________________________________ 
¹ also see published article regarding the subject in Addendum E 
 115 
Treatment area requiring shielding
Patient contact contour
determination
Patient non-contact contour
determination
Plaster bandage impression 3D laser scan
LS CNC milling
Plaster model
Nylon polyamide
model
Polyurethane
model
Thermal-spraying
Thermal-sprayed mask
 
 
 
 
Figure 8.1  Flowchart of the thermal-spray field shaping technique 
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8.2.1  Patient-contact contour acquisition 
 
The most basic technique to acquire the contours of the treatment area for producing a 
thermal-sprayed mask is by taking an impression of the area with plaster bandages. This is the 
same technique as is described in section 5.1 for producing a lead mask and section 5.2 for 
producing a wax casting. Taking a plaster bandage impression of the patient may be traumatic 
and uncomfortable to the patient as is also mentioned under the disadvantages of the 
traditional field shaping techniques. If tumor mass shrinkage occurs during the period of 
radiation treatment, the fit of a radiation field shaping mask will become unsatisfactory. This 
necessitates a second plaster bandage impression to be taken of the contour altered treatment 
area to produce a revised field shaping mask. If the skin that is sensitive from the radiation 
comes into contact with the wet plaster bandages, severe skin reaction may result [51, p. 91]. 
Open wounds, such as those commonly encountered with advanced skin cancer patients, pose 
another problem for taking plaster bandage impressions. Placing a thin plastic film over the 
wound makes taking the impression possible but may still be very uncomfortable for the 
patient. 
 
8.2.2  Patient non-contact contour acquisition 
 
Non-contact contour acquisition is understood to mean that no physical contact with the 
patient’s skin is required to determine the treatment area’s contours. Not touching the patient 
during contour acquisition presents some obvious advantages over the traditional plaster 
bandage technique as described in the previous section. Literature describes various non-
contact contour acquisition techniques including: 
 
 Iso-height light projection [27, p. 741] 
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 Moiré fringes [33, p. 513], [7, p. 20] 
 Stereo imaging [15, p. 646] 
 Computer tomography (CT) scanning [23, pp. 241–245], [45] 
 3D laser scanning 
 
8.2.2.1  3D laser scanning 
 
A 3D laser scanning technique that was first developed by the National Research Council of 
Canada in 1978 shows some advantages over the other mentioned techniques in terms of 
either speed or accuracy of contour acquisition [30]. This technique, also known as laser 
triangulation scanning, makes use of a low power laser emitter and a monochrome solid state 
video camera. The working principal of the scanner is explained with reference to Figure 8.2. 
 
 
 
Figure 8.2  Schematic representation of a triangulation(3D) laser scanner 
 
The laser emitter is mounted perpendicular to the working surface and the camera at a set 
angle (Q) with respect to the laser emitter. The laser emitter shines a laser dot on the object to 
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be scanned while the camera views the location of the dot on the object. Depending on how 
far away from the laser emitter the dot strikes the object, the dot appears at different places in 
the camera’s field of view. The laser dot, laser emitter and the camera forms a triangle where 
the distance between the emitter and the camera is known (z) as well as the distance of the 
laser emitter from the working surface (u). The distance between the camera lens and the 
charged couple device (CCD) inside the camera is also known (w). The angle of the camera’s 
view of the laser dot (S) can be determined through the location of the dot in the camera’s 
field of view (y). With all the variables known, the displacement from the working surface to 
the object surface (x) can be determined through triangulation. A projected laser line instead 
of a single dot is used in most cases to speed up the contour acquisition process. The object to 
be scanned is moved across the laser line at a steady speed while the camera takes frames of 
the deformation of the line. The frames are taken at equal increments of linear motion of the 
object by making use of a frame-grabber equipped personal computer. By combining all the 
taken frames, the contours of the object can be accurately determined. In a radiotherapy 
application, the laser emitter and camera combination can be attached to the head of a linac or 
simulator². Andrew and Aldrich [1, p. 426] describe such an installation on a simulator where 
longitudinal movement of the patient is made possible by making use of the simulator’s 
motorized table. Contour acquisition can also be performed by rotating the linac or 
simulator’s gantry with the patient at isocentre height [11]. A readout of table position or 
gantry angle is required from the machine involved to time the scanner’s frame grabber for 
these two techniques. 
 
___________________________________________________________________________ 
² a diagnostic X-ray unit with dimensions similar to that of a linac that is used in planning patient setup 
8.2.2.2  Konica Minolta™ laser scanner 
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Improving on the basic triangulation laser scanner is a laser scanner developed by Konica 
Minolta™ as shown in Figure 8.3. The VI-910 also makes use of a projected laser line and 
CCD camera but instead of having to move the object to be scanned across the laser line, the 
laser line is swept across the object by a mirror. Very accurate mirror rotation is made 
possible through a high precision galvanometer. The deformation of the laser line while 
sweeping across the object is captured by the scanner’s CCD camera which rapidly takes 
frames at equal increments of mirror rotation. The surface contour of the object is derived 
from the image of the line in each frame through triangulation. Two scanning modes are 
available on the VI-910 scanner: Fine mode collects 307200 data points in as little as 
2.5 seconds while Fast mode collects 76800 data points in an even faster 0.3 seconds. 
 
 
 
Figure 8.3  Konica Minolta™ VI- 910 laser scanner 
This quick scanning ability makes the scanner ideal for scanning areas on patients that are 
prone to movement. Examples of these are the torso where movement occurs because of 
breathing and areas on small children which are difficult to keep still during contour 
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acquisition. Scanning areas of approximately 10 cm² to 1 m² are possible with the VI-910 at 
distances of 0.6-2 m. The scanners come standard with their own Polygon Editing Tool (PET) 
software. The software converts the surface data to a lattice of vertices (connected points) to 
create a polygonal-mesh with all connecting information retained. In doing so geometric 
ambiguities are eliminated and detail capture improved. The software also allows the user to 
edit and convert the scanned data into any of several common data formats including: DXF, 
STL, Wavefront, Softimage, VRML 2.0 and MGF. These data formats are applicable to rapid 
prototyping (RP), reverse engineering (RE), computer aided design (CAD), computer aided 
machining (CAM) and 3D modeling technologies. Editing functions that the software 
provides include; filtering of irregular polygons and noise and perform smoothing. The 
scanner captures 24-bit colour images simultaneously with acquiring surface information 
using the same CCD. These colour images are produced through a rotating filter inside the 
scanner that separates the acquired laser light [26]. A colour image can be superimposed onto 
the surface information using the software supplied with the camera. This makes it possible to 
reproduce the borders of the treatment areas that were marked on the patient’s skin in the 
surface information. 
 
8.3  Techniques for producing models for thermal-spraying 
 
Once the topography of the treatment area has been accurately determined, the contours of the 
area need to be reproduced in a suitable medium onto which the molten shielding material can 
be sprayed. This reproduction of the treatment area, or simply referred to as a model of the 
area, can be produced through various techniques and will be used to produce a field shaping 
mask. Three techniques for producing models for thermal-spraying will be discussed next. 
The first technique makes use of a patient contact contour acquisition technique (plaster 
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bandage impression) while the remaining two techniques use a non-contact technique (3D 
laser scanning). 
 
8.3.1  Thermal-spray models through plaster bandage impressions 
 
Plaster bandage impressions can be used to produce plaster models for thermal-spraying 
which is the same as would be done for the traditional lead masks and wax castings. A model 
for thermal-spraying can be produced from standard Plaster of Paris instead of Yellow stone 
plaster that is required for producing a lead mask. Plaster of Paris can be used since the model 
need not be as strong for thermal-spraying as it needs to be for forming a lead mask. The 
markings of the treatment area that were transferred from the patient to the model through the 
plaster bandage impression need to be scribed onto the model using a scriber. When the 
sprayed mask is removed from the model, the scribed markings will be visible inside the 
mask. 
 
8.3.2  Thermal-spray models through laser sintering 
 
Laser sintering (LS) is a rapid manufacturing technique that was developed and patented by 
Dr. Carl Deckard at the University of Texas at Austin in the mid-1980s [41]. The LS process 
is explained with reference to Figure 8.4. 
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Figure 8.4  Schematic representation of the LS process [41] 
 
To manufacture a part through LS, a computer generates cross-sections of the part from a 3D 
digital description of the part. Various software packages (for example Magics RP) are 
commercially available to perform this operation.  The digital description of the part may be 
either a CAD file of the part or it may be a digital scan of an existing part. A laser beam from 
a high power laser is controlled to scan a cross-section of the part onto a bed of powdered 
material thereby selectively fusing the particles of the material. After a cross-section is 
scanned, the powder bed is lowered by one layer thickness. A new layer of material is laid 
down on top of the previous layer and scanning continues. Besides fusing the particles in a 
layer together during scanning, the particles are also fused to the scanned particles in the 
previous layer [41]. This process is repeated until the part is completed. A relatively wide 
range of powder materials are available to produce parts through LS. These include: nylon, 
polystyrene, steel, titanium and composites [52, p. 13]. Figure 8.5 shows an EOSINT™ P385 
LS manufacturing system at the Central University of Technology Free State. 
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Figure 8.5  EOSINT™ P385 LS manufacturing system 
 
If LS is to be used to produce models for thermal-spraying the treatment area on the patient 
needs to be digitized. A laser scanner such as the Konica Minolta™ VI- 910 described in 
section 8.2.2 will be ideal for this purpose. The model can be produced in nylon polyamide 
which is a material well suited to low temperature thermal-spraying. Since the VI- 910 
scanner makes it possible to reproduce the treatment area’s border markings in the surface 
data of the patient, the markings can also be reproduced on the LS model. A convenient 
means of reproducing the markings on the model is by creating a hole in the model according 
to the markings when the digital description of the model is prepared. 
 
8.3.3  Thermal-spray models through CNC milling 
 
A computer numerical controlled (CNC) milling machine can be used to reproduce the 
contours of the cancer affected area on the patient in a block of material that will be suitable 
for thermal-spraying. There are various 3-axis CNC milling machines commercially available 
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that will be able to perform this task. Figure 8.6 shows a Torchmate™ CNC cutting system 
from Applied Robotics Inc. that was used to investigate the feasibility of this model 
fabrication technique. 
 
 
 
Figure 8.6  Torchmate™ CNC cutting system  with router modification 
 
The machine is normally used for CNC plasma cutting and was modified by replacing the 
plasma torch with a router. A 6 mm ball nosed cutter was used for milling the model in a 
block of polyurethane foam. In order to create a digital description of the treatment area, the 
relevant area on the patient needs to be digitized. A 3D laser scanner such as the Konica 
Minolta™ VI-910 is similarly to the LS application also ideally suited to this application. The 
scanned data either in STL or IGES format can be used to generate CNC codes according to 
which the CNC machine will be able to perform the milling operation. There are various 
CAD/CAM packages commercially available to generate the codes using STL files as input. 
The treatment area markings can be reproduced in the digital description of the model 
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allowing the CNC machine to mill a hole in the model to coincide with the treatment area on 
the patient. 
 
8.4  Producing thermal-sprayed masks 
 
The author’s aim in developing the thermal-spray radiation field shaping technique was to 
replace all of the traditional field shaping techniques described in Chapter 5. Through this 
new technique it should be possible to shape any radiation field commonly used in the 
treatment of superficial cancerous lesions independent of the field size or skin surface 
contours. 
 
8.4.1  Thermal-sprayed masks for small treatment fields 
 
Thermal-sprayed masks can be produced to shield around small low energy X-ray or electron 
treatment fields. This task was traditionally performed by lead masks. The procedure for 
fabricating the thermal-sprayed masks is explained with reference to Figure 8.7A-F. The 
model (produced through any of the techniques described in section 8.3) is placed inside the 
spray chamber of the thermal-spray cabinet and layers of Wood’s alloy are sprayed onto it 
(Figure 8.7A). When a sufficient build-up of alloy has formed on the model, the mask is 
removed and its thickness measured by means of a purpose made outside caliper 
(Figure 8.7B). The required mask thickness is determined by the intensity of the radiation to 
be applied during treatment as described in section 9.3. If the mask measures too thin, it is 
replaced onto the model and further layers of alloy are sprayed onto it. 
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Figure 8.7A-F  Fabricating a thermal-sprayed mask for a small electron treatment field 
 
When the thickness measures correctly the mask’s outer dimensions can be determined. This 
entails adding a border of sufficient width (to stop radiation scatter outside the primary beam) 
to the radiation field size that will be applied during treatment. A border width of 4 cm 
measured perpendicular to the central axis of the treatment beam was decided upon. This 
width was derived from the degree of scatter caused by a 4 MeV electron beam with a stand-
off (see section 9.2.4.2) plus an additional margin added for safety. This border width is also 
sufficient for masks used with low energy X-ray treatment on a kilovolt unit. Low energy 
photons scatter less in air than electrons for the same field size and stand-off. Once the mask’s 
outer dimensions have been determined it can be marked out on the surface of the mask. A 
band saw can be used to cut the mask to size (Figure 8.7C) where after all edges need to be 
made smooth using files and sanding paper. If the mask was produced from a plaster model, a 
hole needs to be made in the mask according to the area on the patient that requires radiation 
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treatment. Using a small soldering iron, this hole can be melted into the mask (Figure 8.7D) 
according to the markings of the treatment area that was transferred from the patient (see 
section 8.3.1) to the mask. Melting the portal should be done in a well ventilated area to 
prevent the operator from inhaling any fumes that may result from melting the alloy. If a LS 
or CNC milled model is used there will be a hole in the model according to the treatment 
markings that was produced through the specific model fabrication technique. This hole will 
be reproduced in the mask when the alloy is sprayed onto the model requiring the technologist 
only to make the edges of the hole smooth. A mask that was produced through thermal-
spraying onto a traditional plaster model is shown in Figure 8.8. Figures 8.9 and 8.10 shows 
thermal-sprayed masks that were produced from LS and CNC milled models respectively. 
The LS model was created in nylon polyamide while the CNC milled model was machined 
from a block of polyurethane foam. All the masks shown are intended for shielding low 
energy X-rays in the 100-250 kV range. 
 
  
 
Figure 8.8  Thermal-sprayed mask produced from traditional plaster model 
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Figure 8.9  Thermal-sprayed mask produced from LS model 
 
 
 
Figure 8.10  Thermal-sprayed mask produced from CNC milled model 
 129 
If the mask is to be used for electron beam field shaping, an aluminum frame with outer 
dimensions the same as the end of the electron applicator to be used during treatment needs to 
be attached to the sprayed mask. This has to be done for two reasons. Firstly, the mask’s 
output factor for electrons needs to be determined as described in section 2.5.4. The 
aluminum frame with the mask can be attached to the electron applicator using two bulldog 
clamps. Ionization measurements can then be conveniently done under the mask as required. 
Secondly, the aluminum frame serves as a guide to position the applicator against the mask. 
By bringing the applicator into contact with the frame, the radiation beam will always be 
directed at the treatment area at the same angle from treatment to treatment. The frame is 
attached to the mask through Wood’s alloy rods that are cast for this application. The rods are 
soldered to the mask using four holes drilled into the frame as a guide (Figure 8.7E). The rods 
are then cut to the required length and soldered to the frame. This is done by inserting the 
soldering iron’s tip into each of the four holes in the frame respectively (Figure 8.7F). The 
Wood’s alloy melts and fills the thread that was tapped into the holes thereby firmly fixing the 
rods to the frame. There is no need to attach aluminum frames to masks that will be used for 
shielding low energy X-rays. Instead of measuring the output factor for these masks, the 
output factor for the closest equivalent square to the treatment portal is used. Aluminum 
frames will also not be of much use in aligning the kilovolt unit’s applicators with the 
treatment areas. All these applicators have dome shaped transparent plastic covers attached to 
their treatment ends. The applicators can thus not be brought flush into contact with the 
frames as is the case with electron applicators.  To finish a thermal-sprayed mask, the inside is 
sprayed with a thin layer of clear lacquer paint. This is done to prevent the metal, especially 
the lead and cadmium that forms part of the alloy from being absorbed by the patient’s skin 
when placed upon it. 
 
8.4.2  Thermal-sprayed masks for large electron fields 
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When a large electron field is applied across an uneven area such as a boost to a radical 
mastectomy scar, the surrounding healthy tissue was traditionally shielded using a wax 
casting as described in section 5.2.2. Similar shielding results to the wax casting can be 
achieved with a sprayed mask. The procedure for producing a thermal-sprayed mask for a 
large electron treatment field is the same as that for producing a mask for a small treatment 
field. Instead of melting the treatment portal in the mask using a soldering iron (for masks 
produced from plaster models), it can be cut using the band saw that is used for trimming the 
mask’s edges. Using a soldering iron may be too time consuming since the size of the portal 
may be considerable in this application. The soldering iron is however required to solder the 
entry cut into the treatment portal in the mask. 
 
8.4.3  Thermal-sprayed masks for rotational electron fields 
 
The procedure followed to produce a thermal-sprayed mask for a rotational electron field (see 
section 4.6.3.2c) is the same as for a large stationary electron field. It is not necessary to 
attach an aluminum frame to the mask with this treatment technique since the radiation is 
applied in an arc around the treatment area. 
 
 131 
CHAPTER 9 
 
EVALUATION OF THE THERMAL-SPRAY TECHNIQUE 
 
9.1  Introduction 
 
The thermal-spray technique as a means of producing radiation field shaping shields was 
evaluated by comparing masks produced through the technique to radiation field shaping 
shields produced through traditional techniques. The required thicknesses of the sprayed 
masks to effectively shield both electron and low energy X-rays at different radiation energies 
were also determined. Finally, sprayed sheets of Wood’s alloy were inspected to determine if 
the thermal-spray process caused any defects within the sprayed layers. Any defects may 
adversely influence the shielding ability of masks. 
 
9.2  Comparison between different field shaping techniques 
 
An electron boost to a radical mastectomy operation¹ scar was chosen as an ideal setup for 
comparing the different field shaping techniques. These scars are usually long and extend 
across the side of the chest wall necessitating a large radiation field to be applied. The size of 
the field together with the curvature of the chest wall will in most cases cause a sizeable 
stand-off at the field’s edges with resultant radiation scatter beyond the primary beam. 
 
 
___________________________________________________________________________ 
¹ see section 4.6.3.3 
9.2.1  Perspex™ phantom and radiation field shaping shields 
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To simulate a patient’s chest wall, the author manufactured a Perspex™ phantom as shown in 
Figure 9.1. The curvature of the phantom was based on the average curvature of 12 plaster 
models that were used for producing wax castings for actual patients. 
 
  
 
Figure 9.1  Perspex™ phantom with wooden 
box 
Figure 9.2  Radiation field shaping shields 
produced for arbitrary field shape 
 
The phantom was produced in two halves and was equipped with four locating pins that were 
used to accurately align the halves. The two halves of the phantom were placed in a custom 
made wooden box and clamped together using two clamping screws mounted on one side of 
the box. An arbitrary field shape was marked out on the surface of the phantom. The shape of 
this arbitrary field was based on field shapes that are often encountered with boosting post 
mastectomy scars. Radiation field shaping shields were produced to shield the area around the 
chosen field shape using the shaped end-frame, wax casting and thermal-sprayed mask 
techniques as described in Chapters 5 and 8. These radiation field shaping shields were made 
to fit onto the treatment end of a 20 x 10 cm² electron applicator since this is the field size 
most often used with this type of treatments. Figure 9.2 shows the various radiation field 
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shaping shields produced. The author also compared the effectiveness of the different field 
shaping techniques at the edge of the 20 x 10 cm² treatment field. This can be considered a 
worst case scenario for radiation scattering since the stand-off at the edges of the field is at its 
greatest and will cause the maximum scatter beyond the primary beam. A wax casting and a 
thermal-sprayed mask were produced to shield the area around the entire 20 x 10 cm² 
radiation field. 
 
9.2.2  Field shaping comparison through radiographic film 
 
Radiographic film was chosen as the means through which the different field shaping 
techniques were compared. This type of film is composed of a transparent film base 
(polyester resin or cellulose acetate) that is coated with an emulsion containing minute silver 
bromide crystals. Exposure to ionizing radiation or visible light causes chemical changes to 
take place within the exposed crystals to form what is known as a latent image. When the film 
is processed on an automatic film processor, it is passed through a bath of developer solution 
where the chemically changed exposed crystals are reduced to small grains of metallic silver. 
The film is then passed through a bath of fixing solution where the unaffected crystals are 
washed away leaving clear film in their place. The grains of metallic silver, upon which the 
fixer has no effect, causes the film to darken. The degree to which an area of film is darkened 
is dependant on the amount of silver that was deposited and consequently indicates the 
amount of radiation that was absorbed in that area [23, p. 151]. 
 
 
 
9.2.2.1  Films taken for the arbitrary electron field 
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Diagnostic Kodak™ X-OMAT V Film was used to determine how effectively the different 
field shaping techniques shape the radiation beam to the required treatment area. A film 
within its protective envelope was taped to the surface of the phantom and the 20 x 10 cm² 
electron applicator was attached to an Elekta™ SL25 linac’s radiation head. A rectangular 
end-frame that fits the shape of the arbitrary test shape (in this case 18 x 6 cm²) the closest 
was inserted in the treatment end of the applicator. The linac’s table was raised for the 
treatment end of the applicator to touch the film on the phantom as shown in Figure 9.3A. A 
radiation energy of 4 MeV was selected on the linac and the film was exposed for 50 MU. 
This is the radiation dose recommended by the manufacturers of the film to produce good 
imaging results.  
 
A   B 
 
Figure 9.3A  Linac setup for taking a film to 
determine surface dose 
distribution 
Figure 9.3B  Linac setup for taking a film 
to determine cross-sectional 
dose distribution 
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The shaped end-frame was inserted into the applicator, a new film was taped to the phantom 
and the film taking procedure was repeated. For the wax casting and sprayed mask, the 
20 x 10 cm² end-frame was inserted in the applicator and films were taken with the casting 
and mask positioned on the phantom. The closest fitting end-frame to the arbitrary test shape 
was included in the lineup of field shaping techniques since some cancer departments do not 
do any field shaping at all and merely make use of a standard end-frame. Additional films 
were taken at 6, 8 and 10 MeV with all four radiation field shaping shields for each energy 
level. Radiation energies of 4–10 MeV were chosen to demonstrate the dose distribution for 
the various field shaping techniques since these are the energies most often used for patients 
receiving electron boosts. 
 
9.2.2.2  Films taken for the 20 x 10 cm² electron field 
 
Surface films were also taken for radiation energies of 4-10 MeV for the open field 
(20 x 10 cm² end-frame), wax casting and sprayed mask following the same procedure as for 
the arbitrary field shape. Figure 9.4 shows the setup for taking a surface film on the linac with 
the wax casting and Figure 9.5 with the sprayed mask. All the films taken for surface dose 
distribution for both the arbitrary and 20 x 10 cm² field where developed on a Dürr 
Medicine™ 430 film processor. Not only is it important to know how the different field 
shaping techniques compare in terms of surface dose, it is also important to know how they 
compare in terms of dose distribution within the phantom. To determine what the dose 
distributions within the phantom will be for the different techniques, the author traced the 
outline of the phantom onto the envelope of a sealed film with a pen. The film was then 
carefully cut along the traced lines using a pair of scissors in a darkroom under the 
appropriate lighting conditions so as not to expose the film. 
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Figure 9.4  Linac setup to determine surface 
dose distribution for a wax casting 
Figure 9.5  Linac setup to determine surface 
dose distribution for a thermal-
sprayed mask 
 
The cut piece of film was clamped between the two halves of the phantom using the clamping 
screws that were installed in the phantom’s wooden box. Masking tape that was sprayed black 
was used to seal the joint line between the two halves of the phantom so as not to let any light 
in that might ruin the film. The phantom in its wooden box was placed on the linac’s 
treatment table and the 20 x 10 cm² applicator was attached to the radiation head. A 
20 x 10 cm² end-frame was inserted into the applicator, the table was raised to touch the 
applicator and the film was exposed for 50 MU at 4 MeV. Figure 9.3B shows the setup for 
taking a cross-sectional film on the linac. The film was taken out of the phantom in the 
darkroom and developed. Additional films were taken for 6, 8 and 10 MeV following the 
same procedure used with the 20 x 10 cm² end-frame. The film taking procedure was also 
repeated for the wax casting and sprayed mask for all the radiation energies. 
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9.2.2.3  Films taken for the rotational electron beam field 
 
An investigation was undertaken to determine whether the thermal-spray technique can be 
used to produce field shaping masks for use with rotational electron beam therapy as 
described in section 4.6.3.2c. A field shaping mask was produced as described in Chapter 8 to 
shield the area around a 20 x 10 cm² area on the phantom as shown in Figure 9.6. The 
phantom was placed on the table of the linac and positioned such that the center of the 
phantom coincided with the linac’s isocenter. A film was placed between the radiation field 
shaping shield and the phantom and a special applicator used with rotational therapy was 
attached to the linac’s radiation head. The film was exposed at 6 MeV for 250 MU while the 
gantry was rotated through an arc of 160 degrees around the phantom as shown in Figure 9.7. 
   
  
 
Figure 9.6  Radiation field shaping shield 
produced for rotational electron 
beam therapy 
Figure 9.7  Setup to determine surface dose 
distribution for rotational electron 
beam therapy 
 
Since the center of the phantom was placed at the linac’s isocenter, the distance between the 
applicator and film was kept constant across the arc of rotation. Another surface film was 
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taken at 10 MeV following the same procedure as well as additional cross-sectional films of 
the phantom at both radiation energies. 
 
9.2.3  Film-image conversion to isodensity curves  
 
All the films taken for the arbitrary field shape, 20 x 10 cm² field and rotational electron beam 
field were scanned on a Vidar™ film scanner. This device consists of a light source and a 
light detector (photocell) that measures the light intensity transmitted through an area of film 
when placed between the light source and detector. The light intensity transmitted (i.e. optical 
density) thus indicates the degree of darkening of a given area of film. The scans were next 
converted to isodensity curves using Osiris™ Version 4 software on a personal computer. The 
Osiris™ software displays black as 100% and white as 0% with the degree of darkening 
awarded percentages in between the two extremes. Figure 9.8 shows a scan from the Vidar 
scanner of the arbitrary field shape as defined by a shaped end-frame at a radiation energy of 
8 MeV while Figure 9.9 shows the same image converted to isodensity curves as an example. 
Isodensity curves can be defined as lines passing through points of equal density and are 
expressed as percentages of the density at a reference point. Since film density represents the 
darkening of the film in an area and the darkening of the film represents the amount of dose 
absorbed, isodensity curves can also be considered to connect points of equal absorbed dose. 
Isodensity charts of all the films that were taken to compare the different field shaping 
techniques are shown in Addendum A. 
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Figure 9.8  Example of a film scanned on a 
Vidar™ film scanner 
Figure 9.9  Scanned image converted to 
isodensity curves 
 
The isodensity charts that show surface dose distribution are presented with the original field 
shapes (shown by the hatched areas) superimposed on the isodensity charts. With the cross-
sectional films for the 20 x 10 cm² field, the field’s edges are shown. The original field shapes 
and field edges are indicated to show to what extent the different field shaping techniques 
limit the radiation to the required treatment area. 
 
9.2.4  Discussion on isodensity charts for different radiation shields 
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Isodensity curves produced through the technique described in the previous section are 
discussed with reference to Addendum A1 for the arbitrary electron field shape, 
Addendum A2 for the stationary 20 x 10 cm² field and Addendum A3 for the 20 x 10 cm² 
electron arc field. 
 
9.2.4.1  Arbitrary electron field (Addendum A1) 
 
The closest fitting rectangular end-frame to the marked treatment area proves to be a poor 
alternative to define the treatment area. No attempt is made to shape the radiation field 
according to the treatment area using this technique. A large amount of healthy tissue can thus 
potentially be irradiated depending on the shape of the cancer affected area inside the 
rectangle. The stand-off between the flat undersurface of the end-frame and the phantom’s 
curved surface also causes a significant amount of electron scatter at the rectangular field’s 
edges. This electron scatter causes an even larger area of surrounding healthy tissue to be 
irradiated as shown by the isodensity curves. If one considers that cancer wounds heal after 
regenerative growth of the surrounding healthy tissue after treatment, irradiation of this tissue 
is undesirable. The shaped end-frame provides field shaping but the technique does not make 
provision for a treatment area with irregular contours. The distension of the isodensity curves 
beyond the marked treatment area illustrates the effect of a stand-off on field shaping with the 
shaped end-frame. The isodensity curves for the wax casting and sprayed mask are largely 
contained within the boundaries of the marked treatment area. This indicates effective 
shielding for both these field shaping techniques. The advantage of conforming the radiation 
field shaping shield to the treatment areas contours is thus made clear. 
9.2.4.2  20 x 10 cm² field (Addendum A2) 
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Surface films taken with the 20 x 10 cm² field shape show similar field shaping characteristics 
to the arbitrary field shape for the different field shaping techniques. The open field cross-
sectional isodensity chart shows the extent of electron scatter through air at the field’s edge. 
The scatter is at its worst at an electron energy of 4 MeV where the 20% isodensity curve 
measures 15 mm from the field’ s edges. The distension of the isodensity lines beyond the 
field’s edge diminishes with increase in radiation energy. This is because higher energy 
electrons scatter more in the forward direction in air than low energy electrons do [23, p. 
319]. The cross-sectional isodensity curves for the wax casting and sprayed mask shows that 
these field shaping techniques limit the radiation well to the radiation field’s edges. 
Noteworthy is the 10% isodensity curve which shows significant distension for both the wax 
casting and sprayed mask. The distension is not because of partial radiation transmission 
through the radiation field shaping shields but because of electron scatter in the Perspex™ 
phantom within which the films were taken. All the isodose curves show some bulging 
outside the field’s edges because of electron scatter with the effect becoming more prominent 
with an increase in radiation energy. The cross-section isodensity charts also show an increase 
in depth dose with an increase in radiation energy for each field shaping technique. 
 
9.2.4.3  Rotational electron beam field (Addendum A3) 
 
The thermal-sprayed mask defines the rotational electron beam field well with all the 
isodensity curves contained within the marked treatment area. The cross-sectional isodensity 
chart shows good dose uniformity across the arc of rotation. When compared with the cross-
sectional dose distribution from the stationary electron fields which is less uniform, the 
advantages of rotational electron beam therapy becomes obvious. 
 
9.3  Required thickness of thermal-sprayed masks 
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A prerequisite for producing thermal-sprayed masks is to determine what thickness the masks 
need to be to effectively shield the healthy tissue surrounding the treatment area. 
Measurements were made to determine what the thickness of sprayed Wood’s alloy masks 
need to be to attenuate the open beam by 90% and 95% for both electrons and low energy X-
irradiation. 
 
9.3.1  Mask thickness for electron irradiation 
 
The relative percentage dose reduction for different thicknesses of sprayed Wood’s alloy for 
electrons having accelerator energies of 4, 6, 8, 10, 12, 15, 18 and 20 MeV were determined 
on an Elekta™ SL25 linac. Transmission ionization measurements were made for two field 
sizes namely 10 x 10 cm² and 20 x 20 cm². 
 
9.3.1.1  Apparatus requirements and measurement procedure 
 
In order to determine what amount of radiation is transmitted through a given thickness of 
sprayed Wood’s alloy, thin sheets of the alloy had to be produced. For this purpose the author 
sprayed layers of Wood’s alloy onto a sheet of plate glass inside the spray cabinet. The 
sprayed alloy sheets were then machined on a milling machine to the required thicknesses as 
shown in Figure 9.10. Machining the alloy revealed no inconsistency in the sprayed layers 
such as porosity or cracks that might influence the density of the material during transmission 
measurements. A 1 mm, two 2 mm, one 5 mm, one 10 mm and one 20 mm sheet were 
fabricated as shown in Figure 9.11. 
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Figure 9.10  Machining a sheet of sprayed 
Wood’ s alloy to the required 
thicknesses 
Figure 9.11  Complete set of sheets produced 
for transmission measurements 
 
By selectively stacking these sheets on top of one another, any thickness of Wood’s alloy can 
be produced from 1-40 mm in 1 mm increments. Ionization measurements to determine 
radiation transmission through the sheets of Wood’s alloy were made using a (0.35 cm³ PTW) 
Roos™ parallel-plate ionization chamber Type 34001 with a PTW Unidos™ dose meter. The 
author also manufactured a Perspex™ phantom for use with the Roos™ chamber as shown in 
Figure 9.12. The chamber fits flush with the surface of the phantom into a precisely machined 
hole. The close fit between the chamber and phantom ensures that there will be no air gap 
around the chamber that may influence the ionization readings. The phantom was positioned 
on additional Perspex™ plates on the linac’s table where the purpose of the plates was to 
produce back scatter conditions during irradiation. A 10 x 10 cm² electron applicator was 
attached to the linac’s radiation head and the treatment table was raised for the applicator to 
touch the phantom. An open field ionization measurement (no Wood’s alloy in the beam) was 
taken with the linac set at 4 MeV for 200 MU. The couch was lowered and a 1 mm sheet of 
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Wood’s alloy was placed on the phantom. The table was raised for the applicator to touch the 
alloy sheet as shown in Figure 9.13. 
 
  
Figure 9.12  Phantom produced for the 
Roos™ ionization chamber 
Figure 9.13  Linac setup for transmission 
measurements 
 
Another ionization measurement was taken at the same radiation energy for the same number 
of monitor units. This procedure was repeated with 1 mm of alloy added for each 
measurement until the difference between consecutive ionization measurements became 
negligible. A radiation energy of 6 MeV was selected on the linac and an open field 
measurement was taken followed by transmission measurements of the Wood’s alloy in 1 mm 
increments. This procedure was repeated for the remaining electron energies up to 20 MeV. 
The 10 x 10 cm² applicator was replaced with the 20 x 20 cm² applicator and the measurement 
procedure was repeated for all the radiation energies. Measurements as described here were 
taken to determine the percentage of radiation that would be transmitted through a given 
thickness of Wood’s alloy. Since the sheets of Wood’s alloy were placed directly on the 
ionization chamber, the measurements were effectively taken at skin level. To determine if 
there would be any sizeable difference between transmission measurements taken at and 
below skin level, all the measurements were repeated with the ionization chamber at the depth 
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of D
max
. Table 9.1 shows the thicknesses of buildup required to be able to do ionization 
measurements at the depth of D
max
 
 
Table 9.1  Thickness of buildup required to attain D
max
 at different electron energies for 
ionization measurements 
Electron energy (MeV) 4 6 8 10 12 15 18 20 
Buildup thickness (mm) 8 8 16 20 20 20 20 20 
 
 
 
The required buildup for each radiation energy was placed on the phantom and the different 
thicknesses of Wood’s alloy were placed on the buildup. Transmission measurements were 
taken using this setup for all the radiation energies and field sizes. 
 
9.3.1.2  Results from measurements 
 
All transmission ionization measurements taken for the different thicknesses of sprayed 
Wood’s alloy for each radiation energy, field size and measurement depth are presented in 
Addendum B1. Also shown are the ionization measurements normalized to the open beam 
ionization measurement for each thickness of Wood’s alloy. The relative percentage 
ionization measurements are shown against thickness of sprayed Wood’s alloy in graph form 
in Addendum B2. From the graphs it can be determined what the thicknesses of Wood’s alloy 
field shaping masks need to be to reduce the open beam dose by 90% and 95% for the 
different radiation energies, field sizes and measurement depths. To determine alloy thickness 
for a dose reduction of 95%, for example, a line is drawn through 5% transmission on the 
y-axis. Where it coincides with the transmission curves of the different radiation energies the 
thicknesses of alloy is read from the x-axis. The required thicknesses are listed in Tables 9.2 
and 9.3. 
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Table 9.2  Thickness of sprayed Wood’s alloy required to attenuate the open beam dose by 
95% at different electron energies, measurement levels and field sizes 
Field size 
(cm x cm) 
Measurement 
level 
Radiation energy (MeV) 
Thickness (mm) 
  4 6 8 10 12 15 18 20 
          
10 x 10 Skin 2.00 3.15 4.05 5.00 7.00 14.6 21.6 26.6 
          
10 x 10 Dmax 1.60 2.45 2.55 3.05 4.50 9.10 14.6 19.5 
          
20 x 20 Skin 1.95 3.05 4.10 5.05 7.25 15.5 22.3 27.5 
          
20 x 20 Dmax 1.55 2.50 2.60 3.10 4.65 10.1 16.1 21.0 
 
 
Table 9.3  Thickness of sprayed Wood’s alloy required to attenuate the open beam dose by 
90% at different electron energies, measurement levels and field sizes 
Field size 
(cm x cm) 
Measurement 
level 
Radiation energy (MeV) 
Thickness (mm) 
  4 6 8 10 12 15 18 20 
          
10 x 10 Skin 1.85 2.80 3.60 4.30 5.40 7.05 9.25 11.9 
          
10 x 10 Dmax 1.25 2.05 2.05 2.45 3.60 5.10 6.80 8.05 
          
20 x 20 Skin 1.85 2.70 3.60 4.35 5.45 7.30 9.50 12.4 
          
20 x 20 Dmax 1.20 2.05 2.05 2.50 3.70 5.20 7.00 8.30 
 
 
9.3.1.3  Discussion on measurements 
 
 The determined thicknesses of sprayed Wood’s alloy to attenuate the open beam by 
90% or 95% shown in Tables 9.2 and 9.3 compares favourably with that determined 
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by Purdy et al [42, pp. 251-253]. The latter authors performed transmission 
measurements for Cerrobend™ (which is a trade name for Wood’s alloy) at similar 
radiation energies to the ones used by the author at the depth of D
max
. 
 There is a significant difference in alloy thickness required to attenuate the open beam 
dose to acceptable levels that was determined through transmission measurements 
performed at skin level and at the level of D
max
. This is affirmed by Khan et al 
[25, pp. 712-713] who performed transmission measurements at various depths for 
lead at a radiation energy of 13 MeV, concluding that the thickness of a shielding 
material determined through percentage transmission data depends greatly on 
measurement depth. 
 The thickness of sprayed Wood’s alloy to reduce the open beam to the required 
percentiles increases with field size for all electron energies. This is because smaller 
field sizes cause more electron scatter than larger field sizes. 
 The initial buildup shown in the percentage transmission curves in Addendum B2, 
which is due to scattered radiation, also increases with field size. This buildup effect is 
also much more prominent with percentage transmission measurements taken at skin 
level than at D
max
. 
 An important observation from Tables 9.1 and 9.2 is that a considerable thickness of 
Wood’s alloy is required to reduce the open beam dose to 5% for radiation energies of 
15, 18 and 20 MeV. This is because of the fact that beyond the lower turning point of 
the percentage transmission curve, the radiation is essentially bremsstrahlung photons 
[23, p. 317]. Bremsstrahlung is the effect whereby photons are produced when 
electrons are absorbed by a material with a high atomic number such as lead or 
Wood’s alloy. For the higher electron energies, the weight of the field shaping mask 
becomes a serious consideration. With these higher energies a compromise should be 
made between the mask weight the patient can bear and the reduction in dose that is 
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desired. A reasonable thickness of shielding material can be determined from the 
percentage transmission curves at about the lower turning point of each curve. 
Additional shielding material beyond this area is much less effective for further dose 
reduction since this is the bremsstrahlung region. 
 
9.3.2  Mask thickness for low energy X-irradiation 
 
The relative percentage dose reduction for different thicknesses of sprayed Wood’s alloy for 
100 and 250 kV as produced by a Philips Medical Systems™ RT250 kilovolt unit were also 
determined. Transmission ionization measurements were made with a 10 x 8 cm² and a 
15 x 10 cm² field size for each energy. 
 
9.3.2.1  Apparatus required and measurement procedure 
 
The sheets of Wood’s alloy that were produced for transmission measurements on the linac 
were also used for measurements on the kilovolt unit. Instead of using the parallel-plate 
ionization chamber for measurements such as on the linac, a thimble type PTW Farmer™ 
0.6 cm³ ionization chamber which is better suited to X-ray measurements was used. Ionization 
measurements for X-irradiation were done in air with nothing in close proximity behind the 
ionization chamber that may cause back scatter and influence the reading. The ionization 
chamber was clamped in a retort stand and the stand was placed on a table. The kilovolt unit’s 
radiation head was turned horizontal and a 10 x 8 cm² applicator was attached to the unit’s 
radiation head. The kilovolt unit and stand were positioned such as to bring the graphite tip of 
the ionization chamber into contact with the center of the applicator’s plastic cover as shown 
in Figure 9.14. A radiation energy of 100 kV was selected on the kilovolt unit and the 
ionization chamber was irradiated for 2 minutes where after an ionization measurement was 
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taken on a PTW Unidos™ dose meter. A 1 mm sheet of Wood’s alloy was placed in front of 
the kilovolt unit’s applicator and was kept upright by clamping it to two angle plates as shown 
in Figure 9.15. The ionization chamber was taped to the back of the Wood’s alloy sheet in 
such a way that the tip of the chamber was positioned over the center of the applicator. 
 
  
 
Figure 9.14  Kilovolt unit setup for open field 
ionization measurement 
Figure 9.15  Transmission measurement for a 
sheet of Wood’ s alloy 
 
An ionization measurement was taken at the same radiation energy and exposure time. This 
procedure was repeated for increasing thickness of Wood’s alloy until there was no 
significant difference in measured ionization from measurement to measurement. The 
10 x 8 cm² applicator was replaced with the 15 x 10 cm² applicator and the measurements 
were repeated at the same energy and exposure time. Measurements were also taken at 
250 kV for both applicators. There was no need to repeat the measurements at any level 
below skin level, such as with electrons, since D
max
 is attained at skin level with X-rays. 
 
9.3.2.2  Results from measurements 
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All the transmission ionization measurements taken on the kilovolt unit for the different 
thicknesses of sprayed Wood’s alloy at the two radiation energies are presented in 
Addendum B1. The ionization measurements normalized to the open beam ionization 
measurement are shown for each thickness of Wood’s alloy. The relative percentage 
ionization measurements are shown against thickness of sprayed Wood’s alloy in graph form 
in Addendum B2. The data are used to determined what the thickness of sprayed Wood’s 
alloy needs to be to reduce the open field dose by 90, 95 and 98% for the two radiation 
energies and field sizes. The required thicknesses are listed in Table 9.4. 
 
Table 9.4  Thickness of sprayed Wood’s alloy required to attenuate the open beam dose by 
90, 95 and 98% at two X-ray energies and field sizes 
Field size 
(cm x cm) 
Attenuation 
% 
Radiation energy (kV) 
Thickness (mm) 
  100 250 
    
10 x 8 98.0 0.98 1.39 
    
15 x 10 98.0 0.98 1.39 
    
10 x 8 95.0 0.94 1.13 
    
15 x 10 95.0 0.94 1.13 
    
10 x 8 90.0 0.86 0.99 
    
15 x 10 90.0 0.86 0.99 
9.3.2.3  Discussion on measurements 
 
 There is very little difference between transmission measurements taken at the two 
different field sizes shown in Addendum B1. The required thicknesses of sprayed 
Wood’s alloy to attenuate the open X-ray beam to the percentiles indicated are 
consequently shown the same for the two field sizes in Table 9.4. Field size does not 
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have such a significant effect on the transmission measurements for X-rays as it has on 
electrons. 
 The percentage transmission curves in Addendum B2 for X-rays show a rapid falloff 
with no initial buildup, such as was observed with the percentage transmission curves 
for electrons. 
 
9.4  Testing for defects in thermal-sprayed layer of Wood’s alloy 
 
An investigation was undertaken to determine whether there are any defects such as cracks or 
porosity present in thermal-sprayed layers of Wood’s alloy. Any of these defects may 
negatively affect the shielding ability of masks produced through the technique. X-ray 
imaging was chosen as the means through which the thermal-sprayed masks were inspected. 
An Elekta™ Precise linac equipped with an iViewGT™ portal imaging system as shown in 
Figure 9.16 was employed to this end. A portal imaging system is generally used to verify 
patient setup before a dose of radiation is administered to a patient. The system however also 
proved useful in the application described here. Any defects within a sprayed sheet of Wood’s 
alloy will show up as variation in density of the material under X-ray imaging. 
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Figure 9.16  Elekta™ Precise linac equipped with an iViewGT™ portal imaging system 
 
To check for uniformity in density across a sprayed sheet, it is important for the sheet to be 
uniform in thickness. Any variation in thickness may be mistaken for variation in density 
within the sheet. The Wood’s alloy sheets that were used to determine the required thickness 
of thermal-sprayed masks in section 9.3 were also used in this experiment. The thicknesses of 
these sheets were verified by the author to be uniform at the time that they were fabricated. A 
thermal-sprayed Wood’s alloy step wedge as shown in Figure 9.17 was also fabricated. This 
was done by spraying the alloy onto a strip of aluminum. The sprayed layer of alloy was then 
machined on a milling machine to thicknesses of 1-6 millimeters in 0.5 mm increments. The 
treatment table was adjusted to isocentric height and the field size to 20 x 20 cm² which is the 
maximum field size detectable by the portal imager. 
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Figure 9.17  Thermal-sprayed Wood’s alloy step wedge 
 
The step wedge was positioned in the center of the field on the table and the linac was set at a 
radiation energy of 8 MV. The step wedge was irradiated while the image of the radiation 
transmission through the wedge was simultaneously captured on the portal imager. The portal 
imager’s computer automatically switches off the linac when the imager receives a pre-set 
dose of radiation. This dose is sufficient to create an image on the portal imager without 
overexposing the unit. Any object placed in the radiation field will cause radiation absorption 
requiring the linac to produce a higher radiation dose before the portal imager threshold dose 
value is reached. The higher the density of the object placed in the field the higher the 
radiation dose needs to be before the imager switches off the linac. With the wedge placed in 
the radiation field, the required dose delivered by the linac is determined by the open field 
surrounding the wedge. If the linac is to deliver the same dose with the alloy sheets, an area of 
open field also needs to be present when the images of the sheets are taken. For this reason 
each of the sheets were positioned such that a 2 cm gap was left between the edge of the field 
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and the edge of each sheet when the images of the sheets were taken. Since the wedge and the 
sheets were exposed to the same dose of radiation when the images were taken, it is possible 
to compare the images. The gray scale images produced by the iViewGT™ software were 
converted to colour images using the Osiris™ software introduced in section 9.2.3. The 
Osiris™ software allows different colours to be allocated to different densities. By placing the 
coloured image of the step wedge next to the images of the sheets of Wood’s alloy (as 
presented in Addendum C), variation in the densities of the sheets can be identified. Radiation 
scatter from the linac’s collimation system that defines the field size distorts the edges of the 
20 x 20 cm² portal image. For this reason only a 10 x 10 cm² area of each sheet of Wood’s 
alloy is shown. The image of the step wedge allows for comparison with the alloy sheets with 
thicknesses of 1, 2 and 5 mm since the wedge is only 6 mm thick at its highest step. To 
determine variation in density for the 10 mm sheet an image was taken of the wedge placed 
on top of the two 2 mm sheets. This places the wedge’s highest step at a thickness of 10 mm. 
By comparing this image of the step wedge with the image of the 10 mm sheet, density 
variation of up to 5 mm can be observed within the sheet. This procedure was repeated with 
the wedge positioned on top of the sheets that were stacked to a thickness of 14 mm thereby 
placing the wedge’s highest step at 20 mm. This image of the wedge was then compared with 
the image of the 20 mm alloy sheet. 
 
9.4.1  Discussion on portal X-ray images 
 
The colour images of the sheets of Wood’s alloy shows slight variation in colour from the 
center to the corners of each radiation field. This variation in colour can be attributed to non-
uniformity in delivered radiation dose (field flatness) by the linac rather than variation in 
density of the sheets of alloy. Consequent measurements with test equipment confirmed slight 
variation in dose delivered across the treatment plane to coincide with the variation in dose 
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observed with the portal X-ray images. The variation in dose was however still well within 
acceptable limits for treatment as set by international standards. Also contributing to the 
colour variation is the slightly greater thickness a photon has to traverse through the corners 
of the sheet compared to the center if one considers that the radiation originates from a point 
source. None of the images shows abrupt colour changes signifying non-uniformity in density 
and thus indicating defects such as air pockets, cracks or porosity. From this it can be 
concluded that thermal-sprayed layers of Wood’s alloy shows no unexpected internal defects 
and can be safely used to produce radiation field shaping masks for patients. 
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CHAPTER 10 
 
CONCLUSION TO THE RESEARCH PROJECT 
 
10.1  Conclusion 
 
The purpose of the research project was to implement an improved field shaping technique for 
low energy radiation in radiotherapy. Through the introduction of a new low temperature 
thermal-spray field shaping technique this goal was met. Field shaping masks produced 
through the thermal-spray technique show some clear advantages over the traditional 
techniques. This statement is motivated with reference to Table 10.1. 
 
Producing radiation field shaping masks through thermal-spraying onto plaster models is 
much less labor intensive and faster than producing field shaping shields through the 
traditional lead mask or wax casting techniques¹. This is to the advantage of both the 
technologist who fabricates the shields as well as patients who require field shaping during 
radiation treatment. A patient that has to attend a radiotherapy centre from a rural area (for a 
cancerous skin lesion in an early stage as an example) will be able to have a field shaping 
mask prepared and receive radiation treatment within the same day. This saves the patient the 
inconvenience and cost of having to stay over for a day or more to have the field shaping 
mask prepared through the traditional techniques. 
 
 
___________________________________________________________________________ 
¹ see disadvantages of the lead mask and wax casting field shaping techniques in sections 5.2.1 and 5.2.2 
respectively 
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Producing thermal-sprayed masks from LS or CNC milled models presents the patient with 
some unique advantages in comparison with plaster models. The 3D laser scanner used to 
capture the treatment area geometry for the model fabrication techniques requires no physical 
contact with the patient. This procedure appears to be less traumatic for the patient than the 
plaster bandage impression required for the plaster models. This is particularly the case if the 
impression needs to be taken in the facial area or if the treatment area involves open wounds. 
The fast scanning speed of the scanners also makes it ideal to determine treatment area 
contours of areas prone to movement such as experienced on small children for example. The 
high cost involved in producing a LS model is unfortunately a disadvantage. The price shown 
in Table 10.1 is for growing a single model. Should more than one model be grown 
simultaneously, the production price will be reduced significantly. 
 
Masks produced from CNC milled models prove to be the most effective of all the radiation 
field shaping techniques. The masks can be produced at a relative low cost and within a 
reasonable time frame when compared to the other techniques. The initial procurement cost in 
obtaining a 3D laser scanner and CNC milling machine may be considered too high. The cost 
of these devices should however be measured against the benefits they will bring to patients. 
It is also possible for a radiotherapy centre equipped with a CNC milling machine to service 
other centres without such a device since the treatment area geometry file is easily 
transferable via the internet over any distance. 
 
Experimental work carried out to evaluate the thermal-spray radiation field shaping technique 
showed that the shielding ability of masks produced through the technique compared 
favourably with those produced through the wax casting technique. The thermal-sprayed field 
shaping masks also showed a marked improvement over field shaping shields produced 
through the shaped end-frame technique. Although these shields are relatively cheap and 
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quick to produce, they make no provision for any curvature of the treatment area. Additional 
experiments showed that there are no defects within thermal-sprayed layers of Wood’s alloy 
that may negatively affect the shielding ability of masks produced through the technique. 
 
The equipment used to produce thermal-spray masks fulfil the criteria (section 7.1) set for the 
equipment at the onset of the research project well. Field shaping masks are safely and cleanly 
produced at reasonable cost (depending on the process) within an acceptable time frame using 
the thermal-spray equipment described in this thesis. The thermal-spray equipment was 
manufactured from affordable components using locally available tools and equipment. The 
weight of masks produced for patients were found to be acceptable with an average weight of 
676 g measured for 14 facial masks. At present, technologists only produce masks for patients 
who receive X-ray treatment in the orthovoltage range at the Department of Oncotherapy at 
National Hospital, Bloemfontein where the thermal-spray field shaping technique is 
implemented. 
 
10.2  Further research proposals 
 
Towards the end of the study, the author learned of an alloy that can be used instead of 
Wood’s alloy to produce field shaping masks through thermal-spraying. The alloy 
commercially known as Field’s alloy [9] has approximately the same melting point as Wood’s 
alloy but contains no lead or cadmium. Producing masks without these harmful substances 
will be safer for the technologist and patient. Radiation transmission measurements of the 
alloy will have to be carried out to determine the required thicknesses of masks produced 
using the alloy for different radiation energies. 
A second proposal is to use wax instead of polyurethane foam as a medium for machining a 
model of the patient using a CNC milling machine. Waxes are available with a melting point 
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higher than that of Wood’s alloy which will be ideal for the thermal-spray radiation field 
shaping technique. The wax shavings from milling, together with the produced model can be 
remelted and cast into a block ready for machining a new model. Since both the shielding and 
model fabrication materials are recyclable, masks can be produced at low cost. Keeping in 
mind that the polyurethane model is discarded after use and polyurethane dust is produced 
during milling, the wax model technique is also more environmentally friendly. 
 161 
REFERENCES 
 
 
 
1. Andrew, J.W. & Aldrich, J.E. A video-based patient contour acquisition system for the 
design of radiotherapy compensators. Medical Physics, vol. 16, no. 3, 1989, pp. 425-
430 
 
2. Azomaterials (2000) Thermal spray coatings – Processes and properties 
Available from: <http://www.azom.com/details.asp?ArticleID=1581> 
[Accessed 8 November 2002] 
 
3. Azomaterials (2000) Thermal spray technology Available from: 
<http://www.azom.com/features.asp> [Accessed 28 October 2002] 
 
4. Baiker, L. Apparatus for spraying of thermo-plastic materials. Patent Nr. 297507, 1954 
 
5. Blazdell, P. & Kuroda, S. Thermal spraying in the new millennium. Materials World, 
vol. 7, no. 4, 1999, pp. 205-207 
 
6. Boyer, A.L., Fullerton, G.D. & Mira, J.G. An electron beam pseudoarc technique for 
irradiation of large areas of chest wall and other curved surfaces. International Journal 
of Radiation Oncology, Biology, Physics, vol. 8, no. 11, 1982, pp. 1969-1974   
 
7. Boyer, A.L. & Goitein, M. Simulator mounted Moiré topography camera for 
constructing compensating filters. Medical Physics, vol. 7, no. 1, 1980, pp. 19-26 
 
 162 
8. Brennan, J.B. Method and apparatus for melting metals. Patent Nr. 2322787, 1943 
 
9. Dirac Delta Consultants Limited (2001) Fields metal Available from: 
<http://www.diracdelta.co.uk/science/source/f/i/fields%20metal/source.html> 
[Accessed 8 November 2007] 
 
10. Dollinger, M., Rosenbaum, E.H. & Gable, G. Everyone’s Guide to Cancer Therapy. 3rd. 
Edition. Kansas City: Andrew McMeel Publishing, 1997 
 
11. Duncan Hynd Associates Limited (2000) Laser contouring Available from: 
<http://www.dha.co.uk/laser_contouring2.html> 
[Accessed 25 April 2004] 
 
12. Fentiman, I.S. Detection and Treatment of early Breast Cancer. London: Martin Dunitz 
Ltd, 1990 
 
13. Filt Air (2004) HEPA filters Available from: 
 <http://www.filt-air.com/Resources/Articles/hepa/hepa_filters.aspx> 
[Accessed 14 August 2005] 
 
14. Flame Spray Incorporated (2001) Thermal spray coatings Available from: 
<http://www.flamesprayinc.com> [Accessed 8 November 2002] 
 
15. Gerbi, B.J. Compensating filter design using radiographic stereo shift information. 
Medical Physics, vol. 12, 1985, p. 646 
16. Giarratano, J.C., Duerkes, R.J. & Almond, P.R. Lead shielding thickness for dose 
 163 
reduction of 7 to 28 Mév electrons. Medical Physics, vol. 2, 1975, p. 336 
 
17. Goede, M.R., Gooden, D.S., Ellis, R.G. & Brickner, T.J. A versatile electron 
collimation system to be used with electron cones supplied with Varian’s Clinac 18. 
International Journal of Radiation Oncology, Biology, Physics, vol. 2, no. 7, 1977, pp. 
791-795 
 
18. Greene, D. & Williams, P.C. Linear Accelerators for Radiation Therapy. 2
nd
. Edition. 
Manchester: Institute of Physics Publishing, 1997   
 
19. Griffiths, S.E. & Short, C.A. Radiotherapy: Principles to Practice. Edinburgh: 
Churchhill Livingstone, 1994 
 
20. Gross, K. (2000) Thermal Spraying – An introduction Available from: 
<http://www.azom.com/details.asp?ArticleID=542> [Accessed 28 October 2002] 
 
21. Horwich, A. Oncology A multidisciplinary textbook. London: Chapman & Hall 
Medical, 1995 
 
22. Johns, H.E. & Cunningham, J.R. The Physics of Radiology. 4
th
. Edition. Illinois: 
Charles Thomas Publishers, 1983 
 
23. Khan, F.M. The Physics of Radiation Therapy. 3
rd
. Edition. Philidelphia: Lippencott, 
Williams and Wilkins, 2003 
24. Khan, F.M., Moore, V.C. & Levitt, S.H.  Field shaping in electron beam therapy. 
British Journal of Radiology, vol. 49, 1976, p. 883 
 164 
 
25. Khan, F.M., Werner, B.L. & Deibel, F.C. Lead shielding for electrons. Medical 
Physics, vol. 8, no. 5, 1981, pp. 712-713 
 
26. Konica Minolta (2000) VI-910 Non-contact 3D digitizer Available from: 
<http://www.minolta-3d.com> [Accessed 25 April 2003] 
 
27. Laursen, J.F., Andersen, H.C. & Hansen, H.P. 3D thin lead sheet compensating system. 
Medical Physics, vol. 9, no. 5, 1982, pp. 741-745 
 
28. Leavitt, D.D., Peacock, LM., Gibbs, F.A. & Stewart, J.R. Electron arc therapy: 
Physical measurements and treatment planning techniques. International Journal of 
Radiation Oncology, Biology, Physics, vol. 11, no. 5, 1985, pp. 987-999  
 
29. Levitt, S.H., Khan, F.M. & Potish, R.A. Technological Basis of Radiation Therapy. 2
nd
. 
Edition. Malvern: Lea & Febiger, 1992 
 
30. MCG3D (2004) How does a 3D scanning machine based on laser technology work? 
Available from: <http://www.mcg3d.com/article.php3?id_article=33>  
[Accessed 25 April 2004] 
 
 
 
31. McNeely, L.K., Jacobson, G.M., Leavitt, D.D. & Stewart, J.R. Electron arc therapy: 
Chest wall irradiation of breast cancer patients. International Journal of Radiation 
Oncology, Biology, Physics, vol. 14, no. 6, 1988, pp. 1287-1294 
 165 
 
32. Miller, W.R. Estrogen and Breast Cancer. Austin, Texas: R.G. Landes Company, 1996 
 
33. Mok, E.C. & Boyer, A.L. Compensator filters made with compact Moiré camera and 
computer. Medical Physics, vol. 11, no. 4, 1984, pp. 513-515 
 
34. MSS Worldwide (1999) Metal spray Available from: <http://www.metal-spray.co.nz> 
[Accessed 8 November 2002] 
 
35. Myung, C.C., Purdy, J.A., Gerbi, B., Abrath, F.G. & Glasgow, G.P. Variation in output 
factor caused by secondary blocking for 7-16 MeV electron beams. Medical Physics, 
vol. 6, no. 2, 1979, pp. 137-139 
 
36. Payne, P.H. Metal spraying apparatus. Patent Nr. 3776462, 1973 
 
37. Peacock, LM., Leavitt, D.D., Gibbs, F.A. & Stewart, J.R. Electron arc therapy: Clinical 
experience with chest wall irradiation. International Journal of Radiation Oncology, 
Biology, Physics, vol. 10, no. 11, 1984, pp. 2149-2153 
 
38. Perez, C.A. & Brady, L.W. Principals and Practice of Radiation Oncology. 2
nd
. Edition. 
Philadelphia: J.B. Lippincott Company, 1992 
 
39. Plane, J.H. & Usher, C. A rapid method of production of irregular-shaped fields for use 
with patients receiving electron radiotherapy. British Journal of Radiology, vol. 63, no. 
755, 1990, pp. 882-883   
 
 166 
40. Precise Treatment System Corrective Maintenance Manual. Linac House, Crawley, 
West Sussex, UK: Elekta Limited, 2003 
 
41. ProtoCAM (2002) Selective Laser Sintering Available from: 
<http://www.protocam.com/html/sls.html> [Accessed  19 May 2005] 
 
42. Purdy, J.A. & Choi, C. Lipowitz metal shielding thickness for dose reduction of 6-
20 MeV electrons. Medical Physics, vol. 7, no. 3, 1980, pp. 251-253 
 
43. Reade Advanced Materials (1997) Wood’s metal alloy Available from: 
<http://www.reade.com/Products/Alloys/wood’s_metal.html> [Accessed 4 June 2004] 
 
44. Rippey, J.J. General Pathology. Pretoria: Witwatersrand University Press, 1994 
 
45. Siemens AG, Medical solutions (2006) Computed Tomography History and 
Technology  Available from: 
<http://www.scribd.com/doc/3986451/Computed-Tomography-History-and-
Technology-MIND-4561699-2>  [Accessed 8 March 2007] 
 
46. Smith, P.B. Irregular-shaped fields in electron radiation. British Journal of Radiology, 
vol. 64, no. 762, 1991, p. 561   
47. Souhami, R.L. & Tobias, J. Cancer and its Management. 2
nd
. Edition. Oxford: 
Blackwell Science Ltd, 1995 
 
48. Spiritus Temporis (2003) Cerrobend Available from: 
<http://www.spiritus-temporis.com/cerrobend> [Accessed  4 June 2004] 
 167 
 
49. Tobias, J.S. & Thomas, P.R.M. Current Radiation Oncology. vol. 1, London: Edward 
Arnold, 1994 
 
50. Underwood, J.C.E. General and Systematic Pathology. 4
th
. Edition. Sheffield: Elsevier 
Limited, 2004 
 
51. Walter, J. Cancer and Radiotherapy. 2
nd
. Edition. Edinburgh: Churchhill Livingstone, 
1977 
 
52. Wohlers, T.T. Wohlers Report 2004. Colorado: Wohlers associates, 2004 
 
 
 168 
 
 
 
ADDENDUM A1 
 
ISODENSITY CHARTS 
 
Arbitrary field shape 
 
Printing scale: 1:1.92 
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ADDENDUM A2 
 
ISODENSITY CHARTS 
 
20 x 10 cm² field 
 
Printing scale: Surface charts: 1:2.1 
 Cross-sectional charts: 1:1.9 
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ADDENDUM A3 
 
ISODENSITY CHARTS 
 
Rotational electron beam field 
 
Printing scale: Surface charts: 1:2.1 
 Cross-sectional charts: 1:1.9 
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ADDENDUM B1 
 
REQUIRED THICKNESS OF THERMAL-SPRAYED MASKS 
 
Transmission ionization measurements 
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B1.1.1 Measurements at 4 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2027  100.0  
1  1313  64.78  
2  101.5  5.007  
3  21.38  1.055  
4  17.96  0.886  
5  16.12  0.795  
      
      
      
B1.1.2 Measurements at 6 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2109  100.0  
1  2379  112.8  
2  746.1  35.38  
3  141.9  6.728  
4  39.62  1.879  
5  33.76  1.601  
6  31.00  1.470  
      
      
      
B1.1.3 Measurements at 8 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2246  100.0  
1  2847  126.8  
2  1476  65.72  
3  523.1  23.29  
4  122.7  5.463  
5  67.56  3.008  
6  60.54  2.695  
7  55.08  2.452  
8  51.60  2.297  
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B1.1.4 Measurements at 10 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2294  100.0  
1  3015  131.4  
2  2113  92.11  
3  1053  45.90  
4  325.5  14.19  
5  117.9  5.139  
6  80.68  3.517  
7  70.54  3.075  
8  65.90  2.873  
9  61.56  2.684  
10  57.48  2.506  
      
      
      
B1.1.5 Measurements at 12 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2385  100.0  
1  3021  126.7  
2  2676  112.2  
3  1737  72.83  
4  792.3  33.22  
5  329.3  13.81  
6  171.9  7.208  
7  119.7  5.019  
8  107.8  4.520  
9  100.7  4.222  
10  93.96  3.940  
11  89.22  3.741  
12  83.92  3.519  
13  79.90  3.350  
14  74.76  3.135  
15  70.58  2.959  
16  67.26  2.820  
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B1.1.6 Measurements at 15 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2515  100.0  
1  3001  119.3  
2  3046  121.1  
3  2416  96.06  
4  1470  58.45  
5  799.0  31.77  
6  451.7  17.96  
7  257.2  10.23  
8  200.0  7.952  
9  177.8  7.070  
10  164.3  6.533  
11  156.8  6.235  
12  148.2  5.893  
13  140.8  5.598  
14  132.6  5.272  
15  126.4  5.026  
16  120.4  4.787  
17  113.8  4.525  
18  108.5  4.314  
19  103.8  4.127  
20  99.44  3.954  
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B1.1.7 Measurements at 18 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2616  100.0  
1  2964  113.3  
2  3188  121.9  
3  2891  110.5  
4  2133  81.54  
5  1404  53.67  
6  903.0  34.52  
7  521.5  19.94  
8  362.4  13.85  
9  277.7  10.62  
10  238.6  9.121  
11  221.9  8.482  
12  208.9  7.985  
13  198.9  7.603  
14  187.5  7.167  
15  178.4  6.820  
16  170.2  6.506  
17  161.2  6.162  
18  154.2  5.894  
19  146.9  5.615  
20  140.6  5.375  
21  136.3  5.210  
22  130.2  4.977  
23  124.9  4.774  
24  118.6  4.534  
25  113.4  4.335  
26  108.5  4.148  
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B1.1.8 Measurements at 20 MeV, 10 x 10 cm² Field size, Skin dose 
      
mm alloy measured ionization % of open field 
      
0  2622  100.0  
1  2921  111.4  
2  3160  120.5  
3  2987  113.9  
4  2355  89.82  
5  1669  63.65  
6  1183  45.12  
7  731.3  27.89  
8  507.8  19.37  
9  374.7  14.29  
10  307.0  11.71  
11  279.6  10.66  
12  261.3  9.966  
13  248.3  9.470  
14  234.3  8.936  
15  222.5  8.486  
16  213.1  8.127  
17  202.1  7.708  
18  193.0  7.361  
19  184.0  7.018  
20  179.0  6.827  
21  171.6  6.545  
22  163.8  6.247  
23  157.2  5.995  
24  149.4  5.698  
25  142.4  5.431  
26  137.0  5.225  
27  130.3  4.969  
28  125.0  4.767  
29  119.2  4.546  
30  114.5  4.367  
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B1.2.1 Measurements at 4 MeV 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2480  100.0  
1  411.0  16.57  
2  22.52  0.908  
3  18.70  0.754  
4  17.16  0.692  
      
      
      
B1.2.2 Measurements at 6 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2391  100.0  
1  1538  64.32  
2  253.6  10.61  
3  51.46  2.152  
4  35.84  1.499  
5  32.78  1.371  
      
      
      
B1.2.3 Measurements at 8 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2520  100.0  
1  1249  49.56  
2  264.7  10.50  
3  80.90  3.210  
4  59.42  2.358  
5  56.04  2.224  
6  52.48  2.083  
      
      
      
B1.2.4 Measurements at 10 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2549  100.0  
1  1565  61.40  
2  454.6  17.83  
3  137.9  5.410  
4  71.56  2.807  
5  63.68  2.498  
6  59.72  2.343  
7  56.72  2.225  
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B1.2.5 Measurements at 12 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2573  100.0  
1  2199  85.46  
2  1064  41.35  
3  462.9  17.99  
4  181.1  7.038  
5  108.1  4.201  
6  93.92  3.650  
7  89.28  3.470  
8  84.46  3.283  
9  80.00  3.109  
      
      
      
B1.2.6 Measurements at 15 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2651  100.0  
1  2600  98.08  
2  1802  67.97  
3  1090  41.12  
4  551.5  20.80  
5  283.5  10.69  
6  188.8  7.122  
7  155.2  5.854  
8  144.0  5.432  
9  135.3  5.104  
10  127.5  4.810  
11  122.1  4.606  
12  115.7  4.364  
13  111.0  4.187  
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B1.2.7 Measurements at 18 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2715  100.0  
1  2767  101.9  
2  2308  85.01  
3  1691  62.28  
4  1055  38.86  
5  607.6  22.38  
6  376.5  13.87  
7  254.6  9.378  
8  207.7  7.650  
9  184.8  6.807  
10  172.4  6.350  
11  164.9  6.074  
12  156.1  5.750  
13  149.6  5.510  
14  142.5  5.249  
15  136.3  5.020  
16  130.1  4.792  
17  124.8  4.597  
18  119.4  4.398  
19  114.8  4.228  
20  110.2  4.059  
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B1.2.8 Measurements at 20 MeV, 10 x 10 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2733  100.0  
1  2770  101.4  
2  2468  90.30  
3  1953  71.46  
4  1339  48.99  
5  838.5  30.68  
6  541.3  19.81  
7  359.1  13.14  
8  276.4  10.11  
9  232.8  8.518  
10  213.7  7.819  
11  203.5  7.446  
12  193.0  7.062  
13  184.6  6.754  
14  176.2  6.447  
15  168.6  6.169  
16  160.9  5.887  
17  154.3  5.646  
18  147.7  5.404  
19  142.2  5.203  
20  136.7  5.002  
21  130.8  4.786  
22  124.8  4.566  
23  119.8  4.383  
24  114.7  4.197  
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B1.3.1 Measurements at 4 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2130  100.0   
1  1393  65.40   
2  77.10  3.620   
3  22.36  1.050   
4  19.04  0.894   
5  16.88  0.792   
       
       
       
B1.3.2 Measurements at 6 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2129  100.0   
1  2480  116.5   
2  663.8  31.18   
3  121.5  5.707   
4  41.94  1.970   
5  35.18  1.652   
6  32.48  1.526   
       
       
       
B1.3.3 Measurements at 8 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2235  100.0   
1  2915  130.4   
2  1389  62.15   
3  473.3  21.18   
4  126.6  5.664   
5  68.26  3.054   
6  61.62  2.757   
7  57.20  2.559   
8  54.40  2.434   
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B1.3.4 Measurements at 10 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2180  100.0   
1  2992  137.2   
2  1999  91.70   
3  959.9  44.03   
4  324.9  14.90   
5  117.3  5.381   
6  79.48  3.646   
7  70.52  3.235   
8  65.30  2.995   
9  60.52  2.776   
10  56.18  2.577   
       
       
       
B1.3.5 Measurements at 12 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2294  100.0   
1  3020  131.6   
2  2605  113.6   
3  1657  72.23   
4  799.8  34.86   
5  331.7  14.46   
6  173.8  7.576   
7  122.1  5.323   
8  109.0  4.752   
9  99.82  4.351   
10  93.62  4.081   
11  88.26  3.847   
12  82.02  3.575   
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B1.3.6 Measurements at 15 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2407  100.0   
1  2983  123.9   
2  3028  125.8   
3  2366  98.30   
4  1497  62.19   
5  825.6  34.30   
6  465.5  19.34   
7  276.2  11.47   
8  207.4  8.617   
9  177.8  7.387   
10  164.6  6.838   
11  156.0  6.481   
12  146.5  6.086   
13  138.7  5.762   
14  131.6  5.467   
15  125.9  5.231   
16  120.1  4.990   
17  114.8  4.769   
18  109.4  4.545   
19  105.3  4.375   
20  101.1  4.200   
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B1.3.7 Measurements at 18 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2464  100.0   
1  2918  118.4   
2  3181  129.1   
3  2853  115.8   
4  2145  87.05   
5  1410  57.22   
6  907.1  36.81   
7  551.3  22.37   
8  373.7  15.17   
9  273.7  11.11   
10  234.3  9.509   
11  218.4  8.864   
12  203.5  8.259   
13  194.0  7.873   
14  183.9  7.463   
15  174.4  7.078   
16  167.2  6.786   
17  159.7  6.481   
18  152.2  6.177   
19  146.3  5.938   
20  140.3  5.694   
21  133.9  5.434   
22  127.5  5.175   
23  122.2  4.959   
24  116.9  4.744   
25  111.9  4.541   
26  106.9  4.338   
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B1.3.8 Measurements at 20 MeV, 20 x 20 cm² Field size, Skin dose 
       
mm alloy measured ionization % of open field  
       
0  2493  100.0   
1  2889  115.9   
2  3183  127.7   
3  2996  120.2   
4  2424  97.23   
5  1727  69.27   
6  1195  47.93   
7  769.9  30.88   
8  529.9  21.26   
9  373.6  14.99   
10  305.6  12.26   
11  278.0  11.15   
12  256.7  10.30   
13  244.1  9.791   
14  232.3  9.318   
15  220.4  8.841   
16  210.9  8.460   
17  201.6  8.087   
18  192.2  7.710   
19  181.5  7.280   
20  177.8  7.132   
21  169.9  6.815   
22  161.9  6.494   
23  155.0  6.217   
24  148.1  5.941   
25  141.8  5.688   
26  135.4  5.431   
27  129.9  5.211   
28  124.3  4.986   
29  118.8  4.765   
30  113.2  4.541   
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B1.4.1 Measurements at 4 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2594  100.0  
1  417.6  16.10  
2  24.76  0.955  
3  20.38  0.786  
4  18.28  0.705  
      
      
      
B1.4.2 Measurements at 6MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2417  100.0  
1  1556  64.38  
2  266.0  11.01  
3  53.98  2.233  
4  37.68  1.559  
5  34.64  1.433  
      
      
      
B1.4.3 Measurements at 8 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2550  100.0  
1  1269  49.76  
2  274.4  10.76  
3  86.98  3.411  
4  63.36  2.485  
5  58.46  2.293  
6  55.14  2.162  
      
      
      
B1.4.4 Measurements at 10 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2482  100.0  
1  1539  62.01  
2  454.4  18.31  
3  144.0  5.802  
4  74.14  2.987  
5  66.94  2.697  
6  62.92  2.535  
7  59.08  2.380  
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B1.4.5 Measurements at 12 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2507  100.0  
1  2176  86.80  
2  1075  42.88  
3  472.5  18.85  
4  188.1  7.503  
5  113.8  4.539  
6  99.98  3.988  
7  93.60  3.734  
8  88.64  3.536  
9  83.48  3.330  
      
      
      
B1.4.6 Measurements at 15 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2567  100.0  
1  2560  99.73  
2  1795  69.93  
3  1092  42.54  
4  554.9  21.62  
5  288.2  11.23  
6  193.2  7.526  
7  159.7  6.221  
8  148.1  5.769  
9  139.6  5.438  
10  131.9  5.138  
11  126.0  4.908  
12  119.7  4.663  
13  114.3  4.453  
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B1.4.7 Measurements at 18 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2604  100.0  
1  2708  104.0  
2  2300  88.33  
3  1688  64.82  
4  1051  40.36  
5  611.3  23.48  
6  379.1  14.56  
7  258.9  9.942  
8  211.4  8.118  
9  188.8  7.250  
10  176.3  6.770  
11  168.4  6.467  
12  159.1  6.110  
13  152.7  5.864  
14  145.1  5.572  
15  139.1  5.342  
16  133.0  5.108  
17  127.2  4.885  
18  121.4  4.662  
19  117.2  4.501  
20  112.9  4.336  
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B1.4.8 Measurements at 20 MeV, 20 x 20 cm² Field size, Dmax 
      
mm alloy measured ionization % of open field 
      
0  2623  100  
1  2729  104.0  
2  2468  94.09  
3  1944  74.11  
4  1339  51.05  
5  837.5  31.93  
6  545.6  20.80  
7  361.5  13.78  
8  281.1  10.72  
9  237.4  9.051  
10  218.5  8.330  
11  207.0  7.892  
12  196.5  7.491  
13  187.7  7.156  
14  179.7  6.851  
15  171.7  6.546  
16  163.7  6.241  
17  157.1  5.989  
18  150.4  5.734  
19  144.9  5.524  
20  139.4  5.315  
21  133.7  5.097  
22  127.9  4.876  
23  122.7  4.678  
24  117.5  4.480  
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B1.5.1 Measurements at 100 kV, 10 x 8 cm² Field size 
      
mm alloy measured ionization % of open field 
      
0  1740  100.0  
1  22.11  0.892  
2  0.940  0.038  
      
      
      
B1.5.2 Measurements at 100 kV, 15 x 10 cm² Field size 
      
mm alloy measured ionization % of open field 
      
0  1708  100.0  
1  22.52  0.942  
2  0.960  0.040  
      
      
      
B1.6.1 Measurements at 250 kV, 10 x 8 cm² Field size 
      
mm alloy measured ionization % of open field 
      
0  871.1  100.0  
1  238.8  9.476  
2  76.28  3.027  
3  35.39  1.404  
4  16.48  0.654  
5  8.460  0.336  
6  4.000  0.159  
      
      
      
B1.6.2 Measurements at 250 kV, 15 x 10 cm² Field size 
      
mm alloy measured ionization % of open field 
      
0  787.6  100.0  
1  240.5  9.433  
2  76.09  2.985  
3  35.68  1.400  
4  16.73  0.656  
5  8.490  0.333  
6  4.040  0.158  
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ADDENDUM B2 
 
REQUIRED THICKNESS OF THERMAL-SPRAYED MASKS 
 
Percentage transmission curves 
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ADDENDUM C 
 
TESTING FOR DEFECTS IN THERMAL-SPRAYED 
SHEETS OF WOOD’S ALLOY 
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C1 Testing for defects in 1, 2 and 5 mm thermal-sprayed sheets of Wood’s alloy 
 213 
 
 
 
C2 Testing for defects in 10 and 20 mm thermal-sprayed sheets of Wood’s alloy 
 214 
 
 
 
ADDENDUM D 
 
PATENT DOCUMENT 
  
 
 
 
 
 
 
 
 
A SPRAY APPARATUS AND METHOD 
 
BACKGROUND OF THE INVENTION 
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[0001] This invention relates to a spray apparatus used for the spraying of molten 
metal material as well as a method of spraying molten metal material making use of  the 
spray apparatus. 
 
[0002] Skin cancer is treated by radiation with low energy x-rays (100-250kV) or 
electrons (4-6MeV). Low energy x-rays are produced by a kilovolt unit and electrons with 
a linear electron accelerator. The size of the electron field is determined by a square 
or rectangular applicator that attaches to the radiation unit. 
 
[0003] Radiation of a cancerous growth often affects healthy skin between the cancerous 
growth and the edge of the radiation field. It is known to protect healthy skin from 
radiation by manufacturing a lead mask which is placed over a part of a patient's 
anatomy which is to be treated. A cut out, in the form of the cancerous growth, is made in 
the mask to limit radiation to the area of the cancerous growth. 
 
[0004] The manufacture of the mask is an onerous, time consuming and costly operation. 
An impression of the affected area on the patient's anatomy is taken by means of 
plaster of Paris bandages and a female mould is made of the affected area. Once removed 
the female mould is filled with stone plaster in order to form a male mould of the 
affected area. The stone plaster is allowed to set and the female mould is removed. A 
lead sheet with an appropriate thickness, which depends on the intensity of the 
radiation to be applied, is beaten over the male mould in order for the lead sheet to take 
the shape of the affected area. The size, shape and location of the cancerous growth is 
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marked on the lead sheet and a saw is used to cut a hole in the lead sheet which 
corresponds to the cancerous growth. The completed mask is coated with bee's wax 
to prevent metal to skin contact during radiation. During treatment the mask is placed 
over the affected area in order for radiation of healthy skin to be restricted. 
 
[0005] The manufacture of the mask requires skill, effort and is time consuming 
especially where the lead sheet is thicker than 2mm. The cost of the stone plaster is 
significant and the mask can only be made once the stone plaster has set completely in order to 
prevent the disintegration of the male mould during the working of the lead sheet over the 
male mould. 
 
[0006] As the shape and size of each mask are unique each mask must be custom 
made for the relevant patient. The recycling of used masks requires that the masks 
must be melted, the molten material rolled into sheets and that the sheets be cut into appropriate 
sizes. The recovery process of used masks is in itself a lengthy and costly exercise. 
 
SUMMARY OF INVENTION 
 
[0007] This invention aims to provide a spray apparatus with which molten metal 
material can be sprayed as well as a method of spraying molten metal material which may 
be used to manufacture a metal mask for use in the radiation of cancerous 
growths on the skin of a patient. 
 
[0008] The invention provides a spray apparatus for applying molten metal material to an 
object which includes an atomizer, feeder means connected to the atomizer to supply the 
material to the atomizer, which feeder means has a furnace member wherein the material 
is produced and a conduit formation connected to both the furnace member and the 
 5 
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atomizer through which the material is delivered to the atomizer, and heating means 
engaged with the feeder means and connectable to a power supply. 
 
[0009] Preferably the atomizer includes a spray gun which pneumatically atomizes the 
material. 
 
[0010] The heating means may include a first heating element engaged with the furnace 
member and a second heating element in the form of a coiled wire resistor which is 
engaged with the conduit formation. 
 
[0011] The spray apparatus may include a third heating element which is engaged with 
the atomizer. 
 
[0012] The spray apparatus may include a first heat sensor engaged with the atomizer, a 
second heat sensor engaged with the conduit formation and a third heat sensor engaged 
with the furnace member. 
 
[0013] The spray apparatus may include a control circuit which is connected to the 
heating means and the first, second and third heat sensors. 
 
[0014] Preferably the spray apparatus includes air supply means connected to the 
atomizer. The air supply means may include a compressor, an air tube which extends 
between the compressor and the atomizer, an air pressure regulator which is connected 
to the air tube and a valve connected to the air tube. 
 
 [0015] The spray apparatus may include a fourth heating element engaged with the air 
supply means. 
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[0016] The spray apparatus may include a housing wherein the atomizer is located. The 
housing may include a sealable cavity formation. The cavity formation may include a drain 
and an air vent. 
 
[0017] The housing preferably includes a transparent lid member and a switch which is 
actuated by the lid member. 
 
[0018] The spray apparatus may include a filtration device which is in communication with 
the cavity formation. 
 
[0019] The filtration device may include a vacuum pump and a boiler. A hose may 
be attached to the boiler and a circulation pump may be connected to the hose. 
 
[0020] The spray apparatus may include a stand which is insertable into the cavity 
formation. The stand may include at least one rail with which a runner is movably 
engaged. The stand may include a rotation means. The rotation means may be a ball 
and cup joint, alternatively a bearing member. 
 
[0021] The stand may include a holder which may include a platform or a cradle. 
 
[0022] The invention also provides a method of applying a cover to an object which 
includes the steps of: 
 
20 
 
 
 
a. 
 
 
 
 
feeding molten metal material by way of a feeder means to a pneumatic 
atomizer, which feeder means includes a furnace member wherein the material 
is produced and a conduit formation connected to both the feeder means and the 
atomizer through which the material is delivered to the atomizer; 
 
  
5 
b. 
 
c. 
 
d. 
heating the material in the feeder means by way of a heating means; 
 
atomizing the material by means of the atomizer; 
 
and spraying the material onto the object 
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[0023] The method may include the step of making a mould of an article and of 
covering at least part of the mould with the material to form the cover over the mould. 
 
[0024] The method may include the step of allowing the material to solidify on the 
mould to form the cover. The cover may include a mask. Preferably a spray apparatus 
for applying molten metal material to an object of the aforementioned kind is used in the 
method. 
 
BRIEF DESCRIPTION OF THE DRAWINGS 
 
[0025] The invention is further described by way of examples with reference to the 
accompanying drawings in which: 
Figure 1 is a perspective top view of a spray apparatus according the invention; 
Figure 2 is a schematic representation of the spray apparatus of Figure 1; 
Figure 3 is a schematic cross-sectional side view of the spray apparatus of Figure 1; and 
Figures 4A and 4B are perspective views of two alternative stands used in the spray 
apparatus of Figure 1. 
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DESCRIPTION OF PREFERRED EMBODIMENTS 
 
[0026] Figures 1, 2 and 3 illustrate a spray apparatus 10 for spraying molten metal 
material 12 which has a housing 14, an open ended cavity 16 in the housing 14, a 
transparent lid 18 which is hinged to the housing 14 and which lockingly seals the 
cavity 16, a pneumatic atomizer 20 in the form of a spray gun located in the cavity 16 and 
housing 14 and a feeder means or arrangement 22 which is connected to the spray 
gun 20 and which supplies the material 12 to the spray gun 20. 
 
[0027] The housing 14 has two access openings 24A, B which extend into the cavity 16. A 
left hand glove 26A is attached to the opening 24A and a right hand glove 26B is 
attached to the opening 24B in order to allow a user (not shown) to extend his 
hands and arms at least partially into the cavity 16 through the gloves 26. The user can 
in this manner handle and manipulate the spray gun 20, a stand 28 and an object 30 
inside the cavity 16. 
 
[0028] A compartment 32 is formed in the housing 14 below the cavity 16, which 
compartment 32 is accessible by way of hinged doors 34. The housing 14 is made in a 
known manner from metal tubing and sheeting. The cavity 16 is made from 
galvanized steel and is in the form of a square shaped container with a sump plate 36 
at its lower end. The sump plate 36 depends downwardly towards a drain hole 38. 
 
[0029] The lid 18 has a metal frame 40 and a transparent Perspex™ sheet 42 is attached 
to the frame 40. The lid 18 seals the cavity 16 and is lockable to the housing 14 by way of 
clamp locks 41. 
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[0030] An air inlet 44 with an air filter 46 is formed through side walls of the housing 14 
and cavity 16 and allows airflow from an outside of the housing 14 into the cavity 16. 
 
[0031] The feeder 22 has a furnace or melting vessel 48 which is attached to the 
housing 14. The vessel 48 has an outer cover 50 which is insulated from an internal 
holder 52. A first heating element 54 is located inside the holder 52 which is used to melt 
metal 56 placed in the holder 52. The molten metal material 12 is fed to the spray gun 
20 through a flexible metal conduit 58 which extends between the vessel 48 and the 
spray gun 20. A second heating member 60 in the form of a nickel chrome resistance wire 
is coiled around the conduit 58. 
 
[0032] The spray gun 20 is of known construction and has a third heating element 62 to 
heat the material 12 in the spray gun 20. 
 
[0033] The first, second and third heating elements 54, 60, 62 are connected to a 
control circuit 64 which is fed with electrical power from a power source 66. Sensors 
68A, B, C are respectively attached to the spray gun 20, conduit 58 and vessel 48 
and are also connected to the control circuit 64. The control circuit 64 measures the 
temperature of the material 12 in the vessel 48, conduit 58 and spray gun 20 and 
depending on requirements increases power supply to the first, second and third heating 
elements 56, 60, 62. This ensures that the material 12 reaches the spray gun 20 at 
the correct temperature. 
 
[0034] An air supply arrangement 66 is connected to the spray gun 20. The air supply 
arrangement 66 consists of an air tube 68 and a compressor 70 which is connected to the 
air gun 20 by the tube 68. An air pressure regulator 72 of known construction is fitted 
to the tube 68. A solenoid valve 74 is connected to the tube 68 between the compressor 
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70 and the spray gun 20. The compressor 70 is connected to the power source 66 and 
generates compressed air in a known manner which is fed to the spray gun 20. 
 
[0035] A drainage pipe 76 is fixed to the drain hole 38 and extends from the cavity 16 
into the compartment 32. A particle trap and boiler 78 sits in the compartment 32 and the 
drain pipe 76 extends into the boiler 78. The boiler 78 has a cup-shaped body 80 
which is sealingly closed by a removable cap 82. A horizontally extending buffer plate 84 
extends at least partially across the interior of the body 80. A metal water trap 86 stands 
inside the body 80 below the buffer plate 84 and the drainage pipe 76 extends into the 
water trap 86. The body 80 is at least partially filled with an appropriate liquid 88 such as 
for example water. It is important to note that there is enough water 88 in the body 80 to 
allow the drainage pipe 76 to extend into the water 88 in the water trap 86. A fourth 
heating element 89 is attached to the cap 82 and extends into the water 88. The fourth 
heating element 89 is connected to the power source 66. 
 
[0036] A hose 90 is attached to and extends from the body 80 through the cap 82 and into 
the cavity 16. A circulation pump 92 is connected to the hose 90 to pump heated water 88 
from the body 80 into the cavity 16. 
 
[0037] A ventilation pipe 94 extends from the cap 82 to a vacuum pump 96. The vacuum 
pump 96 is of conventional design and includes known wet and dry particle filters. The 
vacuum pump 96 is in communication with the boiler 78 and the cavity 16 and withdraws 
air from the boiler 78 and expels excess air to atmosphere through an outlet 98. 
 
[0038] A contact switch 100 which is actuated by the lid 18 is attached to the housing 14. 
The switch 100 is connected to the power source 66 as well as the solenoid valve 
74 and the vacuum pump 96. When the lid 18 is closed the switch 100 allows the 
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activation of the vacuum pump 96 and the opening of the solenoid valve 74. 
 
[0039] A stand 28A shown in Figure 4A is used when a small object is sprayed with the 
material 12 inside the cavity 16 and a stand 28B shown in Figure 4E3 is used in the 
cavity 16 when a large object is sprayed with the material 12. The stand 28A has a base 
102A with two elongate parallel rails 104A. A runner 106A is movingly engaged with the 
rails 104A and a rotatable and pivotable holder in the form of a turntable 108 is 
attached to the runner 106A by way of a universal or ball and cup joint 110. The stand 
286 has a base 102B with two elongate parallel rails 104B with which a runner 106B is 
movably engaged. A holder in the form of a cradle 112 is rotatably attached to the runner 
106B by way of a bearing member 114. The cradle 112 has a beam 116 which is 
attached to the bearing member 114 and two spaced apart arms 118 which are movably 
connected to the beam 116. 
 
[0040] In use the metal 56 which has a low melting point of between 70°C and 75°C is 
inserted into the vessel 48. Metal alloy materials such as those sold under the trade names 
MCP70™, WOOD'S ALLOYTM or FRY'S METAL™ can be used. Depending on the melting 
point of the metal 56 the control circuit 64 applies an appropriate power supply to the 
first heating element 54 to melt the metal 56. The sensors 68A, B,  C measure the 
temperature of the material 12 and the measurements are relayed to the control circuit 
64. By controlling the power supplied to the first, second and third heating elements 54, 
60, 62 the temperature and liquidity of the material 12 are controlled. 
 
[0041] The appropriate stand 28 is inserted into the cavity 16, the object 30 which is to be 
covered or sprayed with the material 12 is placed on the stand 28 and the lid 18 is 
closed, sealed and locked. As the lid 18 is closed the contact switch 100 causes 
the opening of the solenoid valve 74 and activates the vacuum pump 96.Compressed 
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air 124 is supplied to the spray gun 20 from the compressor 70 by way of the tube 68. 
The pressure of the compressed air 124 is regulated by the regulator 72. In the event that 
the lid 18 is inadvertently opened the switch 100 causes the solenoid valve 74 to close and 
the supply of compressed air 124 to the spray gun 20 is interrupted. 
 
[0042] The vacuum pump 96 withdraws air from the boiler 78 by way of the ventilation 
pipe 94. In order to fill the vacuum created in the boiler 78 air is drawn from the cavity 
16 through the drain hole 38 and drain pipe 76 into the boiler 78. Air drawn from the 
cavity 16 is fed through the water 88 in the water trap 86. The buffer plate 84 prevents 
water 88 from splashing out of the body 80 into the ventilation pipe 94. 
 
[0043] The vacuum created in the cavity 16 is filled by air which is drawn from atmosphere 
through the inlet 44 and filter 46 or fed through the spray gun 20 from the compressor 70.  
 
[0044] In order to operate the spray gun 20 a user grips the spray gun 20 by means of his 
hands which are inserted into the cavity 16 through the gloves 26A, B. The spray 
gun 20 is operated and the material 12 is atomized and sprayed onto the object 30. 
The number of layers of material 12 sprayed onto the object 30 depends 
on the required thickness of a metal cover 130 formed over the object 30. The 
second and third heating elements 60, 62 ensure that the material 12 atomized by 
the spray gun 20 is in the molten state. Once the material 12 is sprayed onto the 
object 30 the material 12 cools, solidifies and sets to form the cover 130 on the object 30. 
 
[0045] Once the cover 130 has reached its desired thickness the spray gun 20 is 
deactivated and set aside and the compressor 70 is switched off. The user removes the 
object 30 and cover 130 from the holder 28 and activates the circulation pump 92. The 
fourth heating element 89 heats the water 86 to boiling point and the boiling water 88 is 
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delivered to the cavity 16 by way of the hose 90. The user uses the hose 90 and water 88 
to clean all contact surfaces inside the cavity 16. Any excess metal 56 in the cavity 16 is 
melted by the water 88 and washed away along the sump plate 36 and through the drain 
hole 38 and drain pipe 76 into the water trap 86. In this manner any material 56 which 
remains in the cavity 16 is removed, scrubbed and trapped in the water trap 86 and boiler 
78. The wet and dry particle filters in the vacuum pump 96 remove any particles which 
might escape the water trap 86 and boiler 78. The waste metal 56 trapped in the water 
trap 86, boiler 78 and vacuum pump 96 is recovered for re-use. 
 
[0046] Once the cavity 16 is cleaned the lid 18 is opened in order to remove the object 30 
and cover 130 from the cavity 16. The cover 130 is removed from the object 30 and 
processed as required. 
 
[0047] In this example cold compressed air 124 is fed to the spray gun 20 from the 
compressor 70. It is however possible to attach a fifth heating element 132 in the 
form of a heat radiator to either the compressor 70 or inline on the tube 68. It is also 
possible to combine the compressor 70 and vacuum pump 96 in order to form a 
closed circuit for air movement through the spray apparatus 10. 
 
[0048] An important application of the spray apparatus 10 is the manufacture of metal 
masks used in radiation treatment of cancerous skin growths. In order to manufacture 
such a mask a female mould (not shown) is taken of the relevant area of the patient's 
anatomy. This female mould is made from plaster of Paris bandages. Once the female 
mould has set the mould is removed and a male mould made from plaster of Paris is 
cast inside the female mould. Once set, the male mould is removed and used as the 
object 30. The cover 130 applied to the male mould 30 is in the form of a metal mask. The 
mask 130 is removed from the male mould 30 and an appropriately sized and shaped 
  
20 
 
 
 
 
 
 
 
 
5 
 
 
 
 
10 
aperture is burnt through the mask 130 through which the cancerous growth can be 
radiated. As a final step a clear lacquer is applied to the mask 130 to prevent metal to 
skin contact. The mask 130 is thereafter used in the conventional manner. 
 
[OO49] When the mask 130 is discarded the mask 130 is broken into appropriate sized 
pieces to provide a source of the metal 56 which is re-used. 
 
[0050] By limiting the use of hardened settable materials such as stone plaster which 
takes time to set, the manufacture of the male mould and the production time of the 
mask 130 are reduced. The use of softer materials for the male mould also results in 
cost savings. Recovery of the metal 56 from which the mask 130 is made is also 
improved. 
 
[0051] The material 12 is sprayed onto the object 30 in the sealed cavity 16 in order to 
prevent accidental inhalation of the atomized material 12 by the user as this could be 
damaging to the user's health. For the same reason the air and excess material 12 in 
the cavity 16 are and withdrawn therefrom, and are washed, scrubbed and filtered 
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6. 
 
 
 
A spray apparatus [10] for applying molten metal material [12] to an object [30] 
which includes an atomizer [20], feeder means [22] connected to the atomizer 
to supply the material to the atomizer, which feeder means has a furnace 
member (50] wherein the material is produced and a conduit formation [58] 
connected to both the furnace member and the atomizer through which the 
material is delivered to the atomizer, heating means [54,60] engaged with the 
feeder means and connectable to a power supply [66] and characterised in a 
housing [14] which has a sealable cavity formation [16] wherein the atomizer is 
located. 
 
A spray apparatus according to claim 1 characterised therein that the atomizer 
includes a spray gun [20]. 
 
A spray apparatus according to claim 1 or 2 characterised therein that the 
heating means includes a first heating element [54] engaged with the furnace 
member. 
 
A spray apparatus according to claim 1, 2 or 3 characterised therein that the 
heating means includes a second heating element [60] which is engaged with 
the conduit formation. 
 
A spray apparatus according to claim 4 characterised therein that the 
second heating element includes a coiled wire resistor [60]. 
 
A spray apparatus according to any one of claims 1 to 5 characterised 
therein that it includes a third heating element [62] engaged with the atomizer. 
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A spray apparatus according to any one of claims 1 to 6 characterised 
therein that it includes a first heat sensor (68A) engaged with the atomizer. 
 
A spray apparatus according to any one of claims 1 to 7 characterised 
therein that it includes a second heat sensor [68B] engaged with the conduit 
formation. 
 
A spray apparatus according to any one of claims 1 to 8 characterised 
therein that it includes a third heat sensor [68C] engaged with the furnace 
member. 
 
A spray apparatus according to any one of claims 1 to 9 characterised 
therein that it includes a control circuit [64] connected to the heating means. 
 
A spray apparatus according to any one of claims 1 to 10 characterised 
therein that it includes air supply means [66] connected to the atomizer. 
 
A spray apparatus according to claim 11 characterised therein that the air 
supply means includes a compressor [70]. 
 
A spray apparatus according to claim 12 characterised therein that the air 
supply means includes an air tube [68] which extends between the 
compressor and the atomizer. 
 
A spray apparatus according to claim 13, characterised therein that the air supply 
means includes an air pressure regulator [72] which is fitted to the air tube. 
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A spray apparatus according to claim 13 or 14 characterised therein that the air 
supply means includes a valve [74] connected to the air tube. 
 
A spray apparatus according to any one of claims 11 to 15 characterised 
therein that it includes a fourth heating element [132] engaged with the air 
supply means. 
 
A spray apparatus according to any one of claims 1 to 16 characterised therein 
that the cavity formation includes a drain [38]. 
 
A spray apparatus according to any one of claims 1 to 17 characterised therein 
that the cavity formation includes an air vent [44]. 
 
A spray apparatus according to any one of claims 1 to 18 characterised therein 
that the housing includes a transparent lid member [18]. 
 
A spray apparatus according to claim 19 characterised therein that the housing 
includes a switch [100] which is actuated by the lid member. 
 
A spray apparatus according to any one of claims 1 to 20 characterised therein 
that it includes a filtration device [78,86,96] in communication with the cavity 
formation. 
 
A spray apparatus according to claim 21 characterised therein that the filtration 
device includes a vacuum pump [96]. 
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31. 
 
 
 
 
A spray apparatus according to claim 21 or 22 characterised therein that filtration 
device includes a water trap [78,86]. 
 
A spray apparatus according to claim 21, 22 or 23 characterised therein that 
the filtration device includes a boiler [78]. 
 
A spray apparatus according to claim 24 characterised therein that it includes a 
hose [90] attached to the boiler and a circulation pump [92] connected to the 
hose. 
 
A spray apparatus according to any one of claims 1 to 25 characterised therein 
that it includes a stand [28] which is insertable into the cavity formation. 
 
A spray apparatus according to claim 26 characterised therein that the stand 
includes at least one rail [104] with which a runner [106] is movably engaged. 
 
A spray apparatus according to claim 26 or 27 characterised therein that the 
stand includes a rotation means [110,114]. 
 
A spray apparatus according to claim 28 characterised therein that the rotation 
means includes a ball and cup joint [110]. 
 
A spray apparatus according to claim 28 characterised therein that the rotation 
means includes a bearing member [114]. 
 
A spray apparatus according to any one claims 26 to 30 characterised therein that 
the stand includes a holder [108,118]. 
  
32. 
 
 
 
 
 
33. 
 
 
 
 
 
34. 
 
 
A spray apparatus according to claim 31 characterised therein that the holder 
includes a platform [110]. 
 
A spray apparatus according to claim 31 characterised therein that the holder 
includes a cradle [118]. 
 
A method of applying a cover [130] to an object [30] which includes the steps of: 
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a. 
 
b. 
 
 
 
 
 
c. 
 
 
d. 
 
e. 
making a mould of an article to form the object; 
 
feeding molten metal material to a pneumatic atomizer [20] by way 
of a feeder means [22], which feeder means includes a furnace member 
[50] wherein the material is produced and a conduit formation [58] 
connected to both the feeder means and the atomizer through which 
the material is delivered to the atomizer; 
 
heating the material in the feeder means by way of a heating 
means [54,60,62]; 
 
atomising the material by means of the atomizer; and 
 
spraying the material over the object, 
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35. 
 
 
 
A method of applying a cover according to claim 34 characterised therein that it 
includes the step of allowing the material to solidify on the object to form the 
cover. 
 
 
 
 
 
 
 
20 
36. 
 
 
37. 
A method of applying a cover according to claim 34 or 35 characterised therein 
that the cover includes a mask [130]. 
 
A method of applying a cover according to claim 36 characterised therein that 
the mask is used for the radiation treatment of cancerous skin growths. 
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Rapid manufacturing of patient-specific
shielding masks, using RP in parallel with metal
spraying
Deon J. de Beer, Miche´le Truscott, Gerrie J. Booysen, Ludrick J. Barnard and Jakobus G. van der Walt
Central University of Technology, Free State, Bloemfontein, South Africa
Abstract
Purpose – The purpose of the present work is to develop a methodology to manufacture patient-specific models (lead masks) to be used as protective
shields during cancer treatment, using 3D photography, rapid prototyping (RP) and metal spraying. It is also intended to reduce the trauma experienced
by the patient, by removing any physical contact as with conventional methods, and also to reduce the manufacturing lead time.
Design/methodology/approach – Patient-specific data are collected using 3D photography. The data are converted to.STL files, and then prepared
for building with an LS 380 in nylon polyamide. Next, the sculpted model is used as the mould in a newly patented metal-spraying device, spraying
liquid metal on to the sculpted surface.
Findings – Intricate body geometries can be reproduced to effectively create metal shields, to be used in radiography applications. The models created
fit the patients more accurately than through conventional methods, reducing the trauma experienced by the patient, and in a reduced time-frame, at
similar costs to conventional methods. The new process and its materials management are less of a an environmental risk than conventional methods.
Research limitations/implications – Access to 3D photography apparatus will be necessary, as well as to RP or CNC equipment. Using this approach,
files can be transferred to a central manufacturing facility, i.e. hospitals or treatment units do not need their own facilities. Added implications are the
design of jigs and fixtures, which will ensure accuracy in reuse.
Practical implications – Metal shields can be created with ease and great accuracy using RP machines. It takes less time without inflated costs.
Models are more accurately and easy to use, with less trauma experienced by the patient during the manufacturing phase.
Originality/value – Novel applications, combined with a new process. The research expands the fast-growing field of medical applications of RP
technologies. Its practical application will benefit patients on a daily basis.
Keywords Cancer, Lead, Lasers, Sintering, Metals, Spraying
Paper type Case study
1. Introduction
The Concise Encyclopaedia of Science and Technology (Yule,
1985) describes cancer as
A group of diseases in which some body cells change their nature, start to
divide uncontrollably and may revert to an undifferentiated type. They may
form a malignant tumour, which enlarges and may spread to adjacent tissues.
In many cases cancer cells enter the blood or lymph system and are carried
to distant parts of the body.
Although the mortality rate due to skin cancer is high,
treatment can be curative in some instances if carried out in
the early stages. Caccialanza et al. (2004) reviewed 115 cases
in 108 patients and report complete remission in 96.52 per
cent cases. Treatments include surgical excision, radiation
therapy, chemotherapy or combinations of these. The latter of
the two methods are used to destroy or slow down the growth
of cancerous cells. The difficulty, however, is to do so without
also damaging healthy tissue. Sanghera et al. (2001) discussed
the manufacturing of shields from plaster of paris moulds, and
described the process as crude and unpleasant for the patient.
Rapid prototyping (RP) offers numerous possibilities to
support the medical profession, some of which may impact
positively on the conventional approaches.
In radiotherapy, it is necessary to differentiate between
superficial and deep cancer treatment. Radiation of skin cancer
(commonly found amongst fair skinned people in countries
with a high intensity of sunshine) is a typical example of
superficial cancer treatment while deep treatment will involve
radiation treatment of internal organs, glands and so forth. This
paper focuses on the use of 3D photography, RP and a
customised metal spraying process to “manufacture” shields to
protect healthy tissue during the treatment of superficial cancer
infiltration.
2. Treatment procedure
The radiation treatment required for superficial infiltration
depends on the degree of cancer infiltration required. For very
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superficial infiltration, low energy X-rays ((100-250 kV) or
electrons (4-10MeV)), as produced by a kilovolt unit, will be
sufficient. Once the degree of infiltration has been determined
and the level of radiation energy selected for treatment, a
radiation field size needs to be decided upon. Each treatment
unit is equipped with a number of standard applicators that
determines the field sizes available from which therapists can
select a suitable applicator.
A typical problem is that applicators produce either a
rectangular, square or round field shapes, while the cancerous
growths normally are irregular in shape as shown in Figure 1.
There will thus always be an area of healthy tissue between
the edges of the growth and the field’s edges. Physicians create
blocking devices to shield the healthy tissue surrounding the
tumour from radiation. The shields are normally made from
alloys of which the density is close to that of lead, but easier to
mould, due to a lower melting temperature, and the need to
be individualised for each patient (Cancer Research, 2005;
Lowell, 2005; Willis-Knighton, 2004).
Furthermore, the part of the applicator making contact with
the patient’s skin is flat, as shown in Figure 2. Should the
exposed area be large and curved, there will be a considerable
amount of scattering past the field’s edges. This is especially
problematic with electron treatments since the electrons scatter
past the edges of the treatment field, resulting in a larger area
being irradiated than intended – exposing a larger part of the
patient’s body (normally healthy flesh) to radiation.
Plate 1 shows a film, placed on a curved phantom and which
was irradiated with electrons to simulate a patient’s treatment.
(Note: A phantom is a term that is used in radiography for an
object that will closely resemble the shape of a human body,
or part of the body, and which is normally manufactured from
a medium that also has the same density as human tissue, for
radiography purposes.)
The original treatment field size is shown by the rectangle,
thereby highlighting the degree of scatter past the field’s edges.
2.1 Traditional shielding methods
The traditional way to reduce the degree of scatter is to shield the
healthy tissue, surrounding the cancerous growth, by means of a
lead mask or a wax mould. A lead mask would typically be used
for skin cancer. Inorder to fabricate suchmasks, an impressionof
the cancer-affected area on the patient needs to be taken by
means of plaster bandages. When the plaster bandages have set,
they are removed from the patient and Yellow-Stonee plaster is
moulded into the negative impression they create. After the
plaster has set, the bandages are removed to release a positive
impression of the patient. Next, a lead sheet with a thickness
corresponding to the intensity of the radiation to be applied
during treatment is formed onto the impression with a special
hammer. Lastly, a hole is sawn into the mask, according to the
position of the cancerous growth on the patient, allowing
radiationonly topass through the selected areaduring treatment.
Plate 2 shows a lead mask on a plaster impression of the patient.
2.2 Disadvantages of the lead mask technique
The following are disadvantages of the lead mask technique:
. The Yellow-Stonee plaster has to be left at least overnight
to harden sufficiently to prevent it from breaking up while
forming the lead sheet on it. A technologist can thus at
earliest, only start fabricating the mask a day after the
plaster bandage impression was taken.
. The technique of forming the lead sheet on the model
requires a great deal of skill, effort and time – especially if
the lead sheet is thicker than 2mm.
. It is difficult to recycle the lead since it has to be melted
and rolled into a sheet to be used again. Radiotherapy
departments subsequently seldom do this, which makes
the lead mask technique expensive, and it contributes to
environmentally unfriendly waste.
Figure 1 Irregular shaped cancerous growth in rectangular treatment
field
Figure 2 Electron applicator in contact with patient’s skin
Plate 1 Film taken on curved phantom
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. The procedure of taking a plaster bandage impression of a
patient, especially in the facial area, is often traumatic and
uncomfortable for the already traumatised patient.
Various data sources consulted, mention the practice of
manufacturing a lead shield on an individual (customised)
basis, according to patient/physician needs. The process,
however, is not well described or published, except for
remarks that it is a crude and an unpleasant process for the
patient (Sanghera et al., 2001). This work also mentioned the
production of waste products, and a messy environment,
which necessitates dedicated/facilities for material storage and
disposal. Furthermore, face-movement during formation of
the positive with a conventional process using Yellow-Stonee
is a recognised problem.
3. Development of the new process
The ideal would therefore be to create a process chain, which
can replicate the patient’s affected area without physical
contact with the patient. Cutting the Yellow-Stonee plaster
out of the process would result in enormous time-savings. It
would also contribute to relieve the trauma experienced by
patients receiving treatment. Furthermore, the process of
forming the lead onto the mask should be replaced by a faster,
easier and more controllable method.
As a hypothetical solution, the following process chain was
envisaged:
1 Reverse engineering. Creation of 3D computer data (.STL)
of the patient’s affected area through 3D photography.
2 Rapid prototyping. A physical model of the 3D data in a
suitable RP material through laser sintering.
3 Metal spraying. Manufacturing of a lead mask fitting the
physical model through the use of metal spraying.
3.1 Reverse engineering
Through the use of a 3D camera (Minolta Vivid 910), the
geometry of treatment areas can be captured. The benefit of
this process is that no physical contact with the patient is
necessary, which means no plaster bandages that need to set,
no pipes in a patient’s nose, mouth, etc. and no contact with
possibly irritated skin. Output formats from the Minolta Vivid
910 supports various commercial software systems including
Alias Wavefront/Maya, 3D Studio Max, Raindrop Geomagic,
Softimage, Lightwave, RapidForm and is applicable to RP,
reverse engineering, CAD/CAM and 3D modelling
technologies. Figure 3 shows the steps that are involved in
the 3D capturing of facial-data.
3.2 Rapid prototyping
Laser sintering with nylon polyamide was selected as the
RP technology, as it offers various advantages over other RP
systems available in the research facility, namely:
. No support system is needed, as the powder supports
itself, thus reducing post-growing cleanup.
. Thin walled parts can be grown, which will save both time
and costs.
. Durability of prototypes which have to be used as a model
for the metal to be sprayed upon. Material flexibility will
also allow bending/flexing to release the sprayed metal.
3.3 CNC machining
Using the scanned data, either from.STL or IGES format,
CNC codes can be generated, to use three axis CNCmilling as
alternative to produce the facial geometry. As the cuttingmedia,
Superwoodewould be used. Various CAD/CAM packages are
commercially available to execute the operation, using.STL
files as input. Except for undercuts that may occur in the nose
and ear environments, the milling is an easy operation, and
should be a mere formality for any experienced CNC operator.
3.4 Metal spraying
To overcome some of the disadvantages of the lead mask and
wax mould techniques, the possibility of using a custom-
designed metal spray technique to fabricate shielding masks
was investigated.
The design criteria for the metal spray equipment were:
. The metal spraying process needs to be clean, since the
equipment will be used in a hospital set-up.
. The equipment should be user friendly and not expose the
operator or the immediate environment to hazardous
metal dust or gasses.
. The metal used in the process should be recoverable in
order to make the technique cost-effective.
. The equipment should be able to lay down low melt alloy
up to a thickness of 12mm on a field size of
400 £ 400mm2 in a reasonably short time-frame.
. It should be possible to fabricate themetal spray equipment
with locally available tools and machinery from affordable
components to make the project financially viable.
Plate 2 Lead mask
Figure 3 Process of 3D photograph assembly
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3.5 Low melting point alloys
The alloy considered for fabricating the masks was
commercially available under the trade names of Wood’s
alloye, MCP 70e or Fry’s metale. These alloys are
commonly used for shielding radiation sensitive areas during
high-energy radiation in radiotherapy. It is cast in 9 cm blocks
according to the shape of the area to be shielded, and is placed
in the radiation field during treatment. The alloys consist of
mixtures of bismuth, tin, lead and cadmium and have a
melting points within the region of 708C.
Because of its low melting point, it was considered to use it
in a liquid state. This would be a less complex procedure to
feed the alloy to the spray gun, as opposed to the solid or
powder form as is done with commercially available metal
spray equipment. The technique would offer a high metal
flow-rate, resulting in a rapid build-up of metal on the
substrate during spraying.
4. Results
4.1 3D scanning
Using a Minolta scanner, facial-data can be scanned, and
manipulated through a few easy steps. Plates 3 and 4 show the
scanning and image processing, whilst Plates 5 and 6 show the
STL data obtained through Magics RP.
4.2 Rapid prototyping
Laser sintering, applied through an EOS P380 machine was
selected as the method of prototyping. Nylon polyamide was
used due to its thin walled characteristics. Horizontal growing
of a face image in 2.5mm wall-thickness (119mm diameter
and a highest point of 50mm high, weighing 30 g, and with
total material volume of 32,006mm3) was achieved in 3.5 h.
Growing the model upright, would take 6.25 h.
4.3 Metal spraying
Through a newly patented metal spraying process (PCT/04/
00021), the metal is sprayed in an enclosed cabinet, operated
by a spray gun, accessed through rubber gloves. The spray
gun is similar to that used for spray paint purposes but was
modified by attaching a heating element to its frame.
Molten metal is fed from a double walled (insulated)
melting pot attached to the outside of the cabinet by means of
Plate 5 .STL data processing
Plate 6 .STL data processing
Plate 4 Image processing
Plate 3 Scanning process
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a heated feeding tube, to prevent the metal from cooling and
setting while passing through the tube. Compressed air is
supplied to the spray gun via a pressure regulator/water trap
to ensure a constant flow of clean air. A 4mm thick mask,
weighing 629 g, was achieved in 2.5 h.
Plate 7 shows the initial mask, manufactured on traditional
Yellow-Stonee plaster mould, whilst Plate 8 shows the RP
and sprayed metal mask.
Table I gives a comparison between the traditional
masking technique and the newly developed metal spray
masks. In order to do a complete comparison, time and cost
estimation is included for the conventional method and for
RP using SL.
5. Conclusions
Contrary to the conventional process, data capturing with 3D
photography proved to be an effective method, both in time
taken, as well as the fact that no physical contact with the
patient was necessary. RP, although fast and efficient,
unfortunately is far more expensive than the conventional
method. However, if patient trauma and production costs
(man hours), skills needed or specialised storage/material
wastes are taken into account, RP costs become less of a
factor. The high degree of accuracy and speed involved in the
3D photography/RP process eliminates previous problems
such as inaccuracy due to movement during casting or setting
of the plaster bandages, and offers better treatment/isolation
due to improved definition of face edges, such as the chin.
Due to the nature of the combined RP/3D photography
method, radiography units not having access to biomedical
engineering support may be serviced over any given distance.
The recycling of material also becomes a much more
environmentally-friendly process, which further impacts on
hospital facilities, and may impact on the evaluation of the RP
costs.
A further “mechanical” advantage of the new process is
having the face data in a 3D format, which allows
“construction” or modelling and addition of features in
CAD to include fixation accessories or other needs, prior
to RP model fabrication. Other medical benefits include
Plate 7 Initial mask manufactured on Yellow-Stonee plaster mould
Plate 8 RP and sprayed metal mask
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the possibility that the radiologist can mark exact areas on the
patient’s face or body to be treated, with “markers” which can
be transferred to CAD through the reverse engineering
process. Next, precise geometry can be modelled in CAD,
which may be turned into a positive “feature” that will
“prevent” metal to be sprayed on a well-defined geometry.
Through the use of specialised software such as MedCad
from materialise, modelling can be done in the.STL
environment.
Initial investigations into the use of CNC milling as an
alternative to produce the external geometry of the face mask,
has shown that it would take approximately 2 h to prepare the
CNC file, together with another 2 h to execute the milling,
making this the fastest prototyping route. Costs compare
favourably to RP costs (about 80 per cent of the costs involved
for the growing of one mask). These estimates have been
added to Table I. However, it should be borne in mind that
the price used is for the growing of one mask. Should two or
more masks be grown simultaneously, the RP cost is lowered
drastically, and might outperform any of the other processes.
Furthermore, the addition of devices such as fixtures, buckles,
etc. may not be as easy in CNC. It is, however, acknowledged
that further research into the combination of 3D/CNC and
customised CNC machines/processes may impact on the
manufacturing costs and delivery time.
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Table I Comparison between traditional masking techniques and metal spray masks
Manufacturing method Production time Cost Comments
Lead mask 48 h Lead: R185/kg
Approximately 2 kg of Yellow-Stonee
used at R10/kg
Human inputs/costs: Approximately R1500
To withstand the lead-forming process,
the plaster needs to be completely dry
RP
Metal spraying
3.5 h
2.5 h
Nylon: R2300
Approximately 1 kg of material melted,
to produce a 629 g mask
Human inputs/costs less that R300
Although initially expensive, costs are limited
because the alloys can be recycled. Also, if facility
management is such that more than one mask can
be grown simultaneously, costs will drastically
come down
CNC
Metal spraying
3 h Using Superwoode: R1850
Same as above
Probably the fastest method, but less easy to use
for undercuts
Using RP in parallel with metal spraying
Deon J. de Beer et al.
Rapid Prototyping Journal
Volume 11 · Number 5 · 2005 · 298–303
303
